
<html lang="en"     class="pb-page"  data-request-id="cb9ec442-5ea7-48a3-ab7c-7aabd166cb49"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00797;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2016.59.issue-18"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with Katanin" /></meta><meta name="dc.Creator" content="Ting-Chun  Kuo" /></meta><meta name="dc.Creator" content="Ling-Wei  Li" /></meta><meta name="dc.Creator" content="Szu-Hua  Pan" /></meta><meta name="dc.Creator" content="Jim-Min  Fang" /></meta><meta name="dc.Creator" content="Jyung-Hurng  Liu" /></meta><meta name="dc.Creator" content="Ting-Jen  Cheng" /></meta><meta name="dc.Creator" content="Chia-Jen  Wang" /></meta><meta name="dc.Creator" content="Pei-Fang  Hung" /></meta><meta name="dc.Creator" content="Hsuan-Yu  Chen" /></meta><meta name="dc.Creator" content="Tse-Ming  Hong" /></meta><meta name="dc.Creator" content="Yuan-Ling  Hsu" /></meta><meta name="dc.Creator" content="Chi-Huey  Wong" /></meta><meta name="dc.Creator" content="Pan-Chyr  Yang" /></meta><meta name="dc.Description" content="Microtubule targeting agents (MTAs) constitute a class of drugs for cancer treatment. Despite many MTAs have been proven to significantly improve the treatment outcomes of various malignancies, res..." /></meta><meta name="Description" content="Microtubule targeting agents (MTAs) constitute a class of drugs for cancer treatment. Despite many MTAs have been proven to significantly improve the treatment outcomes of various malignancies, res..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 30, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00797" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00797" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00797" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00797" /></link>
        
    
    

<title>Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with Katanin | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00797" /></meta><meta property="og:title" content="Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with Katanin" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0010.jpeg" /></meta><meta property="og:description" content="Microtubule targeting agents (MTAs) constitute a class of drugs for cancer treatment. Despite many MTAs have been proven to significantly improve the treatment outcomes of various malignancies, resistance has usually occurred. By selection from a two million entry chemical library based on the efficacy and safety, we identified purine-type compounds that were active against lung small cell lung cancer (NSCLC). The purine compound 5a (GRC0321) was an MTA with good effects against NSCLC. Lung cancer cells H1975 treated with 5a could induce microtubule fragmentation, leading to G2/M cell cycle arrest and intrinsic apoptosis. Compound 5a directly targeted katanin and regulated the severing activity of katanin, which cut the cellular microtubules into short pieces and activated c-Jun N-terminal kinases (JNK). The microtubule fragmenting effect of 5a is a unique mechanism in MTAs. It might overcome the resistance problems that most of the MTAs have faced." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00797"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00797">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00797&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00797&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00797&amp;href=/doi/10.1021/acs.jmedchem.6b00797" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8521-8534</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00930" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00989" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with Katanin</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ting-Chun++Kuo">Ting-Chun Kuo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ling-Wei++Li">Ling-Wei Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Szu-Hua++Pan">Szu-Hua Pan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim-Min++Fang">Jim-Min Fang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jyung-Hurng++Liu">Jyung-Hurng Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ting-Jen++Cheng">Ting-Jen Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chia-Jen++Wang">Chia-Jen Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>□</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pei-Fang++Hung">Pei-Fang Hung</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hsuan-Yu++Chen">Hsuan-Yu Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>△</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tse-Ming++Hong">Tse-Ming Hong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⬡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuan-Ling++Hsu">Yuan-Ling Hsu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chi-Huey++Wong">Chi-Huey Wong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pan-Chyr++Yang">Pan-Chyr Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>■</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>●</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Ph.D. Program in Translational Medicine, National Taiwan University and Academia Sinica, Taipei, Taiwan</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Chemistry, National Taiwan University, Taipei 106, Taiwan</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Graduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei 100, Taiwan</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Genome and Systems Biology Degree Program, National Taiwan University and Academia Sinica, Taipei 106, Taiwan</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 402, Taiwan</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">Agricultural Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">○</span> <span class="aff-text">Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan</span></div><div class="aff-info" id="aff9"><span class="aff-symbol">◆</span> <span class="aff-text">Genomics Research Center, Academia Sinica, Taipei 115, Taiwan</span></div><div class="aff-info" id="aff10"><span class="aff-symbol">¶</span> <span class="aff-text">Department of Internal Medicine, National Taiwan University College of Medicine, Taipei 100, Taiwan</span></div><div class="aff-info" id="aff11"><span class="aff-symbol">□</span> <span class="aff-text">Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial HospitalTaipei 105, Taiwan</span></div><div class="aff-info" id="aff12"><span class="aff-symbol">△</span> <span class="aff-text">Institute of Statistical Science, Academia Sinica, Taipei 115, Taiwan</span></div><div class="aff-info" id="aff13"><span class="aff-symbol">⬡</span> <span class="aff-text">Institute of Clinical Medicine, National Cheng Kung University College of Medicine, Tainan 701, Taiwan</span></div><div class="aff-info" id="aff14"><span class="aff-symbol">■</span> <span class="aff-text">Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan</span></div><div class="aff-info" id="aff15"><span class="aff-symbol">●</span> <span class="aff-text">NTU Center for Genomic Medicine, National Taiwan University, Taipei 100, Taiwan</span></div><div class="corresp-info"><strong>*</strong>(S.-H.P.) Phone: 8862-2312-3456, ext. 88661. Fax: 8862-3393-6523. E-mail: <a href="/cdn-cgi/l/email-protection#dba8b3abbab59bb5afaef5bebfaef5afac"><span class="__cf_email__" data-cfemail="3c4f544c5d527c524849">[email protected]</span>.edu.tw</a></div><div class="corresp-info"><strong>*</strong>(J.-M.F.) Phone: 8862-3366-1663. Fax: 8862-2363-7812. E-mail: <a href="/cdn-cgi/l/email-protection#bed4d3d8dfd0d9fed0cacb90dbdacb90cac9"><span class="__cf_email__" data-cfemail="abc1c6cdcac5ccebc5dfde85cecfde85dfdc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00797&amp;href=/doi/10.1021%2Facs.jmedchem.6b00797" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8521–8534</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 18, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 June 2016</li><li><span class="item_label"><b>Published</b> online</span>30 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 September 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00797" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00797</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8521%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTing-Chun%2BKuo%252C%2BLing-Wei%2BLi%252C%2BSzu-Hua%2BPan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D18%26contentID%3Dacs.jmedchem.6b00797%26title%3DPurine-Type%2BCompounds%2BInduce%2BMicrotubule%2BFragmentation%2Band%2BLung%2BCancer%2BCell%2BDeath%2Bthrough%2BInteraction%2Bwith%2BKatanin%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8534%26publicationDate%3DSeptember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00797"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1966</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00797" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with Katanin&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ting-Chun&quot;,&quot;last_name&quot;:&quot;Kuo&quot;},{&quot;first_name&quot;:&quot;Ling-Wei&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Szu-Hua&quot;,&quot;last_name&quot;:&quot;Pan&quot;},{&quot;first_name&quot;:&quot;Jim-Min&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Jyung-Hurng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Ting-Jen&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Chia-Jen&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Pei-Fang&quot;,&quot;last_name&quot;:&quot;Hung&quot;},{&quot;first_name&quot;:&quot;Hsuan-Yu&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Tse-Ming&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Yuan-Ling&quot;,&quot;last_name&quot;:&quot;Hsu&quot;},{&quot;first_name&quot;:&quot;Chi-Huey&quot;,&quot;last_name&quot;:&quot;Wong&quot;},{&quot;first_name&quot;:&quot;Pan-Chyr&quot;,&quot;last_name&quot;:&quot;Yang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;8521-8534&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00797&quot;},&quot;abstract&quot;:&quot;Microtubule targeting agents (MTAs) constitute a class of drugs for cancer treatment. Despite many MTAs have been proven to significantly improve the treatment outcomes of various malignancies, resistance has usually occurred. By selection from a two million entry chemical library based on the efficacy and safety, we identified purine-type compounds that were active against lung small cell lung cancer (NSCLC). The purine compound 5a (GRC0321) was an MTA with good effects against NSCLC. Lung cancer cells H1975 treated with 5a could induce microtubule fragmentation, leading to G2/M cell cycle arrest and intrinsic apoptosis. Compound 5a directly targeted katanin and regulated the severing activity of katanin, which cut the cellular microtubules into short pieces and activated c-Jun N-terminal kinases (JNK). The microtubule fragmenting effect of 5a is a unique mechanism in MTAs. It might overcome the resistance problems that most of the MTAs have faced.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00797&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00797" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00797&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00797" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00797&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00797" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00797&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00797&amp;href=/doi/10.1021/acs.jmedchem.6b00797" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00797" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00797" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00797%26sid%3Dliteratum%253Aachs%26pmid%3D27536893%26genre%3Darticle%26aulast%3DKuo%26date%3D2016%26atitle%3DPurine-Type%2BCompounds%2BInduce%2BMicrotubule%2BFragmentation%2Band%2BLung%2BCancer%2BCell%2BDeath%2Bthrough%2BInteraction%2Bwith%2BKatanin%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D18%26spage%3D8521%26epage%3D8534%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291305" title="Cell physiology">Cell physiology</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/jmcmar.2016.59.issue-18/20160922/jmcmar.2016.59.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Microtubule targeting agents (MTAs) constitute a class of drugs for cancer treatment. Despite many MTAs have been proven to significantly improve the treatment outcomes of various malignancies, resistance has usually occurred. By selection from a two million entry chemical library based on the efficacy and safety, we identified purine-type compounds that were active against lung small cell lung cancer (NSCLC). The purine compound <b>5a</b> (GRC0321) was an MTA with good effects against NSCLC. Lung cancer cells H1975 treated with <b>5a</b> could induce microtubule fragmentation, leading to G2/M cell cycle arrest and intrinsic apoptosis. Compound <b>5a</b> directly targeted katanin and regulated the severing activity of katanin, which cut the cellular microtubules into short pieces and activated c-Jun N-terminal kinases (JNK). The microtubule fragmenting effect of <b>5a</b> is a unique mechanism in MTAs. It might overcome the resistance problems that most of the MTAs have faced.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Lung cancer remains the leading cause of cancer-related mortality worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although treatment advances have been made over the past 20 years, the response rate and prognosis of lung cancer patients remain poor,<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> and drug resistance has become one of the main causes of treatment failure.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Therefore, the development of anticancer drugs with novel mechanisms for lung cancer treatment is urgently needed.</div><div class="NLM_p">Microtubules, long, hollow cylinders composed of polymerized α- and β-tubulin dimers, are an important component of the cytoskeleton. They play an irreplaceable role in a variety of cellular functions, including the maintenance of cell shape, polarity, vesicles, and mitosis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> During mitosis, microtubules form the mitotic spindle, which separates the daughter chromosomes to the opposite ends of the poles. Because of this characteristic, microtubules become a suitable target for anticancer agents to kill rapidly dividing cancer cells.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> Usually, the tubular polymers of tubulin can grow as long as 50 μm, and the processes of microtubule assembly and disassembly are highly dynamic and are controlled by GTP binding and hydrolysis events. Regulating this unstable characteristic of microtubules is crucial for cells to respond to different circumstances.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Until now, many microtubule-targeting agents (MTAs) have been found to target this property of the microtubules, and they can be further classified into two groups: stabilizing and destabilizing agents. The microtubule-stabilizing agents, including taxanes and epothilones, can stabilize the polymer formation of microtubules and increase the polymer mass of the microtubules in the cells. In contrast, microtubule-destabilizing agents, such as the vinca alkaloids, depolymerize microtubules and decrease the polymer mass. To date, taxanes and a series of vinca alkaloids are two major MTAs that are used in current chemotherapeutic regimes with excellent effects on different human malignancies.<a onclick="showRef(event, 'ref5 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref10">(5, 10)</a> However, after a prolonged treatment, the clinical activity of the MTAs will usually be reduced due to drug resistance.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> As a result, there is an ongoing effort to develop novel agents within each class, to improve their efficacy and to overcome drug resistance.</div><div class="NLM_p">In addition to developing novel MTAs, targeting microtubule-associated proteins (MAPs) is identified as an alternative mechanism to overcome the drug resistance problem of MTAs.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The MAPs are a class of proteins that associate with microtubules, usually at the ends of the filaments. They regulate the dynamic behaviors of the microtubules by enhancing the rate of microtubule growth or increasing the frequency of catastrophes of microtubules.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Among MAPs, stathmin and tau are two important target proteins for cancer therapy. Inhibiting the expression of stathmin by antistathmin ribozyme, either as monotherapy or in combination with chemotherapeutic agents, has been demonstrated to reduce cell proliferation and increase apoptosis in breast cancer cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The expression level of tau protein is associated with the sensitivity of paclitaxel in breast cancer cells; thus, decreasing tau expression would make breast cancer cells hypersensitive to paclitaxel.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In addition, a class of proteins known as microtubule severing proteins can also bind to microtubules and regulate their dynamics by cutting microtubules into short fragments.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> For example, katanin, one of the microtubule severing proteins, is a heterodimer hydrolase that is composed of two subunits called p60 and p80, according to their molecular weights. The p60 subunit is the catalytic subunit that contains the AAA (ATPase associated with diverse cellular activities) region, which functions in microtubule severing activity. The other subunit, p80, serves a regulatory function.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Although katanin has received little attention in the context of cancer in the past, some of the literature has recently revealed its potential roles in cancer formation and progression. Ye and colleagues found that the expression of katanin p60 was up-regulated in prostatic adenocarcinomas.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Sudo and Maru also found that LAPSER1, a tumor suppressor gene in prostate cancer, participated in cytokinesis by interacting with katanin p80, and the disruption of this interaction might cause genetic instability and cancer.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p last">Recently, our laboratory has been devoted to screening novel effective inhibitors to overcome drug resistance in nonsmall-cell lung cancer (NSCLC). In this study, GRC0321 (compound <b>5a</b>) was one of the compounds that was selected from a two million compound library through a two-step high-throughput screening of several lung cancer cell lines with different epidermal growth factor receptor (EGFR) status (including EGFR wild-type and EGFR mutants).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The purine-type compound <b>5a</b> was selected due to its excellent <i>in vitro</i> and <i>in vivo</i> activities against NSCLC. We demonstrated that <b>5a</b> could disrupt the microtubule into small fragments in NSCLC cells by interacting with microtubule severing proteins katanin p60 and p80. The damage further activated c-Jun N-terminal kinases (JNK)-related signaling pathways, which caused G2/M cell cycle arrest and triggered mitochondria-mediated intrinsic apoptosis. Our results demonstrated that microtubule severing proteins could serve as a target for anticancer therapy.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Identification of Purine-Type Compounds That Possess NSCLC Inhibitory Activities</h3><div class="NLM_p">Through high-throughput screening of efficient drugs for the treatment of NSCLC cells, we found a purine-type compound <b>5a</b>, which was active to several lung cancer cell lines with IC<sub>50</sub> values of 0.23–0.33 μM (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The cytotoxic effect of <b>5a</b> in NSCLC cells is less related to EGFR status in these cells.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities of <b>5a</b> against Different Lung Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">cell line<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H1975</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.03</td><td class="colsep0 rowsep0" align="left">CL1-0</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PC9</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.01</td><td class="colsep0 rowsep0" align="left">CL1-5</td><td class="colsep0 rowsep0" align="char" char="±">0.28 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PC9/gef</td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.01</td><td class="colsep0 rowsep0" align="left">A549</td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NBE</td><td class="colsep0 rowsep0" align="char" char="±">21.7 ± 1.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">CL1-0, CL1-5, and A549 are human lung adenocarcinoma cell lines with wide-type EGFR. PC9 is a human lung adenocarcinoma cell line with EGFR exon-19 deletion. H1975 and PC9/gef are two human lung adenocarcinoma cell lines with different resistant mechanisms to EGFR TKIs. H1975 harbors EGFR T790M mutation and PC9/gef acquires EGFR TKIs resistance by long-term and low-dose treatment of EGFR TKIs <i>in vitro.</i> NBE is a human normal bronchial epithelial cell.</p></div></div></div><div class="NLM_p">To further investigate the structure–activity relationship, we synthesized a series of derivatives with varied aryl moieties at the C2 and N9 positions. <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> shows the synthetic route to the purine compounds <b>5a</b>–<b>g</b> by consecutive coupling reactions of diaminomaleonitrile (<b>1</b>) with isocyanates <b>2a</b>–<b>c</b> and aldehydes <b>4a</b>–<b>e</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The phenyl isocyanates <b>2a</b>–<b>c</b> (1.05 equiv) that bear 2-methoxy, 3-CO<sub>2</sub>Me, or 4-CO<sub>2</sub>Me substituents were added to diaminomaleonitrile to afford the corresponding urea compounds <b>3a</b>–<b>c</b>, which then underwent condensation reactions with substituted benzaldehydes <b>4a</b>–<b>e</b> (1.05–2.0 equiv) to yield the desired 8-oxopurine products <b>5a</b>–<b>g</b>, which have an amido group at C6 and two aryl substituents at the N9 and C2 positions.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Purine-Type Compounds <b>5a</b>–<b>5g</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The growth inhibitory activity of <b>5a</b>–<b>5g</b> against H1975 was examined, and the IC<sub>50</sub> values were determined by MTT assays (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The effect of the R<sup>1</sup> substituent in the N9-aryl group was variable. Compound <b>5e</b>, which has a CO<sub>2</sub>Me substituent at the <i>meta</i>-position of the N9-aryl group, showed superior inhibitory activity (IC<sub>50</sub> = 0.19 μM) compared with the hit <b>5a</b> (IC<sub>50</sub> = 0.30 μM), whereas the analogue <b>5f</b> has a <i>para</i>-CO<sub>2</sub>Me substituent that exhibited lower activity (IC<sub>50</sub> = 4.73 μM). In contrast, the effect of the R<sup>2</sup> substituent in the C2-aryl group was dramatic. Alternation of R<sup>2</sup> from ethoxy in <b>5a</b> to hydroxyl (<b>5b</b>), butoxy (<b>5c</b>), hexoxy (<b>5d</b>), or phenyl (<b>5g</b>) caused a large decrease in the inhibition.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activities of Purine-Type Compounds against the Growth of H1975 Lung Cancer Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">0.30 ± 0.03</td><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">4.73 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">5.80 ± 0.13</td><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">>20.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">4.66 ± 0.05</td><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="left">7.91 ± 0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">>5.0</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">>10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">0.19 ± 0.02</td><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">26.3 ± 0.3</td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Compound <b>5a</b> Inhibits Lung Cancer Cell Growth <i>in Vitro</i> and <i>in Vivo</i></h3><div class="NLM_p">The purine-type compound <b>5a</b> was selected for further efficacy testing and to explore its action mechanism <i>in vitro</i> and <i>in vivo</i>. We first examined the cytotoxic activity of <b>5a</b> in different human NSCLC cells by MTT assay. As the results show in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, <b>5a</b> caused NSCLC cell death in a concentration-dependent manner, with the IC<sub>50</sub> values in the range of 0.26 to 0.33 μM. Compound <b>5a</b> was relatively nontoxic to the normal bronchial epithelial (NBE) cells, with an IC<sub>50</sub> value of 21.66 μM. To further investigate the long-term effect, the colony formation assay was conducted to observe whether <b>5a</b> would interfere with the ability of single cells to form a growing colony. The results indicated that a 14-day treatment of <b>5a</b> inhibited the colony formation of the H1975 cells with an IC<sub>50</sub> of 0.13 μM (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). These data suggested that <b>5a</b> can inhibit NSCLC cell growth <i>in vitro</i>.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>5a</b> inhibits tumor growth in vitro and in vivo. (A) Inhibitory activities of <b>5a</b> against different human nonsmall-cell lung cancer cell lines. The cells were treated with <b>5a</b> for 72 h, and cell proliferation was examined by MTT assay. Data are expressed as the mean of four determinations. (B) H1975 cells were treated with <b>5a</b> (300 nM) for 14 days. The colonies were fixed and stained with crystal violet and counted. Data are expressed as the mean ± SEM of three determinations. (C) H1975 cells were injected subcutaneously into the right flank region of nude mice. Three days after the injection, the mice were treated with vehicle (DMSO) or <b>5a</b> (2 mg/kg) twice a week intraperitoneally for 28 days. Representative tumor images and H&E-stained sections of tumors taken from mice treated for 28 days with either vehicle or <b>5a</b> are shown. The tumor size was measured with a caliper rule every time before compound delivery. Data are presented as the mean tumor volumes of mice in both the treatment and vehicle groups on the days of pretreatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To explore the <i>in vivo</i> antitumor efficacy of <b>5a</b>, athymic nude mice that bear established subcutaneous H1975 tumors were treated intraperitoneal with <b>5a</b> twice a week at 2 mg/kg versus a vehicle control (<i>n</i> = 8 for each group). <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C showed that <b>5a</b> at this dosage markedly reduced the H1975 tumor size to 930.4 ± 324.8 mm<sup>3</sup> (<i>P</i> < 0.01) compared with 1699.3 ± 413.3 mm<sup>3</sup> of the vehicle-treated group on day 28. The body weights of the test mice and the biochemical markers of the liver and kidney functions, including GOT, GPT, BUN, and Cre, were not significantly affected after a 28-day treatment, which indicated that <b>5a</b> was well tolerated at the dosage of 2 mg/kg (Figure S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> (SI)).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Compound <b>5a</b> Induces Cell Cycle Arrest and Apoptosis in H1975 Lung Cancer Cells</h3><div class="NLM_p">To confirm that the cytotoxic effect of <b>5a</b> was caused by an apoptotic cell death, the <b>5a</b>-treated H1975 lung cancer cells were costained with annexin V and propidium iodide (PI), and the positive staining population was analyzed by flow cytometry. The results indicated that positive annexin V- and PI-stained H1975 cells increased significantly after the treatment with <b>5a</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). This experiment suggested that the <b>5a</b>-treatment could cause apoptosis in H1975 cells. When further dissecting the potential apoptotic pathways that are activated by <b>5a</b>, the expression levels of several specific apoptotic markers were detected by immunoblotting. As expected, the cleaved form of two important regulatory proteins in the apoptotic pathway, caspase-3 and PARP-1, appeared after compound treatment. The appearance of cleaved caspase-9 implied that a mitochondria-mediated apoptotic pathway was being activated (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). Therefore, the protein level of the Bcl-2 family proteins and the location of cytochrome C were also detected. The protein level of Bak and Bax, two pro-apoptotic proteins in the Bcl-2 family, did not change significantly after the treatment with <b>5a</b>. However, in the blotting results, we could see a band that had a molecular weight that was higher than that of the total form of Bcl-2 protein, which was detected after the compound treatment (star mark in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). This band might be correlated to the phosphorylation form of the Bcl-2 protein, which increased after compound treatment. As is known, cytochrome C release from mitochondria to the cytosol is another marker that is frequently found after apoptotic induction. Here, we also attempted to clarify whether the compound treatment could cause cytochrome C release in the H1975 cells. The data showed that a 6 h treatment of <b>5a</b> induced an increase in the cytosolic level of cytochrome C (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D). All of these results indicated that <b>5a</b> could induce cell apoptosis in H1975 lung cancer cell lines.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>5a</b> causes cell cycle arrest and induces cell apoptosis in H1975 lung cancer cells. H1975 cells were treated with 300 nM <b>5a</b> for the indicated time periods. Then, the cells were harvested for (A) annexin V–PI double staining of apoptosis FACScan flow cytometer. Data are expressed as the mean ± SEM of three determinations. (B,C) The protein expressions were detected by immunoblotting. The data are representative of three independent experiments. (D) The cytosolic and mitochondrial fractions were obtained for the detection of the cytochrome C protein level by immunoblotting. (E) The cells were fixed and stained with PI to analyze the DNA content with a FACScan flow cytometer. The data are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In addition to the apoptotic inducing effect, we also explored whether the treatment of <b>5a</b> could have any effect on the H1975 cell cycle progression. We found that compound treatment also caused cell cycle arrest in H1975 lung cancer cells. The flow cytometric analysis of the cell cycle by PI staining showed that <b>5a</b> induced an increase in the cell population at the G2/M phase (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>E).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Compound <b>5a</b> Activates the JNK-Related Signaling Pathway and Induces Cell Apoptosis</h3><div class="NLM_p">To characterize the molecular changes that were induced by <b>5a</b>, the human phospho-kinase antibody array was used. H1975 cells were harvested after a 9 h treatment with 300 nM <b>5a</b>, and the assay was then applied to the cell lysate. Cells treated with DMSO alone were used as controls. The results showed that treatment with <b>5a</b> increased the signal intensity of phosphorylated JNK (JNK pT183/Y185 and pT221/Y223) and phosphorylated c-Jun (c-Jun pS63) when compared with the results in the control group (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). To further verify the results, cells treated with <b>5a</b> (300 nM) for 6 and 12 h were harvested, and the phosphorylation levels of these two proteins were detected by immunoblotting. The results showed that a dramatic up-regulation of phospho-JNK and phospho-c-Jun was observed after the compound treatment (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. JNK-related signaling pathway involved in <b>5a</b>-induced cancer cell apoptosis. (A) H1975 cells were incubated in the absence or presence of <b>5a</b> (300 nM) for 9 h. The cells were then harvested and lysed to detect the phosphorylation level of the proteins included in the human phosphor-kinase antibody array. The phosphorylation level of particulate proteins was quantified using the computerized image analysis system ImageJ. (B) H1975 cells treated with <b>5a</b> (300 nM) were harvested and lysed to detect the existence of phospho-JNK and phospho-c-Jun. The data are representative of three independent experiments. (C) H1975 cells were incubated in the indicated agent (<b>5a</b>, 300 nM; SP600125, 10 μM) for 48 h. Then, the cells were harvested and lysed to examine the expression levels of cleavage caspase-3, PARP-1, and phospho-c-Jun. The data are representative of three independent experiments. (D) H1975 cells were treated with the indicated agent (<b>5a</b>, 300 nM; SP600125, 10 μM) for 48 h. Then, the cells were harvested for the annexin V–PI double staining of the apoptosis FACScan flow cytometer. The data are expressed as the mean ± SEM of three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further determine the role of JNK-related signaling pathways in the mechanism of <b>5a</b>-induced cell apoptosis, a JNK inhibitor, 1,9-pyrazoloanthrone (SP600125), was adopted. As the results demonstrated, SP600125 could inhibit the activation of the JNK-related signaling pathways and reverse the apoptotic effects induced by <b>5a</b>. The cleaved form of caspase-3 and PARP-1 decreased after combining SP600125 with the compound (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C). Additionally, SP600125 also reduced the percentage of cells that had positive annexin V and PI staining after treatment with <b>5a</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D). Overall, these data suggested that JNK kinase and its related signaling pathways played important roles in the apoptotic cascade of <b>5a</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>5a</b> Induces Fragmentation of Microtubules and Interrupts Its Organization in H1975 Cells</h3><div class="NLM_p">The results showed that <b>5a</b>-treatment would cause cell cycle arrest at the G2/M phase and apoptosis in H1975 lung cancer cells, which led us to hypothesize that <b>5a</b>-treatment could also interfere with microtubule rearrangement due to its critical role in G2/M regulation. To test this idea, the organization of intracellular microtubules was first detected by immunofluorescence in H1975 cells. The in situ labeling of α-tubulin by antibodies demonstrated that <b>5a</b> would induce microtubule fragmentation (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). An <i>in vitro</i> microtubule assembly assay was also performed to separate the assembled and disassembled microtubules into particulate and soluble fractions by centrifugation. The data showed that a 1 h exposure of <b>5a</b> significantly reduced the amount of α-tubulin in the particulate fraction (the relative expression percentage of the soluble form vs polymer form was 68% vs 32% at 300 nM treatment and 75% vs 25% at 600 nM; <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). The results from the <i>in vitro</i> microtubule assembly assay confirmed the microtubule-damaging effects of <b>5a</b> that were observed by the immunofluorescence staining. To further clarify the change in the microtubule structure after treatment with <b>5a</b>, a gel filtration chromatography method was applied to roughly determine the length of the microtubule in the H1975 cancer cells. The results showed that α-tubulin protein was detected in the latter fraction in the <b>5a</b>-treatment group compared to the DMSO control group. Moreover, there were fewer fractions that contained α-tubulin protein in the treatment group compared to the control group (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). These results indicated that <b>5a</b> reduced the length of the microtubule in H1975 lung cancer cells.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Treatment of <b>5a</b> interrupts microtubule organization in H1975 lung cancer cells. (A) H1975 cells were incubated with vehicle or <b>5a</b> (300 nM) for the indicated times. Then, the cells were fixed and stained with anti-α-tubulin primary antibody. FITC-labeled secondary antibodies were used (green fluorescence), and the protein was detected by a confocal laser microscopic system. The nuclei were detected by DAPI staining (blue fluorescence). (B) H1975 cells were incubated with vehicle, <b>5a</b>, paclitaxel, or nocodazole for 1 h. Then, the cells were harvested and separated into soluble (S, tubulin monomer) and particulate form (P, tubulin polymers), and the level of α-tubulin protein in each fraction was detected by immunoblotting. The protein level of α-tubulin was quantified using the computerized image analysis system ImageJ. (C) H1975 cells were incubated in the absence or presence of <b>5a</b> (300 nM) for 12 h. Then, the cells were harvested and lysed for gel filtration chromatography. The drop-by-drop flowthrough was collected in ∼0.5 mL fractions. The protein level of α-tubulin in each fraction was detected by immunoblotting. (D) Purified tubulins were incubated at 37 °C with GTP in the vehicle (control) or in the presence of <b>5a</b> (10 μM or 300 nM), paclitaxel (10 μM), vincristine (10 μM), or nocodazole (10 μM). Tubulin polymerization was examined turbidimetrically. Data are expressed as the mean of three determinations. (E) Purified tubulins were incubated with GTP and paclitaxel at 37 °C for 30 min and then were held at room temperature for at least 1 h to obtain microtubule stock. The microtubule stock was further incubated at 37 °C with GTP in the vehicle (control) or in the presence of <b>5a</b> (10 μM, 3 μM, or 300 nM), paclitaxel (30 μM), or vincristine (30 μM). Tubulin depolymerization was examined turbidimetrically. The data are expressed as the mean of three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">All of the above data indicated that <b>5a</b> interfered with the microtubule structure of H1975 lung cancer cells. Next, the turbidity assay for tubulin polymerization and depolymerization was adopted to examine whether <b>5a</b> displayed a direct regulatory function in microtubule assembly. As demonstrated in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D,E, in the presence of GTP at 37 °C, the tubulins were triggered to polymerize in a time-dependent manner. Nocodazole, vincristine, and paclitaxel were used as reference agents to compare with <b>5a</b>. Surprisingly, according to the results, we found that <b>5a</b> did not influence the dynamics of microtubule polymerization and depolymerization (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D,E).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Using a Biotin-Annexed Probe to Identify Katanin as a Direct Target Protein</h3><div class="NLM_p">To identify the target proteins of <b>5a</b>, its analogues carrying azido or diazirinyl group in the C2-aryl moiety were first designed as photoaffinity probes. Two analogues were synthesized by the coupling reactions of <b>3a</b> with 4-azidobenzaldehyde or 3-(4-(formylphenyl)-3-(trifluoromethyl)-3<i>H</i>-diazirine. However, the utilization of these two compounds as photoaffinity probes was hampered due to their instability, poor solubility, and low inhibitory activity. Alternatively, we consider transforming the active compound <b>5e</b> (IC<sub>50</sub> = 0.19 μM) into the desired probe using biotin as the reporter unit. As shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, ester <b>5e</b> was subjected to saponification to give acid <b>6e</b>, which underwent the amide-forming reaction with amine <b>7</b> in the presence of <i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU, 1.0–1.2 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIEA, 1.0–1.2 equiv), to afford the corresponding amide product <b>8</b>. The Boc protecting group in <b>8</b> was readily removed by treatment with trifluoroacetic acid (TFA) at room temperature, and the exposed amino group was successfully linked to <span class="smallcaps smallerCapital">d</span>-(+)-biotin (1.0 equiv) via the amide bond-forming reactions, producing <b>9</b>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Amides <b>8</b> and the Biotin-Annexed Probes <b>9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The biotin-annexed <b>9</b> was used as a probe to catch the target proteins. After incubating with H1975 cell lysate, the proteins that were bound to <b>9</b> were pulled down by streptavidin-conjugated beads. Katanin p60 and p80 were visualized by immunoblotting (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). As a control, the biotin linker that lacked the purine moiety could not trap katanin p60 or p80.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>5a</b> direct interacts with katanin protein as a p60–<b>5a</b> complex. (A) H1975 cell lysate was incubated with probe <b>9</b> or a linker without the purine component (as control) for 24 h. Then, the streptavidin-conjugated beads were added into the lysate and incubated for 2 h. The lysate was washed with IP lysis buffer six times. The binding proteins were visualized by immunoblotting. The data are representative of three independent experiments. H1975 cells were transfected with scrambled control siRNA or katanin p60 siRNA. (B–E) Pharmacophore model and predicted binding modes between katanin p60 hexamer and <b>5a</b>. (B) Best pharmacophore model Hypo-1 represented with distance constraints. (C) Hypo-1 mapping with <b>5a</b>. Pharmacophore features are color-coded as follows: green, hydrogen bond acceptor (HBA); magenta, hydrogen bond donor (HBD); cyan, hydrophobic (HY); orange, ring aromatic (RA). (D,E) Two binding modes with equal predicted binding affinities (Δ<i>G</i> = −10.7 kcal/mol). The green background highlights the amino acids from subunit A of the p60 hexamer, and the pink background highlights those that belong to subunit F.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Molecular Computation of Pharmacophore Models and p60–<b>5a</b> Complex Models</h3><div class="NLM_p">To correlate the chemical structures of the purine-type compounds to their NSCLC inhibition activities in a quantitative manner, we selected the compounds with certain IC<sub>50</sub> values (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) to generate the 3D-QSAR pharmacophore models. The results for the top ten pharmacophore hypotheses and their statistical parameters are shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. In this study, the first pharmacophore hypothesis (Hypo-1) is the best because this model has the lowest total cost value (45.488), the largest cost difference (54.763), the lowest root-mean-square deviation (RMSD) value (0.699), and the highest correlation coefficient (0.984). Hypo-1 includes one hydrogen-bond acceptor (HBA), one hydrogen-bond donor (HBD), one hydrophobic feature (HY), and one ring aromatic feature (RA). The 3D spatial arrangement and distance constraints of these features are represented in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B. The features of Hypo-1 mapped onto <b>5a</b> are shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C. HBA is mapped onto the 8-oxo group, HBD is mapped onto the amino moiety of the 6-carboxamide group, RA is mapped onto the C2-aryl group, and HY is mapped onto the tip of the ethoxy substituent in the C2-aryl group.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Statistical Significance, Predictive Power, and Features of the Top Ten Hypotheses Derived from 3D-QSAR Pharmacophore Generation<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">features<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">hypothesis</th><th class="colsep0 rowsep0" align="center" char=".">correlation<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">RMSD<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">total cost</th><th class="colsep0 rowsep0" align="center" char=".">Δcost<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">HBA</th><th class="colsep0 rowsep0" align="center" char=".">HBD</th><th class="colsep0 rowsep0" align="center" char=".">HY</th><th class="colsep0 rowsep0" align="center" char=".">RA</th><th class="colsep0 rowsep0" align="center" char=".">max. fit</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-1</td><td class="colsep0 rowsep0" align="char" char=".">0.984</td><td class="colsep0 rowsep0" align="char" char=".">0.699</td><td class="colsep0 rowsep0" align="char" char=".">45.488</td><td class="colsep0 rowsep0" align="char" char=".">54.763</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">8.465</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-2</td><td class="colsep0 rowsep0" align="char" char=".">0.970</td><td class="colsep0 rowsep0" align="char" char=".">0.958</td><td class="colsep0 rowsep0" align="char" char=".">47.619</td><td class="colsep0 rowsep0" align="char" char=".">52.632</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">7.572</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-3</td><td class="colsep0 rowsep0" align="char" char=".">0.958</td><td class="colsep0 rowsep0" align="char" char=".">1.121</td><td class="colsep0 rowsep0" align="char" char=".">49.706</td><td class="colsep0 rowsep0" align="char" char=".">50.545</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">6.849</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-4</td><td class="colsep0 rowsep0" align="char" char=".">0.944</td><td class="colsep0 rowsep0" align="char" char=".">1.290</td><td class="colsep0 rowsep0" align="char" char=".">52.029</td><td class="colsep0 rowsep0" align="char" char=".">48.222</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">6.534</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-5</td><td class="colsep0 rowsep0" align="char" char=".">0.930</td><td class="colsep0 rowsep0" align="char" char=".">1.437</td><td class="colsep0 rowsep0" align="char" char=".">54.039</td><td class="colsep0 rowsep0" align="char" char=".">46.212</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">6.530</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-6</td><td class="colsep0 rowsep0" align="char" char=".">0.916</td><td class="colsep0 rowsep0" align="char" char=".">1.567</td><td class="colsep0 rowsep0" align="char" char=".">55.426</td><td class="colsep0 rowsep0" align="char" char=".">44.825</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">7.272</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-7</td><td class="colsep0 rowsep0" align="char" char=".">0.906</td><td class="colsep0 rowsep0" align="char" char=".">1.657</td><td class="colsep0 rowsep0" align="char" char=".">57.579</td><td class="colsep0 rowsep0" align="char" char=".">42.672</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">6.402</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-8</td><td class="colsep0 rowsep0" align="char" char=".">0.890</td><td class="colsep0 rowsep0" align="char" char=".">1.784</td><td class="colsep0 rowsep0" align="char" char=".">59.697</td><td class="colsep0 rowsep0" align="char" char=".">40.554</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">6.461</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-9</td><td class="colsep0 rowsep0" align="char" char=".">0.822</td><td class="colsep0 rowsep0" align="char" char=".">2.232</td><td class="colsep0 rowsep0" align="char" char=".">68.011</td><td class="colsep0 rowsep0" align="char" char=".">32.240</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">8.615</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hypo-10</td><td class="colsep0 rowsep0" align="char" char=".">0.822</td><td class="colsep0 rowsep0" align="char" char=".">2.228</td><td class="colsep0 rowsep0" align="char" char=".">68.346</td><td class="colsep0 rowsep0" align="char" char=".">31.905</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">8.402</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The null cost, fixed cost, and configuration cost are 100.251, 42.969, and 18.175, respectively.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Correlation coefficient is calculated based on linear regression derived from the geometric fit index.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Root mean square difference of log(estimated activity) from log(measured activity) normalized to log(uncertainty).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Δcost = null cost – total cost of the hypothesis.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">HBA, hydrogen-bond acceptor; HBD, hydrogen-bond donor; HY, hydrophobic; RA, aromatic ring.</p></div></div></div><div class="NLM_p">To demonstrate the predictive power of Hypo-1, regression analysis was used to estimate the activity of each training-set compound. As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, all of the training-set compounds showed an error value of less than 2. An error value below 10 indicated that only 1 order of magnitude of difference was observed in the discrepancy between the estimated and actual activity. The most active <b>5e</b> (IC<sub>50</sub> = 0.19 μM) showed a fitness score value of 7.46 when mapped to Hypo-1, whereas the least active <b>6e</b> (IC<sub>50</sub> = 7.91 μM) showed a fitness value of 6.04. This result indicates that Hypo-1 is a reliable model that consists of reasonable chemical features of the training-set compounds and accurately estimates the experimental activity of the training-set compounds. The calculated IC<sub>50</sub> values through this 3D-QSAR pharmacophore model supports that <b>5a</b> and its analogue <b>5e</b> have the most potent inhibitory activity. Therefore, small molecules that completely satisfy the chemical feature arrangement of Hypo-1 could be good candidates for NSCLC inhibition. However, the high structural homology among the compounds used in this study combined with their small activity range made this 3D-QSAR pharmacophore model slightly imperfect. For example, the smaller difference (54.763) between the total and null cost values suggests that Hypo-1 might not have more than 90% statistical significance as a model. This difference value should be greater than or equal to 60, according to the Discovery Studio (DS) manual.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Actual and Estimated IC<sub>50</sub> Values of 10 Purine-Type Compounds Calculated Based on the Pharmacophore Hypo-1</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center" char=".">fit<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">mapping<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> HBA HBD HY RA</th><th class="colsep0 rowsep0" align="center" char=".">act.<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">est.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">error<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="char" char=".">7.46</td><td class="colsep0 rowsep0" align="left">[13 11 28 15]</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">+1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="char" char=".">7.37</td><td class="colsep0 rowsep0" align="left">[13 11 28 15]</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">–1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="char" char=".">6.29</td><td class="colsep0 rowsep0" align="left">[13 11 30 15]</td><td class="colsep0 rowsep0" align="char" char=".">4.66</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">–1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="char" char=".">5.93</td><td class="colsep0 rowsep0" align="left">[30 * 28 15]</td><td class="colsep0 rowsep0" align="char" char=".">4.73</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">+1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="char" char=".">5.92</td><td class="colsep0 rowsep0" align="left">[13 11 * 15]</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char=".">+1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="char" char=".">6.04</td><td class="colsep0 rowsep0" align="left">[13 11 * 15]</td><td class="colsep0 rowsep0" align="char" char=".">7.91</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">–1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Fit value is calculated by fitting the chemical features between the hypothesis and the compound; the higher the value is, the better the fit.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Matching degree of the pharmacophore element with the specific conformation of the compound.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Actual IC<sub>50</sub> value.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Estimated IC<sub>50</sub> value.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Error factor is calculated as the ratio of the actual IC<sub>50</sub> to the estimated IC<sub>50</sub>. A positive value indicates that the estimated IC<sub>50</sub> is higher than the actual IC<sub>50</sub>; a negative value indicates that the estimated IC<sub>50</sub> is lower than the actual IC<sub>50</sub>.</p></div></div></div><div class="NLM_p last">Although we found that katanin p60 and p80 can be pulled down by <b>9</b>, an analogue of <b>5a</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A), we do not know whether <b>5a</b> binds to p60 or p80 or the interface between p60 and p80. Because <b>5a</b> shares a similar purine scaffold with ATP, we hypothesized that <b>5a</b> could bind to the catalytic AAA domain of p60. To assess this possibility, we modeled the homohexameric p60 structure using the crystal structure of transitional endoplasmic reticulum ATPase p97 from mouse (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CF1">3CF1</a>)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> as the template. The sequence alignment indicated that human p60 shares 30% sequence identity with mouse p97, but the protein structure prediction server<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Phyre2 suggested that the confidence score for this model is 100%. The docking software AutoDock Vina<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> successfully docked <b>5a</b> into the ATP-binding pocket of p60, and the theoretically calculated binding affinity is quite high (Δ<i>G</i> = −10.7 kcal/mol). Two plausible binding modes of <b>5a</b> in p60 hexamer are shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>D,E. The predicted binding modes suggested that the backbone nitrogen of Thr256 could bind to the HBA feature of Hypo-1. The interaction to the HBD feature could require the backbone oxygen of Ala358 and the side chain of Asp308 or Asn360. We also noticed that residues from two subunits of a p60 hexamer contribute to the hydrophobic contacts with <b>5a</b>. More specifically, the proposed arginine finger of p60, Arg372, is also involved in the binding to <b>5a</b>. Early study demonstrated that ATP induces p60 oligomerization and that the ATP-bound p60 hexamer has a high microtubule severing activity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Based on the docking model presented in this study, we hypothesize that <b>5a</b> could stabilize the p60 hexamer structure and enhance the severing activity of katanin. However, this hypothesis requires further experimental investigation.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compound <b>5a</b> Induces Cell Apoptosis through Interacting with the Katanin Protein Complex</h3><div class="NLM_p">Taking together the results of the probe study and molecular modeling, one can deduce that katanin could be the direct target of <b>5a</b>. The microtubule fragmentation phenomenon induced by <b>5a</b> was similar to the phenotype observed in the cells that overexpress the katanin protein.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To further establish the role of katanin p60 in the anticancer mechanism of <b>5a</b>, a katanin p60 knock-down H1975 lung cancer cell line was created by siRNA transfection technology. When treating the katanin p60 silencing cells with <b>5a</b>, it would not reduce the amount of α-tubulin in the particulate fraction. The relative expression percentage of the soluble form vs polymer form was 68% vs 32% in the siControl group and 34% vs 66% in the siKatanin group (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Moreover, the microtubule structure was also maintained in a relatively undamaged status after compound treatment in the siKatanin group compared to the siControl group (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). These data all indicated that katanin proteins participated in the mechanism of <b>5a</b>-induced microtubule damage in H1975 lung cancer cells.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>5a</b> induces cell apoptosis through interacting with the katanin protein complex. (A) The cells were treated with <b>5a</b> for 1 h. Then, the cells were harvested and separated into soluble (S, tubulin monomer) and particulate (P, tubulin polymers) forms, and the level of α-tubulin protein in each fraction was detected by immunoblotting. The protein level of α-tubulin was quantified using the computerized image analysis system ImageJ. (B) H1975 cells were incubated with vehicle or <b>5a</b> for 12 h. Then, the cells were fixed and stained with primary antibody to α-tubulin. FITC-labeled secondary antibodies were used (green fluorescence), and the protein was detected by a confocal laser microscopic system. The nuclei were detected by DAPI staining (blue fluorescence). (C,D) H1975 cells were incubated with vehicle or <b>5a</b> for 24 h. Then, the cells were harvested for the identification of indicated proteins by immunoblotting. (E) The cell proliferation activity was examined by MTT assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In addition to the effect of microtubule damage, the apoptotic effects of <b>5a</b> could also be reversed by the knock-down katanin p60 protein. First, the phosphorylation levels of JNK and c-Jun were examined by immunoblotting. According to our expectation, the expressions of phospho-JNK and phospho-c-Jun were increased by treatment with <b>5a</b> and would reduce significantly in katanin p60 knock-down cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). Then, the amount of cleaved forms of caspase-3 and PARP-1 induced by treatment with <b>5a</b> was also explored in katanin silencing cells. Similar to the findings of phospho-JNK and phospho-c-Jun, increasing amounts of cleaved caspase-3 and PARP-1 after treatment with <b>5a</b> were decreased in the knock-down cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D). Finally, the overall cytotoxic effect of <b>5a</b> was measured by MTT assay in both the siControl and siKatanin cell groups. The IC<sub>50</sub> value of this compound increased from 0.25 to 0.95 μM (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>E). Taken together, these data indicated that katanin p60 protein is an important protein for regulating <b>5a</b>-mediated microtubule damage and apoptosis in H1975 lung cancer cells.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Microtubules play a crucial role in several cellular processes, especially in the formation of the mitotic spindle during cell mitosis. The disruption of the microtubule dynamics will lead to cell cycle arrest in the G2/M phase; therefore, interference with the microtubule structure has become an important mechanism in anticancer therapy. Recently, many MTAs have been developed, and some of them have been approved to enter into clinical trials.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In the present study, we demonstrated that the purine-type compound <b>5a</b> was a novel MTA that caused microtubule fragmentation by directly targeting the microtubule severing protein, katanin, to induce apoptosis of the cancer cells. Compound <b>5a</b> had good <i>in vitro</i> and <i>in vivo</i> activities against NSCLC, including the gefitinib-resistant types. Compound <b>5a</b> also shows a relatively wide therapeutic window between proliferating and quiescent cells (over 10-fold), which indicates that the cell-growth inhibiting effects resulted from inhibiting proliferation-dependent processes rather than indiscriminant cytotoxicity.</div><div class="NLM_p">By interfering with the microtubule structure, most of the MTAs will cause cancer cell mitotic catastrophe and induce a G2/M cell cycle arrest. The cell cycle arrest allows cells to repair the damage caused by MTAs. However, if the damage cannot be fixed, then the prolonged cell cycle arrest will, in the end, become a stress and trigger a mitochondria-mediated intrinsic apoptosis.<a onclick="showRef(event, 'ref10 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref10 ref29 ref30">(10, 29, 30)</a> Here, we found that <b>5a</b>, similar to other MTAs, can induce a sustained G2/M cell cycle arrest and activate intrinsic apoptosis. The release of cytochrome C from mitochondria to the cytosol is a marker for mitochondria-mediated apoptosis, which is controlled by the balance between two subfamilies of Bcl-2 family proteins, the antiapoptotic and pro-apoptotic subfamilies.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Among them, the Bcl-2 protein, as an antiapoptotic protein, plays an important role in preventing cell apoptosis by binding and neutralizing the activity of pro-apoptotic subfamily members, such as BAX and BAK. This protecting function of Bcl-2 protein depends not only on their amount in the cytosol but also on their post-transcriptional modification status. Several studies have reported that Cdk1, c-Raf, PKA, JNK1, and p38MAPK kinase can cause the phosphorylation of the Bcl-2 protein; this phosphorylation will then cause a conformational change in the Bcl-2 protein to inactivate the antiapoptotic function.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> In our study, after 6 h of <b>5a</b>-treatment, a band with higher molecular weight than unmodified Bcl-2 protein was detected. This band might represent the level of phosphorylated Bcl-2, which implies an inhibitory effect of its function. Because <b>5a</b>-treatment would induce a G2/M cell cycle arrest and activation of JNK kinase, we suspected that the phosphorylation of Bcl-2 protein might be caused by the G2/M phase-specific Cdk1 kinase or the JNK kinase.</div><div class="NLM_p">JNK kinase can phosphorylate different substrates, which include c-Jun, ATF2, ELK1, SMAD4, p53, and HSF1, and it can be involved in different cellular processes, such as apoptosis, neurodegeneration, cell differentiation, and proliferation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In the apoptotic pathways, JNK kinase plays opposing roles depending on the upstream stimuli and downstream effectors in the different cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> For example, Ma and his colleagues found that the JNK/c-Jun pathway stimulates cell proliferation and protects cells from apoptosis in a pulmonary artery endothelial cell model.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> However, in other cell types, such as human lung cancer cells or breast cancer cells, the activation of the JNK/c-Jun pathway will induce caspase-mediated apoptosis.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Our studies showed that the JNK/c-Jun pathway could induce cell apoptosis in H1975 human lung cancer cells. The apoptotic effect of <b>5a</b> could be alleviated significantly by combining the JNK inhibitor, SP600125. In fact, several studies also reported that different MTAs could activate the JNK/c-Jun pathway to induce an intrinsic apoptosis.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a></div><div class="NLM_p">Although the effects of <b>5a</b> to induce G2/M cell cycle arrest and cell death are similar to those caused by other MTAs, such as taxanes and vinca alkaloids, the target protein and detailed mechanisms of action are different between them. Most of the MTAs directly bind to the tubulin and disrupt the dynamics of microtubule polymerization or depolymerization. The structure of the microtubule will be sustained as a filament when treating the cell with microtubule-stabilizing agents and will disrupt into vague dots when treating with microtubule-destabilizing agents.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> However, after <b>5a</b>-treatment, the microtubules of the cells were cut into fragments instead of dots under microscopic observation. When we further analyzed the dynamics of the microtubules, we found that the rates of microtubule polymerization and depolymerization did not change. To our knowledge, this fragmentation phenotype of microtubule is seldom induced by other MTAs and could imply that a unique microtubule targeting mechanism is used by the purine-type compound <b>5a</b>.</div><div class="NLM_p">Proteins associated with microtubules are responsible for the regulation of microtubule structure.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Microtubule severing proteins are one class of proteins that interact with microtubules and regulate microtubule structure by a severing process. Through the severing process, the microtubule will be cut into short fragments and transported to different regions. This arrangement provides an efficient way of promoting microtubule disassembly and movement.<a onclick="showRef(event, 'ref16 ref43'); return false;" href="javascript:void(0);" class="ref ref16 ref43">(16, 43)</a> Katanin, one of the microtubule severing proteins, has been proven to be an important microtubule structure modulator in many cellular processes.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The overexpression of katanin will cause microtubule fragmentation.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> Because the microtubule structure will undergo intense reorganization in the G2/M phase to help cell division, katanin is also involved in cell dividing processes.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> McNally and his colleagues proved that katanin p60 will concentrate at the ends of the microtubule and control their lengths in mitotic cells.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Maddika and his colleagues also demonstrated that the overexpression of katanin p60 in HeLa cells causes a G2/M cell cycle arrest and an accumulation of polyploid cells.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Our study showed a similar effect of katanin in regulating the microtubule dynamics. Compound <b>5a</b> could target both the p60 and p80 subunits of katanin and affect its severing enzyme activity, causing microtubule fragmentation and then cell cycle arrest in the G2/M phase.</div><div class="NLM_p last">The regulation of katanin activity is a complex process that involves chemical modifications, differential degradation, and the interactions between katanin and other regulating proteins.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> One of the major regulating mechanisms works through the cycle of phosphorylation and dephosphorylation of the NDEL1 protein. Cdk proteins, such as Cdk1, can phosphorylate NDEL1 and facilitate NDEL1 association with the p60 subunit of katanin.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> The NDEL1-associated katanin p60 will tend to concentrate at the centrosome and help break the microtubule into short fragments during cell division.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In the present work, because <b>5a</b> could cause a G2/M cell cycle arrest, Cdk1, a G2/M-specific kinase, would remain in an activating stage. Therefore, we suspected that the up-regulation of katanin activity after compound treatment could be due to an increase in the phosphorylated NDEL1 by Cdk1 kinase.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Currently, taxanes and vinca alkaloids are two of the MTAs that are widely used in clinical treatment. However, the drug resistance poses a major problem after long-term treatment.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Most of the mechanisms of resistance to these MTAs are associated with alterations in the microtubule protein itself, including changes in the tubulin isotype expression, post-translational modifications of tubulin, and the acquisition of tubulin mutations.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> The purine-type compound (e.g., <b>5a</b>), by targeting the microtubule-severing protein katanin, affected the architecture of the microtubules and caused cancer cell apoptosis. These mechanisms might bypass the major resistant mechanisms that were encountered during most of the MTA treatments. Therefore, <b>5a</b> and its analogues could become a novel therapeutic choice for the patients who have MTA-resistant NSCLC.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General</h3><div class="NLM_p">All of the reagents and solvents were reagent grade and were used without further purification unless otherwise specified. All of the solvents were anhydrous grade unless indicated otherwise. CH<sub>2</sub>Cl<sub>2</sub> was distilled from CaH<sub>2</sub>. All of the nonaqueous reactions were performed in dried glassware and with continuous stirring under an argon or nitrogen atmosphere. The reactions were monitored by thin-layer chromatography on 0.25 mm E. Merck silica gel 60 F<sub>254</sub> glass plates using KMnO<sub>4</sub>, <i>p</i>-anisaldehyde, ninhydrin, and iodine vapor as visualizing agents. E. Merck silica gel 60 (0.040–0.063 mm particle sizes) and LiChroprep RP-18 (0.040–0.063 mm particle sizes) were used for the column chromatography.</div><div class="NLM_p">Roswell Park Memorial Institute (RPMI) 1640 medium, Dulbecco’s Modified Eagle Medium (DMEM) medium, and fetal bovine serum (FBS) were obtained from GIBCO/BRL Life Technologies (Grand Island, NY). Antibodies total c-jun, katanin p60, katanin p80, antimouse, and antirabbit IgGs were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibodies to poly(ADPribose) polymerase-1 (PARP-1), phosphor-c-jun S63, and caspase-3 were purchased from Cell Signaling Technologies (Boston, MA). Antibodies to β-actin and α-tubulin were obtained from Sigma–Aldrich (St. Louis, MO). Antibodies to phospho-JNK T183/Y185 and total JNK were obtained from Life Technologies. 1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), propidium iodide (PI), phenylmethylsulfonyl fluoride (PMSF), leupeptin, dithiothreitol (DTT), ethylenediaminetetraacetic acid (EDTA), ethylene glycol tetraacetic acid (EGTA), dimethyl sulfoxide (DMSO), Triton X-100, RNase A, sodium orthovanadate, aprotinin, bovine serum albumin (BSA), crystal violet, ammonium persulfate (APS), <i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethylenediamine (TEMED), sodium dodecyl sulfate (SDS), glycine, TRIS hydrochloride, and paraformaldehyde were obtained from Sigma-Aldrich. The BCA protein assay kit was obtained from Pierce (Rockford, IL, USA). The fluorescein isothiocyanate (FITC) annexin V apoptosis detection kit was obtained from BD Biosciences (San Jose, CA, USA). The tubulin polymerization assay kit was obtained from Cytoskeleton (Denver, CO, USA). The human phospho-kinase antibody array was obtained from R&D Systems (Minneapolis, MN, USA).</div><div class="NLM_p">Infrared (IR) spectra were recorded on a Thermo Nicolet iS-5 FT-IR spectrometer. Nuclear magnetic resonance (NMR) spectra were obtained on Bruker Avanced-400 (400 MHz), Bruker AVIII (400 MHz) NMR, Bruker AVIII (500 MHz) NMR, or Bruker AVIII (800 MHz) NMR. Chemical shifts (δ) are given in parts per million (ppm) relative to δ<sub>H</sub> 7.24/δ<sub>C</sub> 77.00 for CDCl<sub>3</sub>, δ<sub>H</sub> 3.31/δ<sub>C</sub> 48.15 for CD<sub>3</sub>OD, and δ<sub>H</sub> 2.49/δ<sub>C</sub> 39.50 for DMSO-<i>d</i><sub>6</sub>. The coupling constants (<i>J</i>) are given in hertz (Hz), and the splitting patterns are reported as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet), m (multiplet), and br (broad). The ESI–HRMS experiments were conducted on a Bruker Daltonics BioTOF III high-resolution mass spectrometer.</div><div class="NLM_p last">New compounds with ≥95% purity were characterized by their physical and spectroscopic properties (mp, IR, ESI–MS, elemental analysis, and <sup>1</sup>H and <sup>13</sup>C NMR).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Identification of <b>5a</b> by High-Throughput Screening</h3><div class="NLM_p last">A two million compound library was used to screen for the antiproliferation activities against H1975 lung cancer cells at 10 μM concentration. The CV% and <i>Z</i>′ values of primary screening was determined as 4.9% and 0.58, respectively. In the screening, about 6800 different small molecules could inhibit more than 80% of H1975 lung cancer cell growth and were selected for the next screening. Eight cell lines, including clinical isolates (CL25, CL83, CL100, CL97, CL141, CL152)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> as well as two ATCC cell lines (PC9 and PC9/gef, kind gifts from Dr. C. H. Yang, Graduate Institute of Oncology, Cancer Research Center, National Taiwan University) was used in the second screening. The compounds selected from the second screening shall exhibit an IC<sub>50</sub> value smaller than 6 μM in all texted cell lines. Only 232 small molecules fit the criteria and were selected for the further study. Compound <b>5a</b> was one of the hits displaying excellent cytotoxic effects on lung cancer cells and an acceptable therapeutic window between cancer cells and normal cells.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Cell Lines and Culture Conditions</h3><div class="NLM_p last">The human lung adenocarcinoma cell line PC9 and derivative PC9/gef clones were gifts from Dr. C. H. Yang (Graduate Institute of Oncology, Cancer Research Center, National Taiwan University). NBE cultured in BEBM (bronchial epithelial basal media) was kindly provided by Dr. Reen Wu (Department of Anatomy, Physiology and Cell Biology, University of California Davis). The human lung adenocarcinoma cell line A549 and H1975 and the normal human foreskin fibroblast cell line HS68 were purchased from American Type Culture Collection (Rockville, MD, USA). The human lung cancer cell lines CL1-0 and CL1-5 were previously selected from an <i>in vitro</i> modified Boyden Chamber invasion Assay in our laboratory.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> In general, PC9, PC9/gef, H1975, CL1-0, and CL1-5 were cultured in RPMI-1640 medium with 10% FBS (v/v) and penicillin (100 units/mL)/streptomycin (100 μg/mL). A549 and HS68 were cultured in DMEM medium with 10% FBS (v/v) and penicillin (100 units/mL)/streptomycin (100 μg/mL). Cultures were maintained in a humidified incubator at 37 °C in 5% CO<sub>2</sub>/95% air.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> MTT Assay</h3><div class="NLM_p last">Cells were incubated in the absence or presence of the indicated compounds, and the cytotoxic effect was assessed using the MTT assay. The MTT was dissolved in phosphate-buffered saline (PBS) at a concentration of 5 mg/mL and filtered. From the stock solution, 10 μL per 100 μL of medium was added to each well, and the plates were incubated at 37 °C for 1 h. A yellow tetrazole is reduced to dark blue formazan in living cells, whereas no such reaction would be observed in dead cells. After the loading of MTT, the medium was replaced with 100 μL of DMSO for color development, and then, the 96-well plate was read by an enzyme-linked immunosorbent assay (ELISA) reader (540 nm) to obtain the absorbance density values.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Cell Cycle Analysis</h3><div class="NLM_p last">After treatment, the cells were harvested by trypsinization, fixed with 70% (v/v) alcohol at 4 °C for 1 h, and washed with PBS. After centrifugation, the cells were centrifuged and resuspended with 0.5 mL of PI solution that contained RNase (20 μg/mL) and PI (10 μg/mL). The DNA content was analyzed with the FACScan and CellQuest software (Becton Dickinson, Mountain View, CA, USA).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Annexin V and PI Staining of Apoptosis Cells</h3><div class="NLM_p last">Cells were cultured in 6-well plates for 24 h and then treated with or without test compound for the indicated amount of time. Then, the cells were washed twice with PBS and stained with FITC annexin V and PI according to the manufacturer’s directions. The stained cells were evaluated by the FACScan and CellQuest software.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Immunofluorescence Staining</h3><div class="NLM_p last">The cells were fixed with 3.7% cold paraformaldehyde and washed with PBS, followed by permeabilization with 0.1% Triton X-100. The cells were then stained with anti-α-tubulin antibody at 37 °C for 1 h; they were washed twice with PBS and incubated with FITC (1:100) conjugated secondary antibody at 37 °C for another 1 h. The cells were mounted onto microscope slides with Prolong Gold antifade reagent with DAPI (Molecular Probes) and then examined and photographed using the LSM 700 laser scanning confocal microscope from Carl Zeiss.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Tubulin Polymerization Assay</h3><div class="NLM_p last">After treatment, the cells were harvested by trypsinization and collected by centrifugation. The cells were lysed with 0.1 mL of hypotonic buffer (1 mM MgCl<sub>2</sub>, 2 mM EGTA, 0.5% NP-40, 2 mM phenylmethylsulfonyl fluoride (PMSF), 200 U/mL aprotinin, 100 μg/mL soy bean trypsin inhibitor, 5.0 mM ε-amino caproic acid, 1 mM benzamidine, and 20 mM Tris-HCl, pH 6.8). The cytosolic and cytoskeletal fractions of cell lysate were separated by centrifugation at 16000 × <i>g</i> for 15 min. The supernatant contained cytosolic tubulin, and the pellet represented the particulate fraction of polymerized tubulin, which was then resuspended in 0.1 mL of hypotonic buffer. The tubulin content in both fractions was detected by Western blotting.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Gel Filtration Chromatography</h3><div class="NLM_p last">Soluble protein extracts (H1975 cell treated with vehicle or test compound for 12 h) were prepared in IP lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 100 μM Na<sub>3</sub>VO<sub>4</sub>, 50 mM NaF, 30 mM sodium pyrophosphate plus protease inhibitors). Gel filtration chromatography was performed on a Toyopearl HW-65F resin column (Tosoh Bioscience). The column was equilibrated with two column volumes of IP lysis buffer. Each fraction in 0.5 mL (50 mL in total) was separated by 10% SDS–PAGE, and the fractionated proteins were detected with individual antibodies.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Tubulin Turbidity Assay</h3><div class="NLM_p last">Tubulin polymerization and depolymerization were detected by using the tubulin polymerization assay kit (Cytoskeleton Inc.). In both assays, tubulin proteins (>99% purity) were suspended in general tubulin buffer (G-PEM), buffer containing 80 mM piperazine-<i>N</i>,<i>N</i>′-bis(2-ethanesulfonic acid) (PIPES), 2 mM MgCl<sub>2</sub>, 0.5 mM EDTA, 1.0 mM GTP (pH 6.9), and 5% glycerol with or without test compound. The mixture was then transferred to a 96-well plate, and the absorbance was measured at 340 nm at 37 °C (SpectraMAX Plus, Molecular Devices Inc., Sunnyvale, CA, USA).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Phospho-Kinase Assay</h3><div class="NLM_p last">Cells were seeded in 100 mm dishes and incubated overnight. Following a 9 h exposure to test compound, the cells were rinsed once with PBS and solubilized with lysis buffer. The lysates were gently rocked at 4 °C for 30 min, and then, they were microcentrifuged for 30 min at 14000 × <i>g</i>. The supernatants were transferred to clean microcentrifuge tubes, and the total protein was quantified by BCA assay. Equivalent amounts of control and treatment lysates were diluted and incubated with the human phospho-kinase proteome profiler array (R&D Systems) according to the manufacturer’s protocol. The membranes were then scanned, and the density was measured.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Colony-Formation Assay</h3><div class="NLM_p last">Cells (1 × 10<sup>3</sup>) were seeded in a 6-well dish and incubated at 37 °C for 24 h. The cells were then incubated in the presence or absence of test compound for 2 weeks. The colonies obtained were washed with PBS and fixed with 3.7% paraformaldehyde, followed by staining with crystal violet.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Immunoblotting</h3><div class="NLM_p last">The cells were harvested, washed three times with PBS, and lysed in lysis buffer (0.25 M Tris-HCl, pH 6.8, 0.1% SDS). The protein concentration was measured by BCA assay. Equivalent amounts of cell extracts were loaded into SDS–PAGE and transferred to polyvinylidene membranes (Millipore, Billerica, MA). The membranes were blocked with 5% nonfat milk in PBS buffer that contained 0.1% Tween-20 (Sigma-Aldrich) for 1 h and incubated with respective primary antibody overnight at 4 °C followed by incubation with appropriate HRP-conjugated secondary antibody for 1 h at room temperature. The signal was visualized by an ECL detection system.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Xenograft Tumor Growth <i>in Vivo</i></h3><div class="NLM_p last">BALB/c-nu mice were maintained, and all of the animal procedures were in accordance with the Institutional Animal Care and Use Committee procedures and guidelines. Male BALB/c-nu mice (5 weeks of age) were obtained from National Laboratory Animal Center, Taiwan, and acclimatized to laboratory conditions for 1 week before tumor implantation. Human lung cancer H1975 (3 × 10<sup>6</sup> cell/mouse) was subcutaneously injected into the flank of the BALB/c-nu mice. Three days after the inoculation of cancer cells, the animals were divided into two groups. Both vehicle and test compound were suspended in DMSO and given intraperitoneally to the animals twice a week for 28 days. The body weight and tumor size were measured each time before drug delivery. The tumor volume was determined by measuring the largest diameters (<i>l</i>) and smallest diameters (<i>s</i>), and the volumes were calculated (<i>V</i> = 0.5 × <i>sl</i><sup>2</sup>).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-(4-Ethoxyphenyl)-9-(2-methoxyphenyl)-8-oxopurine-6-carboxamide (<b>5a</b>)</h3><div class="NLM_p">Compound <b>3a</b> was prepared according to the previously reported method.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A mixture of diaminomaleonitrile (<b>1</b>, 217 mg, 2 mmol) and 2-methoxyphenyl isocyanate (<b>2a</b>, 0.28 mL, 2.1 mmol) in anhydrous THF (15 mL) was stirred at room temperature for 24 h under an atmosphere of argon. The mixture was concentrated under reduced pressure. The residual solids were filtered and washed by cold ethanol and diethyl ether to yield the urea <b>3a</b> (310 mg, 60% yield).</div><div class="NLM_p last">To a suspension of <b>3a</b> (218 mg, 0.85 mmol) and 4-ethoxybenzaldehyde (0.24 mL, 1.74 mmol) in methanol (10 mL) and triethylamine (125 μL, 0.89 mmol) was added. The mixture was stirred at room temperature, and the solids dissolved in approximately 1 h. The solution was stirred for another 24 h, during which the solid precipitates gradually formed. The mixture was filtered and washed with cold ethanol and diethyl ether to yield the purine-type <b>5a</b> (182.1 mg, 53% yield). C<sub>21</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>; white solid; mp = 261.3–263.2 °C; IR ν<sub>max</sub> (KBr) 3507, 3454, 3290, 3235, 2972, 1744, 1702, 1577 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.62 (1 H, s, N<sub>7</sub>–H), 8.47 (1 H, s, amide), 8.26 (2 H, d, <i>J</i> = 8.8 Hz, H-2″ and H-6″), 7.91 (1 H, s, amide), 7.53 (1 H, dd, <i>J</i> = 8.2, 7.6 Hz, H-4′), 7.46 (1 H, d, <i>J</i> = 7.6 Hz, H-6′), 7.27 (1 H, d, <i>J</i> = 8.2 Hz, H-3′), 7.13 (1 H, dd, <i>J</i> = 8.2, 7.6 Hz, H-5′), 6.93 (2 H, d, <i>J</i> = 8.8 Hz, H-3″ and H-5″), 4.05 (2 H, q, <i>J</i> = 6.8 Hz, OCH<sub>2</sub>), 3.73 (3 H, s, OCH<sub>3</sub>), 1.32 (3 H, t, <i>J</i> = 6.8 Hz, CH<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.6, 160.2, 160.2, 155.4, 154.8, 153.4, 152.8, 132.7, 130.8, 130.1, 129.2 (2×), 129.1, 120.7, 120.6, 114.0 (2×), 112.7, 63.1, 55.8, 14.5; ESI–HRMS (negative mode) calculated for C<sub>21</sub>H<sub>18</sub>N<sub>5</sub>O<sub>4</sub>, 404.1359; found, <i>m</i>/<i>z</i> 404.1374 [M – H]<sup>−</sup>. Anal. Cacld for (C<sub>21</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>·1/2H<sub>2</sub>O): C, 60.86; H, 4.86; N, 16.90. Found: C, 60.76; H, 5.00; N, 16.74.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-(4-Hydroxyphenyl)-9-(2-methoxyphenyl)-8-oxopurine-6-carboxamide (<b>5b</b>)</h3><div class="NLM_p last">By a procedure similar to that for <b>5a</b>, the reaction of diaminomaleonitrile urea <b>3a</b> (80.6 mg, 0.31 mmol) and 4-hydroxybenzaldehyde (78.4 mg, 0.64 mmol) in the presence of triethylamine (45.8 μL, 0.33 mmol) at room temperature for 24 h gave the purine compound <b>5b</b> (38.1 mg, 33% yield). C<sub>19</sub>H<sub>15</sub>N<sub>5</sub>O<sub>4</sub>; pale orange solid; mp = 370.2–371.8 °C; IR ν<sub>max</sub> (KBr) 3472, 3441, 3255, 1732, 1686, 1599, 1510 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.58 (1 H, br s), 9.77 (1 H, s), 8.40 (1 H, s), 8.17 (2 H, d, <i>J</i> = 7.8 Hz), 7.92 (1 H, s), 7.54 (1 H, dd, <i>J</i> = 8.0, 7.6 Hz), 7.47 (1 H, d, <i>J</i> = 7.6 Hz), 7.28 (1 H, d, <i>J</i> = 8.0 Hz), 7.14 (1 H, dd, <i>J</i> = 8.0, 7.6 Hz), 6.78 (2 H, d, <i>J</i> = 7.8 Hz), 3.73 (3 H, s); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.7, 159.4, 155.4, 155.3, 153.3, 152.8, 132.8, 130.8, 130.2, 127.9 (2×), 120.8, 120.7 (2×), 119.1 (2×), 112.7 (2×), 55.9; ESI–HRMS calculated for C<sub>19</sub>H<sub>16</sub>N<sub>5</sub>O<sub>4</sub>, 378.1202; found, <i>m</i>/<i>z</i> 378.1201 [M + H]<sup>+</sup>. Anal. Cacld for (C<sub>19</sub>H<sub>15</sub>N<sub>5</sub>O<sub>4</sub>·1/2CH<sub>3</sub>OH): C, 59.54; H, 4.36; N, 17.80. Found: C, 59.50; H, 3.98; N, 18.24.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-(4-Butoxyphenyl)-9-(2-methoxyphenyl)-8-oxopurine-6-carboxamide (<b>5c</b>)</h3><div class="NLM_p last">By a procedure similar to that for <b>5a</b>, the reaction of diaminomaleonitrile urea <b>3a</b> (115 mg, 0.45 mmol) and 4-butoxybenzaldehyde (163.4 mg, 0.92 mmol) in the presence of triethylamine (65.4 μL, 0.47 mmol) at room temperature for 13 h gave the purine compound <b>5c</b> (65 mg, 34% yield). C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>; white solid; mp = 268.7–270.2 °C; IR ν<sub>max</sub> (KBr) 3453, 3277, 3215, 2954, 1744, 1702, 1577 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.62 (1 H, s), 8.45 (1 H, s), 8.27 (2 H, d, <i>J</i> = 8.2 Hz), 7.94 (1 H, s), 7.53 (1 H, dd, <i>J</i> = 8.0, 7.6 Hz), 7.47 (1 H, d, <i>J</i> = 7.6 Hz), 7.27 (1 H, d, <i>J</i> = 8.0 Hz), 7.14 (1 H, t, <i>J</i> = 7.6 Hz), 6.94 (2 H, d, <i>J</i> = 8.2 Hz), 3.98 (2 H, t, <i>J</i> = 6.0 Hz), 3.73 (3 H, s), 1.67 (2 H, m), 1.42 (2 H, m), 0.91 (3 H, t, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.7, 160.4, 155.4, 154.9, 153.4, 152.8, 132.8, 130.8, 130.2, 129.24 (2×), 129.16, 120.71, 120.68, 114.1 (2×), 112.8, 67.2, 55.9, 30.7, 18.7, 13.7; ESI–HRMS calculated for C<sub>23</sub>H<sub>24</sub>N<sub>5</sub>O<sub>4</sub>, 434.1828; found, <i>m</i>/<i>z</i> 434.1833 [M + H]<sup>+</sup>. Anal. Cacld for C<sub>23</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>: C, 63.73; H, 5.35; N, 16.16. Found: C, 63.81; H, 5.19; N, 15.85.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-(4-Hexoxyphenyl)-9-(2-methoxyphenyl)-8-oxopurine-6-carboxamide (<b>5d</b>)</h3><div class="NLM_p last">By a procedure similar to that for <b>5a</b>, the reaction of diaminomaleonitrile urea <b>3a</b> (89.3 mg, 0.35 mmol) and 4-hexoxybenzaldehyde (146.8 mg, 0.71 mmol) in the presence of triethylamine (51 μL, 0.37 mmol) at room temperature for 54 h produced the purine compound <b>5d</b> (80 mg, 50% yield). C<sub>25</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub>; yellow solid; mp = 219.7–220.3 °C; IR ν<sub>max</sub> (KBr) 3443, 3301, 3129, 2949, 2855, 1760, 1725, 1674 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.62 (1 H, br s), 8.45 (1 H, s), 8.27 (2 H, d, <i>J</i> = 8.8 Hz), 7.94 (1 H, s), 7.54 (1 H, ddd, <i>J</i> = 8.0, 7.6, 1.6 Hz, H-4′), 7.47 (1 H, dd, <i>J</i> = 7.6, 1.6 Hz, H-6′), 7.27 (1 H, dd, <i>J</i> = 8.0, 1.0 Hz, H-3′), 7.14 (1 H, ddd, <i>J</i> = 8.0, 7.6, 1.0 Hz, H-5′), 6.93 (2 H, d, <i>J</i> = 8.8 Hz), 3.97 (2 H, t, <i>J</i> = 6.8 Hz), 3.73 (3 H, s), 1.69 (2 H, quin, <i>J</i> = 6.8 Hz), 1.44–1.35 (2 H, m), 1.33–1.25 (4 H, m), 0.86 (3 H, t, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.7, 160.4, 155.4, 154.9, 153.4, 152.8, 132.8, 130.8, 130.2, 129.24 (2×), 129.18, 120.72, 120.68, 114.1 (2×), 112.8, 67.5, 55.9, 31.0, 28.6, 25.2, 22.0, 13.9; ESI–HRMS calculated for C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>4</sub>, 462.2141; found, <i>m</i>/<i>z</i> 462.2145 [M + H]<sup>+</sup>. Anal. Cacld for (C<sub>25</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub>·1/2H<sub>2</sub>O): C, 63.82; H, 6.00; N, 14.88. Found: C, 64.01; H, 5.83; N, 14.81.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(4-Ethoxyphenyl)-9-(3-methoxycarbonyl)phenyl-8-oxopurine-6-carboxamide (<b>5e</b>)</h3><div class="NLM_p last">The urea compound <b>3b</b> was prepared in 78% yield by stirring the mixture of diaminomaleonitrile and 3-(methoxycarbonyl)phenyl isocyanate (<b>2b</b>) at room temperature for 15 h. By a procedure similar to that for <b>5a</b>, the reaction of urea <b>3b</b> (100 mg, 0.35 mmol) and 4-ethoxybenzaldehyde (52 μL, 0.37 mmol) in the presence of triethylamine (52 μL, 0.37 mmol) for 18 h produced the purine compound <b>5e</b> (76 mg, 50% yield). C<sub>22</sub>H<sub>19</sub>N<sub>5</sub>O<sub>5</sub>; orange solid; mp = 330.5–332.0 °C; IR ν<sub>max</sub> (KBr) 3456, 3285, 3217, 2983, 2942, 1753, 1701, 1597, 1578 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (1 H, br s, N<sub>7</sub>–H), 8.48 (1 H, s, amide), 8.43 (1 H, t, <i>J</i> = 2.0 Hz, H-2′), 8.39–8.36 (2 H, m, H-4′ and H-6′), 8.10–8.01 (2 H, m, H-2″ and H-6″), 7.94 (1 H, s, amide), 7.76 (1 H, dd, <i>J</i> = 8.8, 7.4 Hz, H-5′), 6.99–6.96 (2 H, m, H-3″ and H-5″), 4.08 (2 H, q, <i>J</i> = 7.2 Hz), 3.91 (3 H, s, CO<sub>2</sub>CH<sub>3</sub>), 1.34 (3 H, t, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.6, 165.6, 160.3, 154.6, 152.6, 133.3, 133.1, 130.5, 130.5, 130.3, 129.4, 129.2 (4×), 128.1, 126.5, 114.2 (2×), 63.2, 52.4, 14.6; ESI–HRMS calculated for C<sub>22</sub>H<sub>20</sub>N<sub>5</sub>O<sub>5</sub>, 434.1464; found, <i>m</i>/<i>z</i> 434.1479 [M + H]<sup>+</sup>. Anal. Cacld for (C<sub>22</sub>H<sub>19</sub>N<sub>5</sub>O<sub>5</sub>·1/2H<sub>2</sub>O): C, 59.72; H, 4.56; N, 15.83. Found: C, 59.85; H, 4.55; N, 16.15.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-(4-Ethoxyphenyl)-9-(4-methoxycarbonyl)phenyl-8-oxopurine-6-carboxamide (<b>5f</b>)</h3><div class="NLM_p last">The urea compound <b>3c</b> was prepared in 90% yield by stirring the mixture of diaminomaleonitrile and 4-(methoxycarbonyl)phenyl isocyanate (<b>2c</b>) at room temperature for 20 h. By a procedure similar to that for <b>5a</b>, the reaction of urea <b>3c</b> (475 mg, 1.67 mmol) and 4-ethoxybenzaldehyde (244 μL, 1.75 mmol) in the presence of triethylamine (244 μL, 1.75 mmol) at 19 h produced the purine compound <b>5f</b> (413.6 mg, 58% yield). C<sub>22</sub>H<sub>19</sub>N<sub>5</sub>O<sub>5</sub>; orange solid; mp = 264.0–265.3 °C; IR ν<sub>max</sub> (KBr) 3439, 3371, 3235, 2983, 1754, 1727, 1685, 1597, 1576 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (1 H, br s), 8.46 (1 H, s), 8.38 (2 H, br d, <i>J</i> = 8.8 Hz), 8.17 (2 H, br d, <i>J</i> = 8.8 Hz), 7.97 (2 H, br d, <i>J</i> = 8.8 Hz), 7.95 (1 H, s), 6.96 (2 H, br d, <i>J</i> = 8.8 Hz), 4.06 (2 H, q, <i>J</i> = 7.2 Hz), 3.90 (3 H, s), 1.33 (3 H, t, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.7, 165.6, 160.3, 154.8, 152.4, 152.3, 137.1, 133.3, 129.8 (2×), 129.3 (2×), 129.1, 128.3, 125.7 (2×), 119.3, 114.2 (2×), 63.2, 52.3, 14.6; ESI–HRMS (negative mode) calculated for C<sub>22</sub>H<sub>18</sub>N<sub>5</sub>O<sub>5</sub>, 432.1308; found, <i>m</i>/<i>z</i> 432.1218 [M – H]<sup>−</sup>. Anal. Cacld for (C<sub>22</sub>H<sub>19</sub>N<sub>5</sub>O<sub>5</sub>·H<sub>2</sub>O): C, 58.53; H, 4.69; N, 15.51. Found: C, 58.23; H, 4.72; N, 15.87.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Biphenyl-9-(3-methoxycarbonylphenyl)-8-oxopurine-6-carboxamide (<b>5g</b>)</h3><div class="NLM_p last">By a procedure similar to that for <b>5a</b>, the reaction of diaminomaleonitrile urea <b>3b</b> (30 mg, 0.12 mmol) and 4-phenylbenzaldehyde (44 mg, 0.24 mmol) in the presence of triethylamine (17 μL, 0.13 mmol) for 20 h produced the purine compound <b>5g</b> (31 mg, 56% yield). C<sub>26</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>; white solid; mp = 302.3–302.8 °C; IR ν<sub>max</sub> (KBr) 3510, 3455, 3297, 3228, 3064, 3027, 2835, 1728, 1701, 1686, 1594 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (1 H, s), 8.54 (1 H, s), 8.43 (2 H, d, <i>J</i> = 8.8 Hz), 7.97 (1 H, s), 7.72–7.69 (4 H, m), 7.55 (1 H, dd, <i>J</i> = 8.8, 7.6 Hz), 7.52–7.44 (3 H, m), 7.40–7.35 (1 H, m), 7.30 (1 H, d, <i>J</i> = 8.0 Hz), 7.16 (1 H, td, <i>J</i> = 7.6, 0.8 Hz), 3.75 (3 H, s); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.6, 155.4, 154.4, 153.4, 141.5, 139.5, 135.9, 132.8, 130.8, 130.2, 129.0 (4×), 128.1 (3×), 127.8, 126.7 (4×), 126.6, 120.7, 112.8, 55.8; ESI–HRMS calculated for C<sub>26</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>, 618.2499; found, <i>m</i>/<i>z</i> 618.2486 [M + H]<sup>+</sup>. Anal. Cacld for (C<sub>26</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>·1/4H<sub>2</sub>O): C, 58.53; H, 4.69; N, 15.51. Found: C, 58.23; H, 4.72; N, 15.87.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-(4-Ethoxyphenyl)-9-(3-carboxy)phenyl-8-oxopurine-6-carboxamide (<b>6e</b>)</h3><div class="NLM_p last">To a suspension of ester <b>5e</b> (100 mg, 0.23 mmol) in pyridine (10 mL), we added 1 M NaOH<sub>(aq.)</sub> (1 mL). The mixture was stirred at room temperature for 17 h, in which the solids dissolved. The mixture was stirred for another 5 h until solid precipitates formed. The mixture was concentrated under reduced pressure. The residue was dissolved in methanol and acidified to pH 1.0 by adding 1 M HCl<sub>(aq)</sub>. The suspension was subjected to centrifuge at 8000 rpm for 15 min at 4 °C, and the acid compound <b>6e</b> was collected as orange solids (74.8 mg, 78%). C<sub>21</sub>H<sub>17</sub>N<sub>5</sub>O<sub>5</sub>; orange solid; mp = 343.7–345.6 °C; IR ν<sub>max</sub> (KBr) 3446, 2987, 2913, 2509, 1750, 1704, 1600 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.72 (1 H, s), 8.47 (1 H, s), 8.41–8.34 (3 H, m), 8.02 (2 H, dd, <i>J</i> = 8.0, 2.0 Hz), 7.93 (1 H, s), 7.73 (1 H, dd, <i>J</i> = 8.0, 7.6 Hz), 6.98–6.95 (2 H, m), 4.07 (2 H, q, <i>J</i> = 6.8 Hz), 1.33 (3 H, t, <i>J</i> = 6.8 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.7, 165.6, 160.3, 154.7, 152.7, 152.6, 133.1, 133.1, 131.6, 130.2, 129.3 (4×), 128.4, 126.9, 119.3, 114.2 (2×), 63.2, 14.6; ESI–HRMS (negative mode) calculated for C<sub>21</sub>H<sub>16</sub>N<sub>5</sub>O<sub>5</sub>, 418.1151; found, <i>m</i>/<i>z</i> 418.1159 [M – H]<sup>−</sup>. Anal. Cacld for (C<sub>21</sub>H<sub>15</sub>N<sub>5</sub>Na<sub>2</sub>O<sub>5</sub>·CH<sub>3</sub>OH): C, 53.34; H, 3.87; N, 14.14. Found: C, 53.39; H, 4.01; N, 14.21.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-(4-Ethoxyphenyl)-9-[3-(5-<i>tert</i>-butoxycarbonylamino)pentylcarbamoyl]phenyl-8-oxopurine-6-carboxamide (<b>8</b>)</h3><div class="NLM_p last">To a solution of acid <b>6e</b> (72 mg, 0.17 mmol) in anhydrous DMF (5 mL), we added <i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU, (78 mg, 0.21 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (36 μL, 0.21 mmol), and 5-(<i>tert</i>-butoxycarbonylamino)pentyl amine (<b>7</b>, 70 mg, 0.34 mmol). The mixture was stirred at room temperature under argon for 18 h, and then, it was concentrated under reduced pressure. The residue was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with 1 M HCl<sub>(aq)</sub>, saturated NaHCO<sub>3(aq)</sub>, and brine. The organic phase was dried over MgSO<sub>4</sub>, filtered, and purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 19:1), to afford the desired amide product <b>8</b> (63 mg, 62%). C<sub>31</sub>H<sub>37</sub>N<sub>7</sub>O<sub>6</sub>; yellow solid; mp = 182.2–183.1 °C; TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH= 19:1) <i>R</i><sub>f</sub> = 0.13; IR ν<sub>max</sub> (KBr) 3356, 2976, 2932, 2865, 1684, 1651, 1597 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.70 (1 H, s, N<sub>7</sub>–H), 8.52 (1 H, t, <i>J</i> = 5.2 Hz, NHBoc), 8.45 (1 H, s, amide), 8.32 (2 H, d, <i>J</i> = 8.8 Hz), 8.16 (1 H, s, amide), 7.88–7.84 (2 H, m), 7.83 (1 H, d, <i>J</i> = 8.8 Hz), 7.64 (1 H, dd, <i>J</i> = 8.0, 7.6 Hz, H-5′), 6.94 (2 H, br d, <i>J</i> = 8.8 Hz), 6.71 (1 H, t, <i>J</i> = 5.2 Hz, amide), 4.03 (2 H, q, <i>J</i> = 6.8 Hz), 3.22 (2 H, t, <i>J</i> = 6.0 Hz), 2.84 (2 H, t, <i>J</i> = 6.8 Hz), 1.54–1.44 (2 H, m), 1.40–1.21 (16 H, m); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.6, 165.2, 160.3, 155.6, 154.8, 152.7, 152.7, 135.6, 133.1, 132.8, 129.2 (2×), 128.9, 126.3, 125.3, 119.2, 114.1 (2×), 77.3, 63.2, 29.2, 29.0, 28.8, 28.2 (3×), 23.7, 14.7; ESI–HRMS (negative mode) calculated for C<sub>31</sub>H<sub>36</sub>N<sub>7</sub>O<sub>6</sub>, 602.2727; found, <i>m</i>/<i>z</i> 602.2714 [M – H]<sup>−</sup>. Anal. Cacld for (C<sub>31</sub>H<sub>37</sub>N<sub>7</sub>O<sub>6</sub>·2H<sub>2</sub>O): C, 58.20; H, 6.46; N, 15.33. Found: C, 58.51; H, 6.05; N, 15.22.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Biotin-Annexed Probe (<b>9</b>)</h3><div class="NLM_p last">A solution of <b>8</b> (63 mg, 0.11 mmol) and TFA (2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was stirred at room temperature for 1 h, and then, it was concentrated under reduced pressure to afford the corresponding amine. To a solution of the amine compound in anhydrous DMF (5 mL), HBTU (43 mg, 0.11 mmol), DIEA (27 μL, 0.11 mmol), and a solution of <span class="smallcaps smallerCapital">d</span>-(+)-biotin (28 mg, 0.11 mmol) in anhydrous DMF (3 mL) were added. The mixture was stirred at room temperature for 24 h under an atmosphere of argon, and then, it was concentrated under reduced pressure. Methanol (10 mL) was added, and the mixture was centrifuged at 8000 rpm for 15 min at 4 °C. The biotin-annexed compound <b>9</b> was collected as yellow solids (48 mg, 73% yield). C<sub>36</sub>H<sub>43</sub>N<sub>9</sub>O<sub>6</sub>S; yellow solid; mp = 223.4–224.1 °C (decomposed); [α]<sup>25</sup><sub>D</sub> = +272 (DMSO, <i>c</i> = 1); IR ν<sub>max</sub> (KBr) 3297, 2930, 2860, 1736, 1697, 1598 cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (1 H, s), 8.56 (1 H, t, <i>J</i> = 5.6 Hz), 8.50 (1 H, s), 8.35 (2 H, d, <i>J</i> = 8.8 Hz), 8.21 (1 H, s), 7.94 (1 H, s, H-2′), 7.92 (1 H, d, <i>J</i> = 8.0 Hz), 7.87 (1 H, d, <i>J</i> = 8.8 Hz), 7.76–7.65 (2 H, m), 6.96 (2 H, d, <i>J</i> = 8.8 Hz), 6.40 (1 H, s, biotin-NH), 6.33 (1 H, s, biotin-NH), 4.32–4.25 (1 H, m), 4.13–4.03 (3 H, m), 3.30–3.23 (2 H, m), 3.10–2.98 (3 H, m), 2.82–2.76 (1 H, m), 2.56 (1 H, d, <i>J</i> = 12.4 Hz), 2.02 (2 H, t, <i>J</i> = 7.6 Hz), 1.64–1.37 (8 H, m), 1.37–1.20 (7 H, m); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.8, 165.6, 165.3, 162.7, 160.3, 154.7, 152.7, 135.5, 133.1, 132.9, 129.2 (2×), 129.0, 128.8, 126.3, 125.3, 114.1 (2×), 63.2, 61.0, 59.2, 55.4, 39.8, 38.3, 35.2, 28.9, 28.8, 28.2, 28.0, 25.3, 23.9, 14.6; ESI–HRMS (negative mode) calculated for C<sub>36</sub>H<sub>44</sub>N<sub>9</sub>O<sub>6</sub>S, 730.3135; found, <i>m</i>/<i>z</i> 730.3154 [M + H]<sup>+</sup>. Anal. Cacld for (C<sub>36</sub>H<sub>43</sub>N<sub>9</sub>O<sub>6</sub>S·2.5H<sub>2</sub>O): C, 55.80; H, 6.24; N, 16.27; S, 4.14. Found: C, 56.03; H, 6.07; N, 15.78; S, 4.56.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00797">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00797" class="ext-link">10.1021/acs.jmedchem.6b00797</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional figures illustrating the body weights and biochemical markers of test mice in anticancer experiments, the procedure of the pharmacophore and organization modeling of <b>5a</b> with the katanin p60 subunit, synthetic procedures and compound characterization, and <sup>1</sup>H and <sup>13</sup>C spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Compound p60–<b>5a</b> mode 1 (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Compound p60–<b>5a</b> mode 2 (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_005.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_001.pdf">jm6b00797_si_001.pdf (1.75 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_003.pdb">jm6b00797_si_003.pdb (8.84 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_004.pdb">jm6b00797_si_004.pdb (7.21 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_005.csv">jm6b00797_si_005.csv (1.05 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00797" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Szu-Hua Pan</span> - <span class="hlFld-Affiliation affiliation">Ph.D.
Program in Translational Medicine, National
Taiwan University and Academia Sinica, Taipei, Taiwan</span>; 
    <span class="hlFld-Affiliation affiliation">Graduate
Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei 100, Taiwan</span>; 
    <span class="hlFld-Affiliation affiliation">Genome
and Systems Biology Degree Program, National
Taiwan University and Academia Sinica, Taipei 106, Taiwan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f0839880919eb09e8485de959485de8487"><span class="__cf_email__" data-cfemail="e99a81998887a9879d9cc78c8d9cc79d9e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim-Min Fang</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, National Taiwan University, Taipei 106, Taiwan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#462c2b202728210628323368232233683231"><span class="__cf_email__" data-cfemail="73191e15121d14331d07065d1617065d0704">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ting-Chun Kuo</span> - <span class="hlFld-Affiliation affiliation">Ph.D.
Program in Translational Medicine, National
Taiwan University and Academia Sinica, Taipei, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ling-Wei Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, National Taiwan University, Taipei 106, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jyung-Hurng Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Genomics and Bioinformatics, National
Chung Hsing University, Taichung 402, Taiwan</span>; 
    <span class="hlFld-Affiliation affiliation">Agricultural
Biotechnology Center, National Chung Hsing
University, Taichung 402, Taiwan</span>; 
    <span class="hlFld-Affiliation affiliation">Rong
Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ting-Jen Cheng</span> - <span class="hlFld-Affiliation affiliation">Genomics
Research Center, Academia Sinica, Taipei 115, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chia-Jen Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, National Taiwan University
College of Medicine, Taipei 100, Taiwan</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Stem Cell and Translational Cancer Research, Chang Gung Memorial HospitalTaipei 105, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pei-Fang Hung</span> - <span class="hlFld-Affiliation affiliation">Department
of Internal Medicine, National Taiwan University
College of Medicine, Taipei 100, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsuan-Yu Chen</span> - <span class="hlFld-Affiliation affiliation">Institute
of Statistical Science, Academia Sinica, Taipei 115, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tse-Ming Hong</span> - <span class="hlFld-Affiliation affiliation">Institute
of Clinical Medicine, National Cheng Kung
University College of Medicine, Tainan 701, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuan-Ling Hsu</span> - <span class="hlFld-Affiliation affiliation">Graduate
Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei 100, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chi-Huey Wong</span> - <span class="hlFld-Affiliation affiliation">Genomics
Research Center, Academia Sinica, Taipei 115, Taiwan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pan-Chyr Yang</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan</span>; 
    <span class="hlFld-Affiliation affiliation">NTU
Center for Genomic Medicine, National Taiwan
University, Taipei 100, Taiwan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3963-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the National Taiwan University (NTU-CDP-103R7879 and 1104R7879 to S.-H. P.) and the Ministry of Science & Technology (105-2911-I-0021025 303 to P.-C.Y, MOST 103-2113-M-002-017-MY3 to J.-M.F.; and NSC 102-2314-B-002-046-MY3 and 103-2923-B-002–003 to S.-H.P.) in Taiwan. We thank the Animal Center of the National Taiwan University College of Medicine for technical service support. We thank supports from Academia Sinica and the research grants from National Research Program for Biopharmaceuticals (ChemBank and High-Throughput Screening Resource Center, NSC-100-2325-B-001-022, NSC-101-2325-B-001-029, and NSC-102-2325-B-001-041).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> ABBREVIATIONS USED</h2><tr><td class="NLM_term">AAA</td><td class="NLM_def"><p class="first last">ATPase associated with diverse cellular activities</p></td></tr><tr><td class="NLM_term">BUN</td><td class="NLM_def"><p class="first last">blood urea nitrogen</p></td></tr><tr><td class="NLM_term">Cre</td><td class="NLM_def"><p class="first last">creatinine</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4′,6-diamidino-2-phenylindole</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">GOT</td><td class="NLM_def"><p class="first last">glutamic oxaloacetic transaminase</p></td></tr><tr><td class="NLM_term">GPT</td><td class="NLM_def"><p class="first last">glutamic pyruvic transaminase</p></td></tr><tr><td class="NLM_term">HBA</td><td class="NLM_def"><p class="first last">hydrogen-bond acceptor</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen-bond donor</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HY</td><td class="NLM_def"><p class="first last">hydrophobic feature</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">MAPs</td><td class="NLM_def"><p class="first last">microtubule-associated proteins</p></td></tr><tr><td class="NLM_term">MTA</td><td class="NLM_def"><p class="first last">microtubule targeting agents</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NBE</td><td class="NLM_def"><p class="first last">human normal bronchial epithelial cell</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall-cell lung cancer</p></td></tr><tr><td class="NLM_term">PARP-1</td><td class="NLM_def"><p class="first last">poly[ADP-ribose] polymerase 1</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">ring aromatic feature</p></td></tr><tr><td class="NLM_term">RMSD</td><td class="NLM_def"><p class="first last">lowest root-mean-square deviation</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TKIs</td><td class="NLM_def"><p class="first last">tyrosine kinase inhibitors</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naishadham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer statistics, 2012</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.3322/caac.20138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.3322%2Fcaac.20138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=22237781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A280%3ADC%252BC387jvVaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=10-29&author=R.+Siegelauthor=D.+Naishadhamauthor=A.+Jemal&title=Cancer+statistics%2C+2012&doi=10.3322%2Fcaac.20138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2012</span></div><div class="casAuthors">Siegel Rebecca; Naishadham Deepa; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics.  A total of 1,638,910 new cancer cases and 577,190 deaths from cancer are projected to occur in the United States in 2012.  During the most recent 5 years for which there are data (2004-2008), overall cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.6% per year in women.  Over the past 10 years of available data (1999-2008), cancer death rates have declined by more than 1% per year in men and women of every racial/ethnic group with the exception of American Indians/Alaska Natives, among whom rates have remained stable.  The most rapid declines in death rates occurred among African American and Hispanic men (2.4% and 2.3% per year, respectively).  Death rates continue to decline for all 4 major cancer sites (lung, colorectum, breast, and prostate), with lung cancer accounting for almost 40% of the total decline in men and breast cancer accounting for 34% of the total decline in women.  The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 1,024,400 deaths from cancer.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzMtZQZY6EXFMGsG_HTXYFfW6udTcc2eb9u0Gx1Bphgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387jvVaitg%253D%253D&md5=4d68e55759bf217f9a46c22be1af7f86</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20138%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DNaishadham%26aufirst%3DD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202012%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2012%26volume%3D62%26spage%3D10%26epage%3D29%26doi%3D10.3322%2Fcaac.20138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Nguyen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span> </span><span class="NLM_article-title">Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway</span> <span class="citation_source-journal">Clin. Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.3816/CLC.2009.n.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.3816%2FCLC.2009.n.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19632948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSms7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=281-289&author=K.+S.+Nguyenauthor=S.+Kobayashiauthor=D.+B.+Costa&title=Acquired+resistance+to+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitors+in+non-small-cell+lung+cancers+dependent+on+the+epidermal+growth+factor+receptor+pathway&doi=10.3816%2FCLC.2009.n.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway</span></div><div class="casAuthors">Nguyen, Kim-Son H.; Kobayashi, Susumu; Costa, Daniel B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Lung Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-289</span>CODEN:
                <span class="NLM_cas:coden">CLCLCA</span>;
        ISSN:<span class="NLM_cas:issn">1525-7304</span>.
    
            (<span class="NLM_cas:orgname">CIG Media Group, LP</span>)
        </div><div class="casAbstract">A review.  Most advanced non-small-cell lung cancers (NSCLCs) with activating epidermal growth factor receptor (EGFR) mutations (exon 19 deletions or L858R) initially respond to the EGFR tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib.  However, over time (median of 6-12 mo), most tumors develop acquired resistance to EGFR TKIs.  Intense research in these NSCLCs has identified two major mechanisms of resistance to gefitinib/erlotinib: secondary resistance mutations and "oncogene kinase switch" systems.  The secondary T790M mutation occurs in 50% of EGFR-mutated patients with TKI resistance, and in vitro, this mutation negates the hypersensitivity of activating EGFR mutations.  Sensitive detection methods have identified a proportion of TKI-naive tumors that carry T790M, and these resistant clones may be selected after exposure to gefitinib or erlotinib.  Other secondary resistance mutations (D761Y, L747S, T854A) seem to be rare.  The amplification of the MET oncogene is present in 20% of TKI-resistant tumors; however, in half of the cases with this "oncogene kinase switch" mechanism the T790M is coexistent.  It is possible that other kinases (such as insulin-like growth factor-1 receptor [IGF-1R]) might also be selected to bypass EGFR pathways in resistant tumors.  The growing preclin. data in EGFR-mutated NSCLCs with acquired resistance to gefitinib or erlotinib has spawned the initiation or conception of clin. trials testing novel EGFR inhibitors that in vitro inhibit T790M (neratinib, XL647, BIBW 2992, and PF-00299804), MET, or IGF-1R inhibitors in combination with EGFR TKIs, and heat shock protein 90 inhibitors.  Ongoing preclin. and clin. research in EGFR-mutated NSCLC has the potential to significantly improve the outcomes of patients with these somatic mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzBC9bsn7YdrVg90H21EOLACvtfcHk0lgpBFRTbszcFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSms7bO&md5=3522508ea4f2761e4dcedea18d914fe7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3816%2FCLC.2009.n.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCLC.2009.n.039%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DK.%2BS.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26atitle%3DAcquired%2520resistance%2520to%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520in%2520non-small-cell%2520lung%2520cancers%2520dependent%2520on%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520pathway%26jtitle%3DClin.%2520Lung%2520Cancer%26date%3D2009%26volume%3D10%26spage%3D281%26epage%3D289%26doi%3D10.3816%2FCLC.2009.n.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Nguyen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neal, J. W.</span><span> </span><span class="NLM_article-title">First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors</span> <span class="citation_source-journal">Biologics: Targets & Therapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span><span class="refDoi"> DOI: 10.2147/BTT.S26558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.2147%2FBTT.S26558" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=337-345&author=K.+S.+Nguyenauthor=J.+W.+Neal&title=First-line+treatment+of+EGFR-mutant+non-small-cell+lung+cancer%3A+the+role+of+erlotinib+and+other+tyrosine+kinase+inhibitors&doi=10.2147%2FBTT.S26558"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2147%2FBTT.S26558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FBTT.S26558%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DK.%2BS.%26aulast%3DNeal%26aufirst%3DJ.%2BW.%26atitle%3DFirst-line%2520treatment%2520of%2520EGFR-mutant%2520non-small-cell%2520lung%2520cancer%253A%2520the%2520role%2520of%2520erlotinib%2520and%2520other%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBiologics%253A%2520Targets%2520%2526%2520Therapy%26date%3D2012%26volume%3D6%26spage%3D337%26epage%3D345%26doi%3D10.2147%2FBTT.S26558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Camidge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sequist, L. V.</span><span> </span><span class="NLM_article-title">Acquired resistance to TKIs in solid tumours: learning from lung cancer</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1038/nrclinonc.2014.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrclinonc.2014.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=24981256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWisLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=473-481&author=D.+R.+Camidgeauthor=W.+Paoauthor=L.+V.+Sequist&title=Acquired+resistance+to+TKIs+in+solid+tumours%3A+learning+from+lung+cancer&doi=10.1038%2Fnrclinonc.2014.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired resistance to TKIs in solid tumours: learning from lung cancer</span></div><div class="casAuthors">Camidge, D. Ross; Pao, William; Sequist, Lecia V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The use of advanced mol. profiling to direct the use of targeted therapy, such as tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer (NSCLC), has revolutionized the treatment of this disease.  However, acquired resistance, defined as progression after initial benefit, to targeted therapies inevitably occurs.  This Review explores breakthroughs in the understanding and treatment of acquired resistance in NSCLC, focusing on EGFR mutant and ALK rearrangement-pos. disease, which may be relevant across multiple different solid malignancies with oncogene-addicted subtypes.  Mechanisms of acquired resistance may be pharmacol. (i.e., failure of delivery of the drug to its target) or biol., resulting from evolutionary selection on molecularly diverse tumors.  A no. of clin. approaches can maintain control of the disease in the acquired resistance setting, including the use of radiation to treat isolated areas of progression and adding or switching to cytotoxic chemotherapy.  Furthermore, novel approaches that have already proven successful include the development of second-generation and third-generation inhibitors and the combination of some of these inhibitors with antibodies directed against the same target.  With our increased understanding of the spectrum of acquired resistance, major changes in how we conduct clin. research in this setting are now underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp00ixSKYoDuLVg90H21EOLACvtfcHk0lgpBFRTbszcFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWisLrL&md5=13cc2f49f7ef320ad54f7e84f5102816</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2014.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2014.104%26sid%3Dliteratum%253Aachs%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26atitle%3DAcquired%2520resistance%2520to%2520TKIs%2520in%2520solid%2520tumours%253A%2520learning%2520from%2520lung%2520cancer%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D11%26spage%3D473%26epage%3D481%26doi%3D10.1038%2Fnrclinonc.2014.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Higa, G. M.</span><span> </span><span class="NLM_article-title">The microtubule as a breast cancer target</span> <span class="citation_source-journal">Breast Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span><span class="refDoi"> DOI: 10.1007/s12282-010-0224-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1007%2Fs12282-010-0224-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=103-119&author=G.+M.+Higa&title=The+microtubule+as+a+breast+cancer+target&doi=10.1007%2Fs12282-010-0224-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs12282-010-0224-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12282-010-0224-7%26sid%3Dliteratum%253Aachs%26aulast%3DHiga%26aufirst%3DG.%2BM.%26atitle%3DThe%2520microtubule%2520as%2520a%2520breast%2520cancer%2520target%26jtitle%3DBreast%2520Cancer%26date%3D2011%26volume%3D18%26spage%3D103%26epage%3D119%26doi%3D10.1007%2Fs12282-010-0224-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Stanton, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gernert, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aneja, R.</span><span> </span><span class="NLM_article-title">Drugs that target dynamic microtubules: a new molecular perspective</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1002/med.20242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fmed.20242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=21381049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=443-481&author=R.+A.+Stantonauthor=K.+M.+Gernertauthor=J.+H.+Nettlesauthor=R.+Aneja&title=Drugs+that+target+dynamic+microtubules%3A+a+new+molecular+perspective&doi=10.1002%2Fmed.20242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs that target dynamic microtubules: A new molecular perspective</span></div><div class="casAuthors">Stanton, Richard A.; Gernert, Kim M.; Nettles, James H.; Aneja, Ritu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-481</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle app.  As such, there is a wide variety of compds. currently in clin. use and in development that act as antimitotic agents by altering microtubule dynamics.  Although these diverse mols. are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research.  In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biol. function relative to the mol. vectors of microtubule assembly or disassembly.  These "biol. vectors" can thus be used as a spatiotemporal context to describe mol. mechanisms by which microtubule-targeting drugs work. © 2011 Wiley Periodicals, Inc.  Med Res Rev, 31, No. 3, 443-481, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB6_lcUQbXYrVg90H21EOLACvtfcHk0lhXc9UberziPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D&md5=acce5b9cc89581a7dab0236072b68c72</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fmed.20242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20242%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DR.%2BA.%26aulast%3DGernert%26aufirst%3DK.%2BM.%26aulast%3DNettles%26aufirst%3DJ.%2BH.%26aulast%3DAneja%26aufirst%3DR.%26atitle%3DDrugs%2520that%2520target%2520dynamic%2520microtubules%253A%2520a%2520new%2520molecular%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2011%26volume%3D31%26spage%3D443%26epage%3D481%26doi%3D10.1002%2Fmed.20242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Joshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belani, C. P.</span><span> </span><span class="NLM_article-title">Taxanes, past, present, and future impact on non-small cell lung cancer</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.1097/CAD.0000000000000080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1097%2FCAD.0000000000000080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=571-583&author=M.+Joshiauthor=X.+Liuauthor=C.+P.+Belani&title=Taxanes%2C+past%2C+present%2C+and+future+impact+on+non-small+cell+lung+cancer&doi=10.1097%2FCAD.0000000000000080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000080%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBelani%26aufirst%3DC.%2BP.%26atitle%3DTaxanes%252C%2520past%252C%2520present%252C%2520and%2520future%2520impact%2520on%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2014%26volume%3D25%26spage%3D571%26epage%3D583%26doi%3D10.1097%2FCAD.0000000000000080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Etienne-Manneville, S.</span><span> </span><span class="NLM_article-title">From signaling pathways to microtubule dynamics: the key players</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/j.ceb.2009.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.ceb.2009.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=20031384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslWqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=104-111&author=S.+Etienne-Manneville&title=From+signaling+pathways+to+microtubule+dynamics%3A+the+key+players&doi=10.1016%2Fj.ceb.2009.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">From signaling pathways to microtubule dynamics: the key players</span></div><div class="casAuthors">Etienne-Manneville, Sandrine</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-111</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Microtubules are highly dynamic structures whose regulation is crucial for cell division, cell polarity, cell migration, or neuronal differentiation.  Because they contribute to most cellular functions, they must be regulated in response to extracellular and intracellular signals.  The parameters of microtubule dynamics are numerous and complex and the connection between signaling pathways and regulation of microtubule dynamics remain obscure.  Recent observations reveal key players that can both integrate the diversity of signaling cascades and directly influence microtubule dynamics.  Here, the author reviews how modifications of the tubulin dimer, tubulin-modifying enzymes, and microtubule-assocd. proteins are directly involved in the regulation of microtubule behavior and functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNxwveP-IRE7Vg90H21EOLACvtfcHk0lhXc9UberziPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslWqsLc%253D&md5=d333c13b17b20a6d0776a7f2d92927bf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DEtienne-Manneville%26aufirst%3DS.%26atitle%3DFrom%2520signaling%2520pathways%2520to%2520microtubule%2520dynamics%253A%2520the%2520key%2520players%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2010%26volume%3D22%26spage%3D104%26epage%3D111%26doi%3D10.1016%2Fj.ceb.2009.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Van der Vaart, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhmanova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straube, A.</span><span> </span><span class="NLM_article-title">Regulation of microtubule dynamic instability</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1013</span><span class="refDoi"> DOI: 10.1042/BST0371007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1042%2FBST0371007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19754441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlsL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1007-1013&author=B.+Van+der+Vaartauthor=A.+Akhmanovaauthor=A.+Straube&title=Regulation+of+microtubule+dynamic+instability&doi=10.1042%2FBST0371007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of microtubule dynamic instability</span></div><div class="casAuthors">van der Vaart, Babet; Akhmanova, Anna; Straube, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1007-1013</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Proper regulation of microtubule (MT) dynamics is essential for various vital processes, including the segregation of chromosomes, directional cell migration, and differentiation.  MT assembly and disassembly is modulated by a complex network of intracellular factors that cooperate or antagonize each other, are highly regulated in space and time, and are thus attuned to the cell cycle and differentiation processes.  While researchers have only begun to appreciate how the concerted action of MT stabilizers and destabilizers shapes different MT patterns, a clear picture of how individual factors affect the MT structure is emerging.  Here, the authors review current knowledge about proteins that modulate MT dynamic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4-8yAuqr4-LVg90H21EOLACvtfcHk0lhPkb1XQ0E9aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlsL%252FN&md5=e64a92e3eb9359801448028954985c7c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2FBST0371007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0371007%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BVaart%26aufirst%3DB.%26aulast%3DAkhmanova%26aufirst%3DA.%26aulast%3DStraube%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520microtubule%2520dynamic%2520instability%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2009%26volume%3D37%26spage%3D1007%26epage%3D1013%26doi%3D10.1042%2FBST0371007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Rovini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braguer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carré, M.</span><span> </span><span class="NLM_article-title">Microtubule-targeted agents: when mitochondria become essential to chemotherapy</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Bioenerg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1807</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span><span class="refDoi"> DOI: 10.1016/j.bbabio.2011.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.bbabio.2011.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=21216222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFSitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1807&publication_year=2011&pages=679-688&author=A.+Roviniauthor=A.+Savryauthor=D.+Braguerauthor=M.+Carr%C3%A9&title=Microtubule-targeted+agents%3A+when+mitochondria+become+essential+to+chemotherapy&doi=10.1016%2Fj.bbabio.2011.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-targeted agents: When mitochondria become essential to chemotherapy</span></div><div class="casAuthors">Rovini, A.; Savry, A.; Braguer, D.; Carre, M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Bioenergetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1807</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">679-688</span>CODEN:
                <span class="NLM_cas:coden">BBBEB4</span>;
        ISSN:<span class="NLM_cas:issn">0005-2728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Microtubule-Targeting Agents (MTAs) constitute a class of drugs largely used for cancer treatment in adults and children.  In cancer cells, they suppress microtubule dynamics, and induce cell death via the mitochondrial intrinsic pathway.  To date, links between mitochondria and microtubule network disturbance in MTAs mechanism of action are not obvious.  The aim of the present contribution is to provide elements that could answer to the question: how far are mitochondria essential to anticancer chemotherapy that targets the microtubule cytoskeleton We review the main mol. candidates to link microtubule alteration with the apoptotic mitochondrial pathway control.  Involvement of direct targeting of mitochondria in MTA efficacy is also discussed.  Furthermore, we line up current evidence and emerging concepts on the participation of both mitochondria and microtubule in MTA neurotoxic side effects.  To decipher the interconnections between the mitochondrial and the microtubule networks may help to improve cancer cell response to chemotherapy.  This article is part of a Special Issue entitled: Bioenergetics of Cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCjULnreE0rVg90H21EOLACvtfcHk0lhPkb1XQ0E9aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFSitro%253D&md5=2afa1b9807076eaa0696d5d959f9457b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbabio.2011.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbabio.2011.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DRovini%26aufirst%3DA.%26aulast%3DSavry%26aufirst%3DA.%26aulast%3DBraguer%26aufirst%3DD.%26aulast%3DCarr%25C3%25A9%26aufirst%3DM.%26atitle%3DMicrotubule-targeted%2520agents%253A%2520when%2520mitochondria%2520become%2520essential%2520to%2520chemotherapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Bioenerg.%26date%3D2011%26volume%3D1807%26spage%3D679%26epage%3D688%26doi%3D10.1016%2Fj.bbabio.2011.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Katsetos, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dráber, P.</span><span> </span><span class="NLM_article-title">Tubulins as therapeutic targets in cancer: from bench to bedside</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2778</span><span class="NLM_x">–</span> <span class="NLM_lpage">2792</span><span class="refDoi"> DOI: 10.2174/138161212800626193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.2174%2F138161212800626193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=22390762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslCrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2778-2792&author=C.+D.+Katsetosauthor=P.+Dr%C3%A1ber&title=Tubulins+as+therapeutic+targets+in+cancer%3A+from+bench+to+bedside&doi=10.2174%2F138161212800626193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulins as therapeutic targets in cancer: from bench to bedside</span></div><div class="casAuthors">Katsetos, Christos D.; Draber, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2778-2792</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tubulin is the target of some of the most widely used and time-honored anticancer tubulin-binding agents (TBAs).  The clin. usefulness of many TBAs has been held back as a result of tumor cell drug-resistance.  The elucidation of the three-dimensional structure of αβ-tubulin dimer has provided an opportunity for rational drug design aimed at generating compds. that will target tubulin in therapeutically more efficacious ways compared to presently available drugs.  An issue to be addressed is which one(s) of the tubulin species, their isotypes, or their posttranslationally modified forms, should be specifically targeted in cancer chemotherapy.  This review offers a crit. appraisal of current knowledge on tubulins in cancer and an update on new anti-neoplastic microtubule-targeted treatment strategies.  Specifically, it examines, across disciplines, cellular/mol., biochem., clin./pathol., and pharmacol. aspects of β-tubulin isotypes, posttranslational modifications of tubulin dimers, γ-tubulin and microtubule nucleation, and microtubule regulatory proteins.  Emphasis is placed on the overexpression of (i) the βIII isotypes, which functions as a survival factor assocd. with dynamic instability of microtubules; (ii) γ-tubulin, a key microtubule nucleating protein; and (iii) the microtubule severing enzyme spastin, involved in cell motility and proliferation of glioblastoma cells.  The role of βIII-tubulin in resistance of cancer cells to taxanes is examd.  Attention is called to the novel concept that βIII-tubulin functions as a "gateway" for prosurvival signals in partnership with GTPases, such as GBP1.  Appraisal is also offered on epothilones and the concept of hypersensitization to TBAs as promising therapeutic strategies in taxane resistant epithelial cancers and in high-grade gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxdmReNG2Qw7Vg90H21EOLACvtfcHk0lhPkb1XQ0E9aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslCrs7k%253D&md5=cc9638610d51334759aa081a624f7abe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F138161212800626193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212800626193%26sid%3Dliteratum%253Aachs%26aulast%3DKatsetos%26aufirst%3DC.%2BD.%26aulast%3DDr%25C3%25A1ber%26aufirst%3DP.%26atitle%3DTubulins%2520as%2520therapeutic%2520targets%2520in%2520cancer%253A%2520from%2520bench%2520to%2520bedside%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D2778%26epage%3D2792%26doi%3D10.2174%2F138161212800626193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Perez, E. A.</span><span> </span><span class="NLM_article-title">Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2086</span><span class="NLM_x">–</span> <span class="NLM_lpage">2095</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1158%2F1535-7163.MCT-09-0366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19671735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFCnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2086-2095&author=E.+A.+Perez&title=Microtubule+inhibitors%3A+Differentiating+tubulin-inhibiting+agents+based+on+mechanisms+of+action%2C+clinical+activity%2C+and+resistance&doi=10.1158%2F1535-7163.MCT-09-0366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance</span></div><div class="casAuthors">Perez, Edith A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2086-2095</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Microtubules are important cellular targets for anticancer therapy because of their key role in mitosis.  Microtubule inhibitors (MTI) such as taxanes, vinca alkaloids, and epothilones stabilize or destabilize microtubules, thereby suppressing microtubule dynamics required for proper mitotic function, effectively blocking cell cycle progression and resulting in apoptosis.  In spite of their antitumor activity, innate or acquired drug resistance to MTIs such as the taxanes is common, limiting their overall clin. efficacy.  Further insight into the mechanisms of action of microtubule-targeting drugs has lead to the discovery of novel agents that may provide higher efficacy with limited toxicity and help overcome resistance to conventional MTIs.  This review will focus on the different mechanisms of action of MTIs, potential factors related to resistance and tolerability, and will discuss the recent approval as well as the development of new antineoplastic agents. [Mol Cancer Ther 2009;8(8):2086-95].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1HM8JP4QG8LVg90H21EOLACvtfcHk0lhPkb1XQ0E9aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFCnurw%253D&md5=1d8dec9ed6c0f061032cec57c96c833e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0366%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DE.%2BA.%26atitle%3DMicrotubule%2520inhibitors%253A%2520Differentiating%2520tubulin-inhibiting%2520agents%2520based%2520on%2520mechanisms%2520of%2520action%252C%2520clinical%2520activity%252C%2520and%2520resistance%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2086%26epage%3D2095%26doi%3D10.1158%2F1535-7163.MCT-09-0366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bhat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setaluri, V.</span><span> </span><span class="NLM_article-title">Microtubule-associated proteins as targets in cancer chemotherapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2849</span><span class="NLM_x">–</span> <span class="NLM_lpage">2854</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-3040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1158%2F1078-0432.CCR-06-3040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=17504982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Krsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2849-2854&author=K.+M.+Bhatauthor=V.+Setaluri&title=Microtubule-associated+proteins+as+targets+in+cancer+chemotherapy&doi=10.1158%2F1078-0432.CCR-06-3040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-Associated Proteins as Targets in Cancer Chemotherapy</span></div><div class="casAuthors">Bhat, Kumar M. R.; Setaluri, Vijayasaradhi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2849-2854</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Natural and synthetic compds. that disrupt microtubule dynamics are among the most successful and widely used cancer chemotherapeutic agents.  However, lack of reliable markers that predict sensitivity of cancers to these agents and development of resistance remain vexing issues.  There is accumulating evidence that a family of cellular proteins that are assocd. with and alter the dynamics of microtubules can det. sensitivity of cancer cells to microtubule-targeting agents and play a role in tumor cell resistance to these agents.  This growing family of microtubule-assocd. proteins (MAP) includes products of oncogenes, tumor suppressors, and apoptosis regulators, suggesting that alteration of microtubule dynamics may be one of the crit. events in tumorigenesis and tumor progression.  The objective of this review is to integrate the knowledge on these seemingly unrelated proteins that share a common function and examine their relevance to microtubule-targeting therapies and highlight MAPs-tubulin-drug interactions as a novel avenue for new drug discovery.  Based on the available evidence, we propose that rational microtubule-targeting cancer therapeutic approaches should ideally include proteomic profiling of tumor MAPs before administration of microtubule-stabilizing/destabilizing agents preferentially in combination with agents that modulate the expression of relevant MAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJCwiEFkyEsrVg90H21EOLACvtfcHk0lhzVOVous0dFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Krsrw%253D&md5=719cc6f219556505b5562b1201171911</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-3040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-3040%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DK.%2BM.%26aulast%3DSetaluri%26aufirst%3DV.%26atitle%3DMicrotubule-associated%2520proteins%2520as%2520targets%2520in%2520cancer%2520chemotherapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D2849%26epage%3D2854%26doi%3D10.1158%2F1078-0432.CCR-06-3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Miceli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S. J.</span><span> </span><span class="NLM_article-title">Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1038/cgt.2013.21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fcgt.2013.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=23618950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1WgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=298-307&author=C.+Miceliauthor=A.+Tejadaauthor=A.+Castanedaauthor=S.+J.+Mistry&title=Cell+cycle+inhibition+therapy+that+targets+stathmin+in+in+vitro+and+in+vivo+models+of+breast+cancer&doi=10.1038%2Fcgt.2013.21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer</span></div><div class="casAuthors">Miceli, C.; Tejada, A.; Castaneda, A.; Mistry, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">298-307</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Stathmin is the founding member of a family of microtubule-destabilizing proteins that have a crit. role in the regulation of mitosis.  Stathmin is expressed at high levels in breast cancer and its overexpression is linked to disease progression.  Although there is a large body of evidence to support a role for stathmin in breast cancer progression, the validity of stathmin as a viable therapeutic target for breast cancer has not been investigated.  Here, we used a bicistronic adenoviral vector that co-expresses green fluorescent protein and a ribozyme that targets stathmin mRNA in preclin. breast cancer models with different estrogen receptor (ER) status.  We examd. the effects of anti-stathmin ribozyme on the malignant phenotype of breast cancer cells in vitro and in xenograft models in vivo both as a single agent and in combination with chemotherapeutic agents.  Adenovirus-mediated gene transfer of anti-stathmin ribozyme resulted in a dose-dependent inhibition of proliferation and clonogenicity assocd. with a G2/M arrest and increase in apoptosis in both ER-pos. and ER-neg. breast cancer cell lines.  This inhibition was markedly enhanced when stathmin-inhibited breast cancer cells were exposed to low concns. of taxol, which resulted in virtually complete loss of the malignant phenotype.  Interestingly, breast cancer xenografts treated with low doses of anti-stathmin therapy and taxol showed regression in a majority of tumors, while some tumors stopped growing completely.  In contrast, combination of anti-stathmin ribozyme and adriamycin resulted in only a modest inhibition of growth in vitro and in breast cancer xenografts in vivo.  Although inhibition of tumor growth was obsd. in both the combination treatment groups compared with groups treated with single agent alone, combination of anti-stathmin therapy and taxol had a more profound inhibition of tumorigenicity, as both agents target the microtubule pathway.  Clin., these findings are highly relevant because taxol is one of the most active chemotherapeutic agents in breast cancer.  These studies provide the proof-of-principle that stathmin provides an attractive mol. target, which could serve as a primary focus of novel approaches to breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphv_lNDGlXpbVg90H21EOLACvtfcHk0lhzVOVous0dFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1WgurY%253D&md5=89ae7276231c16300b47fec32ee30dc5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fcgt.2013.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcgt.2013.21%26sid%3Dliteratum%253Aachs%26aulast%3DMiceli%26aufirst%3DC.%26aulast%3DTejada%26aufirst%3DA.%26aulast%3DCastaneda%26aufirst%3DA.%26aulast%3DMistry%26aufirst%3DS.%2BJ.%26atitle%3DCell%2520cycle%2520inhibition%2520therapy%2520that%2520targets%2520stathmin%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520of%2520breast%2520cancer%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2013%26volume%3D20%26spage%3D298%26epage%3D307%26doi%3D10.1038%2Fcgt.2013.21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Rouzier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuerer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symmans, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pusztai, L.</span><span> </span><span class="NLM_article-title">Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8315</span><span class="NLM_x">–</span> <span class="NLM_lpage">8320</span><span class="refDoi"> DOI: 10.1073/pnas.0408974102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1073%2Fpnas.0408974102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8315-8320&author=R.+Rouzierauthor=R.+Rajanauthor=P.+Wagnerauthor=K.+R.+Hessauthor=D.+L.+Goldauthor=J.+Stecauthor=M.+Ayersauthor=J.+S.+Rossauthor=P.+Zhangauthor=T.+A.+Buchholzauthor=H.+Kuererauthor=M.+Greenauthor=B.+Arunauthor=G.+N.+Hortobagyiauthor=W.+F.+Symmansauthor=L.+Pusztai&title=Microtubule-associated+protein+tau%3A+a+marker+of+paclitaxel+sensitivity+in+breast+cancer&doi=10.1073%2Fpnas.0408974102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0408974102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0408974102%26sid%3Dliteratum%253Aachs%26aulast%3DRouzier%26aufirst%3DR.%26aulast%3DRajan%26aufirst%3DR.%26aulast%3DWagner%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DK.%2BR.%26aulast%3DGold%26aufirst%3DD.%2BL.%26aulast%3DStec%26aufirst%3DJ.%26aulast%3DAyers%26aufirst%3DM.%26aulast%3DRoss%26aufirst%3DJ.%2BS.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DBuchholz%26aufirst%3DT.%2BA.%26aulast%3DKuerer%26aufirst%3DH.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DArun%26aufirst%3DB.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26aulast%3DSymmans%26aufirst%3DW.%2BF.%26aulast%3DPusztai%26aufirst%3DL.%26atitle%3DMicrotubule-associated%2520protein%2520tau%253A%2520a%2520marker%2520of%2520paclitaxel%2520sensitivity%2520in%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D8315%26epage%3D8320%26doi%3D10.1073%2Fpnas.0408974102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sharp, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. L.</span><span> </span><span class="NLM_article-title">Microtubule-severing enzymes at the cutting edge</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2561</span><span class="NLM_x">–</span> <span class="NLM_lpage">2569</span><span class="refDoi"> DOI: 10.1242/jcs.101139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1242%2Fjcs.101139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=22595526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=2561-2569&author=D.+J.+Sharpauthor=J.+L.+Ross&title=Microtubule-severing+enzymes+at+the+cutting+edge&doi=10.1242%2Fjcs.101139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-severing enzymes at the cutting edge</span></div><div class="casAuthors">Sharp, David J.; Ross, Jennifer L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2561-2569</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  ATP-dependent severing of microtubules was first reported in Xenopus laevis egg exts. in 1991.  Two years later this observation led to the purifn. of the first known microtubule-severing enzyme, katanin.  Katanin homologs have now been identified throughout the animal kingdom and in plants.  Moreover, members of two closely related enzyme subfamilies, spastin and fidgetin, have been found to sever microtubules and might act alongside katanins in some contexts.  Over the past few years, it has become clear that microtubule-severing enzymes contribute to a wide range of cellular activities including mitosis and meiosis, morphogenesis, cilia biogenesis and disassembly, and cell migration.  Thus, this group of enzymes is revealing itself to be among the most important of the microtubule regulators.  This Commentary focuses on our growing understanding of how microtubule-severing enzymes contribute to the organization and dynamics of diverse microtubule arrays, as well as the structural and biophys. characteristics that afford them the unique capacity to catalyze the removal of tubulin from the interior microtubule lattice.  Our goal is to provide a broader perspective, focusing on a limited no. of particularly informative, representative and/or timely findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg2sHb_W6V1LVg90H21EOLACvtfcHk0ljMBEpoyaiA0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrsrzO&md5=3effc3d0c73720e2a9d77fff656eb6b0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1242%2Fjcs.101139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.101139%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DD.%2BJ.%26aulast%3DRoss%26aufirst%3DJ.%2BL.%26atitle%3DMicrotubule-severing%2520enzymes%2520at%2520the%2520cutting%2520edge%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2012%26volume%3D125%26spage%3D2561%26epage%3D2569%26doi%3D10.1242%2Fjcs.101139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Baas, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V.</span><span> </span><span class="NLM_article-title">Cell migration: katanin gives microtubules a trim</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1016/j.cub.2011.03.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.cub.2011.03.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVOnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=302-304&author=P.+W.+Baasauthor=V.+Sharma&title=Cell+migration%3A+katanin+gives+microtubules+a+trim&doi=10.1016%2Fj.cub.2011.03.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cell migration: Katanin gives microtubules a trim</span></div><div class="casAuthors">Baas, Peter W.; Sharma, Vandana</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">R302-R304</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  New evidence suggests that katanin, best known for severing microtubules in their more stable regions, localizes at the leading edge of migratory cells and trims microtubules at their dynamic plus-ends.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOPdg8P7VAgrVg90H21EOLACvtfcHk0ljMBEpoyaiA0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVOnt70%253D&md5=45c6860667406206961432966e1ccd63</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2011.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2011.03.051%26sid%3Dliteratum%253Aachs%26aulast%3DBaas%26aufirst%3DP.%2BW.%26aulast%3DSharma%26aufirst%3DV.%26atitle%3DCell%2520migration%253A%2520katanin%2520gives%2520microtubules%2520a%2520trim%26jtitle%3DCurr.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D302%26epage%3D304%26doi%3D10.1016%2Fj.cub.2011.03.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ghosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, A.</span><span> </span><span class="NLM_article-title">Models, regulations, and functions of microtubule severing by katanin</span> <span class="citation_source-journal">ISRN Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.5402/2012/596289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.5402%2F2012%2F596289" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1-14&author=D.+K.+Ghoshauthor=D.+Dasguptaauthor=A.+Guha&title=Models%2C+regulations%2C+and+functions+of+microtubule+severing+by+katanin&doi=10.5402%2F2012%2F596289"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.5402%2F2012%2F596289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5402%252F2012%252F596289%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%2BK.%26aulast%3DDasgupta%26aufirst%3DD.%26aulast%3DGuha%26aufirst%3DA.%26atitle%3DModels%252C%2520regulations%252C%2520and%2520functions%2520of%2520microtubule%2520severing%2520by%2520katanin%26jtitle%3DISRN%2520Mol.%2520Biol.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D14%26doi%3D10.5402%2F2012%2F596289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choueiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logothetis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu-Lee, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. H.</span><span> </span><span class="NLM_article-title">Aberrant expression of katanin p60 in prostate cancer bone metastasis</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span><span class="refDoi"> DOI: 10.1002/pros.21431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fpros.21431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=21681775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjsl2itA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=291-300&author=X.+Yeauthor=Y.+C.+Leeauthor=M.+Choueiriauthor=K.+Chuauthor=C.+F.+Huangauthor=W.+W.+Tsaiauthor=R.+Kobayashiauthor=C.+J.+Logothetisauthor=L.+Y.+Yu-Leeauthor=S.+H.+Lin&title=Aberrant+expression+of+katanin+p60+in+prostate+cancer+bone+metastasis&doi=10.1002%2Fpros.21431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant expression of katanin p60 in prostate cancer bone metastasis</span></div><div class="casAuthors">Ye, Xiangcang; Lee, Yu-Chen; Choueiri, Michel; Chu, Khoi; Huang, Chih-Fen; Tsai, Wen-Wei; Kobayashi, Ryuji; Logothetis, Christopher J.; Yu-Lee, Li-Yuan; Lin, Sue-Hwa</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-300</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Katanin p60 is a microtubule-severing protein and is involved in microtubule cytoskeleton organization in both mitotic and non-mitotic processes.  Its role in cancer metastasis is unknown.  Differential protein profiles of bone marrow aspirates were analyzed by chromatog., electrophoresis, and mass spectrometry.  Expression of katanin p60 in primary and metastatic prostate cancer was examd. by immunohistochem.  Cellular function of katanin p60 was further examd. in prostate cell lines.  In a proteomic profiling of bone marrow aspirates from men with prostate cancer, we found that katanin p60 was one of the proteins differentially expressed in bone metastasis samples.  Immunohistochem. staining showed that katanin p60 was expressed in the basal cells in normal human prostate glands.  In prostatic adenocarcinomas, in which the basal cells were absent, katanin p60 was expressed in the prostate cancer cells.  In the specimens from bone metastasis, katanin p60 was detectable in the metastatic cancer cells.  Strikingly, some of the metastatic cancer cells also co-expressed basal cell biomarkers including the tumor suppressor p53-homologous protein p63 and the high mol. wt. cytokeratins, suggesting that the metastatic prostate cancer cells may have a basal cell-like phenotype.  Moreover, overexpression of katanin p60 inhibited prostate cancer cell proliferation but enhanced cell migration activity.  Katanin p60 was aberrantly expressed during prostate cancer progression.  Its expression in the metastatic cells in bone was assocd. with the re-emergence of a basal cell-like phenotype.  The elevated katanin p60 expression may contribute to cancer cell metastasis via a stimulatory effect on cell motility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9sgS_WA-2CbVg90H21EOLACvtfcHk0ljMBEpoyaiA0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjsl2itA%253D%253D&md5=f1d4077463247cff8591da9126e1adc7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fpros.21431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.21431%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DChoueiri%26aufirst%3DM.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%2BF.%26aulast%3DTsai%26aufirst%3DW.%2BW.%26aulast%3DKobayashi%26aufirst%3DR.%26aulast%3DLogothetis%26aufirst%3DC.%2BJ.%26aulast%3DYu-Lee%26aufirst%3DL.%2BY.%26aulast%3DLin%26aufirst%3DS.%2BH.%26atitle%3DAberrant%2520expression%2520of%2520katanin%2520p60%2520in%2520prostate%2520cancer%2520bone%2520metastasis%26jtitle%3DProstate%26date%3D2012%26volume%3D72%26spage%3D291%26epage%3D300%26doi%3D10.1002%2Fpros.21431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sudo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maru, Y.</span><span> </span><span class="NLM_article-title">LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2086</span><span class="NLM_x">–</span> <span class="NLM_lpage">2100</span><span class="refDoi"> DOI: 10.1096/fj.06-7254com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1096%2Ffj.06-7254com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=17351128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvVagsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2086-2100&author=H.+Sudoauthor=Y.+Maru&title=LAPSER1+is+a+putative+cytokinetic+tumor+suppressor+that+shows+the+same+centrosome+and+midbody+subcellular+localization+pattern+as+p80+katanin&doi=10.1096%2Ffj.06-7254com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin</span></div><div class="casAuthors">Sudo, Haruka; Maru, Yoshiro</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2086-2100, 10.1096/fj.06-7254com</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Prostate cancer is one of the most common cancers in men, with more than 500,000 new worldwide cases reported annually, resulting in 200,000 deaths of mainly older men in developed countries.  Existing treatments have not proved very effective in managing prostate cancer, and continuing efforts therefore are ongoing to explore novel targets and strategies for future therapies.  LAPSER1 has been identified as a candidate tumor suppressor gene in prostate cancer, but its true functions remain unknown.  We report here that LAPSER1 colocalizes to the centrosomes and mid-bodies in mitotic cells with γ-tubulin, MKLP1, and p80 katanin, and is involved in cytokinesis.  Moreover, RNAi-mediated disruption of LAPSER1, which is accompanied by the mislocalization of p80 katanin, results in malformation of the central spindle.  Significantly, the enhanced expression of LAPSER1 induces binucleation and renders the cells resistant to oncogenic transformation.  In cells transformed by the v-Fps oncogene, overexpressed LAPSER1 induces abortive cytokinesis, followed by mitotic catastrophe in a p80 katanin-dependent manner.  Cells that are rescued from this apoptotic pathway with Z-VAD-fmk display karyokinesis.  These results suggest that LAPSER1 participates in cytokinesis by interacting with p80 katanin, the disruption of which may potentially cause genetic instability and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6HEJ2ibPbU7Vg90H21EOLACvtfcHk0lgnR9w5-niEIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvVagsL8%253D&md5=d615348025024af922cb3d487f08e641</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-7254com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-7254com%26sid%3Dliteratum%253Aachs%26aulast%3DSudo%26aufirst%3DH.%26aulast%3DMaru%26aufirst%3DY.%26atitle%3DLAPSER1%2520is%2520a%2520putative%2520cytokinetic%2520tumor%2520suppressor%2520that%2520shows%2520the%2520same%2520centrosome%2520and%2520midbody%2520subcellular%2520localization%2520pattern%2520as%2520p80%2520katanin%26jtitle%3DFASEB%2520J.%26date%3D2007%26volume%3D21%26spage%3D2086%26epage%3D2100%26doi%3D10.1096%2Ffj.06-7254com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Yeh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. Y.</span><span> </span><span class="NLM_article-title">Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span><span class="refDoi"> DOI: 10.1164/rccm.201207-1180OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1164%2Frccm.201207-1180OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=23024022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2012&pages=1180-1188&author=C.+T.+Yehauthor=A.+T.+Wuauthor=P.+M.+Changauthor=K.+Y.+Chenauthor=C.+N.+Yangauthor=S.+C.+Yangauthor=C.+C.+Hoauthor=C.+C.+Chenauthor=Y.+L.+Kuoauthor=P.+Y.+Leeauthor=Y.+W.+Liuauthor=C.+C.+Yenauthor=M.+Hsiaoauthor=P.+J.+Luauthor=J.+M.+Laiauthor=L.+S.+Wangauthor=C.+H.+Wuauthor=J.+F.+Chiouauthor=P.+C.+Yangauthor=C.+Y.+Huang&title=Trifluoperazine%2C+an+antipsychotic+agent%2C+inhibits+cancer+stem+cell+growth+and+overcomes+drug+resistance+of+lung+cancer&doi=10.1164%2Frccm.201207-1180OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer</span></div><div class="casAuthors">Yeh, Chi-Tai; Wu, Alexander T. H.; Chang, Peter M.-H.; Chen, Kuan-Yu; Yang, Chia-Ning; Yang, Shuenn-Chen; Ho, Chao-Chi; Chen, Chun-Chi; Kuo, Yu-Lun; Lee, Pei-Ying; Liu, Yu-Wen; Yen, Chueh-Chuan; Hsiao, Michael; Lu, Pei-Jung; Lai, Jin-Mei; Wang, Liang-Shun; Wu, Chih-Hsiung; Chiou, Jeng-Fong; Yang, Pan-Chyr; Huang, Chi-Ying F.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1180-1188</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Cancer stem cell (CSC) theory has drawn much attention, with evidence supporting the contribution of stem cells to tumor initiation, relapse, and therapy resistance.  Objectives: To screen drugs that target CSCs to improve the current treatment outcome and overcome drug resistance in patients with lung cancer.  Methods: We used publicly available embryonic stem cell and CSC-assocd. gene signatures to query the Connectivity Map for potential drugs that can, at least in part, reverse the gene expression profile of CSCs.  High scores were noted for several phenothiazine-like antipsychotic drugs, including trifluoperazine.  We then treated lung CSCs with different EGFR mutation status with trifluoperazine to examine its anti-CSC properties.  Lung CSCs resistant to epidermal growth factor receptor-tyrosine kinase inhibitor or cisplatin were treated with trifluoperazine plus gefitinib or trifluoperazine plus cisplatin.  Animal models were used for in vivo validation of the anti-CSC effect and synergistic effect of trifluoperazine with gefitinib.  Measurements and Main Results: We demonstrated that trifluoperazine inhibited CSC tumor spheroid formation and down-regulated the expression of CSC markers (CD44/CD133).  Trifluoperazine inhibited Wnt/β-catenin signaling in gefitinib-resistant lung cancer spheroids.  The combination of trifluoperazine with either gefitinib or cisplatin overcame drug resistance in lung CSCs.  Trifluoperazine inhibited the tumor growth and enhanced the inhibitory activity of gefitinib in lung cancer metastatic and orthotopic CSC animal models.  Conclusions: Using in silico drug screening by Connectivity Map followed by empirical validations, we repurposed an existing phenothiazine-like antipsychotic drug, trifluoperazine, as a potential anti-CSC agent that could overcome epidermal growth factor receptor-tyrosine kinase inhibitor and chemotherapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPf24lWeMWQbVg90H21EOLACvtfcHk0lgnR9w5-niEIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOjtro%253D&md5=0bc2a899c88f4f891170194d22a32de9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1164%2Frccm.201207-1180OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201207-1180OC%26sid%3Dliteratum%253Aachs%26aulast%3DYeh%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DA.%2BT.%26aulast%3DChang%26aufirst%3DP.%2BM.%26aulast%3DChen%26aufirst%3DK.%2BY.%26aulast%3DYang%26aufirst%3DC.%2BN.%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DHo%26aufirst%3DC.%2BC.%26aulast%3DChen%26aufirst%3DC.%2BC.%26aulast%3DKuo%26aufirst%3DY.%2BL.%26aulast%3DLee%26aufirst%3DP.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BW.%26aulast%3DYen%26aufirst%3DC.%2BC.%26aulast%3DHsiao%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DP.%2BJ.%26aulast%3DLai%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DL.%2BS.%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DChiou%26aufirst%3DJ.%2BF.%26aulast%3DYang%26aufirst%3DP.%2BC.%26aulast%3DHuang%26aufirst%3DC.%2BY.%26atitle%3DTrifluoperazine%252C%2520an%2520antipsychotic%2520agent%252C%2520inhibits%2520cancer%2520stem%2520cell%2520growth%2520and%2520overcomes%2520drug%2520resistance%2520of%2520lung%2520cancer%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D186%26spage%3D1180%26epage%3D1188%26doi%3D10.1164%2Frccm.201207-1180OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Booth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proença, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaki, M. E. A.</span><span> </span><span class="NLM_article-title">The reactions of diaminomaleonitrile with isocyanates and either aldehydes or ketones revisited</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8436</span><span class="NLM_x">–</span> <span class="NLM_lpage">8441</span><span class="refDoi"> DOI: 10.1021/jo010595w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo010595w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=8436-8441&author=B.+L.+Boothauthor=A.+M.+Diasauthor=M.+F.+Proen%C3%A7aauthor=M.+E.+A.+Zaki&title=The+reactions+of+diaminomaleonitrile+with+isocyanates+and+either+aldehydes+or+ketones+revisited&doi=10.1021%2Fjo010595w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo010595w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010595w%26sid%3Dliteratum%253Aachs%26aulast%3DBooth%26aufirst%3DB.%2BL.%26aulast%3DDias%26aufirst%3DA.%2BM.%26aulast%3DProen%25C3%25A7a%26aufirst%3DM.%2BF.%26aulast%3DZaki%26aufirst%3DM.%2BE.%2BA.%26atitle%3DThe%2520reactions%2520of%2520diaminomaleonitrile%2520with%2520isocyanates%2520and%2520either%2520aldehydes%2520or%2520ketones%2520revisited%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D8436%26epage%3D8441%26doi%3D10.1021%2Fjo010595w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Davies, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span> </span><span class="NLM_article-title">Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.str.2008.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.str.2008.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=18462676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslGrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=715-726&author=J.+M.+Daviesauthor=A.+T.+Brungerauthor=W.+I.+Weis&title=Improved+structures+of+full-length+p97%2C+an+AAA+ATPase%3A+implications+for+mechanisms+of+nucleotide-dependent+conformational+change&doi=10.1016%2Fj.str.2008.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Structures of Full-Length p97, an AAA ATPase: Implications for Mechanisms of Nucleotide-Dependent Conformational Change</span></div><div class="casAuthors">Davies, Jason M.; Brunger, Axel T.; Weis, William I.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">715-726</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The ATPases assocd. with various cellular activities (AAA) protein p97 has been implicated in a variety of cellular processes, including endoplasmic reticulum-assocd. degrdn. and homotypic membrane fusion. p97 belongs to a subgroup of AAA proteins that contains two nucleotide binding domains, D1 and D2.  We detd. the crystal structure of D2 at 3.0 Å resoln.  This model enabled rerefinement of full-length p97 in different nucleotide states against previously reported low-resoln. diffraction data to significantly improved R values and Ramachandran statistics.  Although the overall fold remained similar, there are significant improvements, esp. around the D2 nucleotide binding site.  The rerefinement illustrates the importance of knowledge of high-resoln. structures of fragments covering most of the whole mol.  The structures suggest that nucleotide hydrolysis is transformed into larger conformational changes by pushing of one D2 domain by its neighbor in the hexamer, and transmission of nucleotide-state information through the D1-D2 linker to displace the N-terminal, effector binding domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopNlv0unl11rVg90H21EOLACvtfcHk0lgr5nPBqugFQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslGrtrY%253D&md5=bd90feb2579bd98e76c9e22f5814d605</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2008.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2008.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DJ.%2BM.%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DImproved%2520structures%2520of%2520full-length%2520p97%252C%2520an%2520AAA%2520ATPase%253A%2520implications%2520for%2520mechanisms%2520of%2520nucleotide-dependent%2520conformational%2520change%26jtitle%3DStructure%26date%3D2008%26volume%3D16%26spage%3D715%26epage%3D726%26doi%3D10.1016%2Fj.str.2008.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kelley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezulis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wass, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, M. J.</span><span> </span><span class="NLM_article-title">The Phyre2 web portal for protein modeling, prediction and analysis</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span><span class="refDoi"> DOI: 10.1038/nprot.2015.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnprot.2015.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=25950237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFSqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=845-858&author=L.+A.+Kelleyauthor=S.+Mezulisauthor=C.+M.+Yatesauthor=M.+N.+Wassauthor=M.+J.+Sternberg&title=The+Phyre2+web+portal+for+protein+modeling%2C+prediction+and+analysis&doi=10.1038%2Fnprot.2015.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Phyre2 web portal for protein modeling, prediction and analysis</span></div><div class="casAuthors">Kelley, Lawrence A.; Mezulis, Stefans; Yates, Christopher M.; Wass, Mark N.; Sternberg, Michael J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">845-858</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phyre2 is a suite of tools available on the web to predict and analyze protein structure, function and mutations.  The focus of Phyre2 is to provide biologists with a simple and intuitive interface to state-of-the-art protein bioinformatics tools.  Phyre2 replaces Phyre, the original version of the server for which the authors previously published a paper in Nature Protocols.  In this updated protocol, the authors describe Phyre2, which uses advanced remote homol. detection methods to build 3D models, predict ligand binding sites and analyze the effect of amino acid variants (e.g., nonsynonymous SNPs (nsSNPs)) for a user's protein sequence.  Users are guided through results by a simple interface at a level of detail they det.  This protocol will guide users from submitting a protein sequence to interpreting the secondary and tertiary structure of their models, their domain compn. and model quality.  A range of addnl. available tools is described to find a protein structure in a genome, to submit large no. of sequences at once and to automatically run weekly searches for proteins that are difficult to model.  The server is available at http://www.sbg.bio.ic.ac.uk/phyre2.  A typical structure prediction will be returned between 30 min and 2 h after submission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNEic1KXsLCrVg90H21EOLACvtfcHk0lgr5nPBqugFQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFSqurs%253D&md5=e69b1b5c799cc3b8e3a562c90299a813</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2015.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2015.053%26sid%3Dliteratum%253Aachs%26aulast%3DKelley%26aufirst%3DL.%2BA.%26aulast%3DMezulis%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DC.%2BM.%26aulast%3DWass%26aufirst%3DM.%2BN.%26aulast%3DSternberg%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520Phyre2%2520web%2520portal%2520for%2520protein%2520modeling%252C%2520prediction%2520and%2520analysis%26jtitle%3DNat.%2520Protoc.%26date%3D2015%26volume%3D10%26spage%3D845%26epage%3D858%26doi%3D10.1038%2Fnprot.2015.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lgr5nPBqugFQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hartman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vale, R. D.</span><span> </span><span class="NLM_article-title">Microtubule disassembly by ATP-dependent oligomerization of the AAA enzyme katanin</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span><span class="refDoi"> DOI: 10.1126/science.286.5440.782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1126%2Fscience.286.5440.782" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=782-785&author=J.+J.+Hartmanauthor=R.+D.+Vale&title=Microtubule+disassembly+by+ATP-dependent+oligomerization+of+the+AAA+enzyme+katanin&doi=10.1126%2Fscience.286.5440.782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.782%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DJ.%2BJ.%26aulast%3DVale%26aufirst%3DR.%2BD.%26atitle%3DMicrotubule%2520disassembly%2520by%2520ATP-dependent%2520oligomerization%2520of%2520the%2520AAA%2520enzyme%2520katanin%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D782%26epage%3D785%26doi%3D10.1126%2Fscience.286.5440.782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowska, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karabay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korulu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baas, P. W.</span><span> </span><span class="NLM_article-title">The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span><span class="refDoi"> DOI: 10.1091/mbc.E07-09-0878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1091%2Fmbc.E07-09-0878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=18234839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1485-1498&author=W.+Yuauthor=L.+Qiangauthor=J.+M.+Solowskaauthor=A.+Karabayauthor=S.+Koruluauthor=P.+W.+Baas&title=The+microtubule-severing+proteins+spastin+and+katanin+participate+differently+in+the+formation+of+axonal+branches&doi=10.1091%2Fmbc.E07-09-0878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches</span></div><div class="casAuthors">Yu, Wenqian; Qiang, Liang; Solowska, Joanna M.; Karabay, Arzu; Korulu, Sirin; Baas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1485-1498</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Neurons express 2 different microtubule-severing proteins, namely p60-katanin and spastin.  Here, the authors performed studies with cultured neurons to ascertain whether these 2 proteins participate differently in axonal branch formation.  The protein, p60-katanin, was more highly expressed in the neuron, but spastin is more concd. at sites of branch formation.  Overexpression of spastin dramatically enhanced the formation of branches, whereas overexpression of p60-katanin did not.  The excess spastin resulted in large nos. of short microtubules, whereas the excess p60-katanin resulted in short microtubules intermingled with longer microtubules.  The authors hypothesized that these different microtubule-severing patterns may be due to the presence of mols. such as tau on the microtubules that more strongly shield them from being severed by p60-katanin than by spastin.  Consistent with this hypothesis, it was found that axons depleted of tau showed a greater propensity to branch, and that this was true whether or not the axons were also depleted of spastin.  It was proposed that there are 2 modes by which microtubule severing is orchestrated during axonal branch formation, one based on the local concn. of spastin at branch sites and the other based on local detachment from microtubules of mols. such as tau that regulate the severing properties of p60-katanin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsDVWe6cKEtbVg90H21EOLACvtfcHk0lj15yJDAof0tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemtLs%253D&md5=af4798f7192e067c0f75d771933dd336</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E07-09-0878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E07-09-0878%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DSolowska%26aufirst%3DJ.%2BM.%26aulast%3DKarabay%26aufirst%3DA.%26aulast%3DKorulu%26aufirst%3DS.%26aulast%3DBaas%26aufirst%3DP.%2BW.%26atitle%3DThe%2520microtubule-severing%2520proteins%2520spastin%2520and%2520katanin%2520participate%2520differently%2520in%2520the%2520formation%2520of%2520axonal%2520branches%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26spage%3D1485%26epage%3D1498%26doi%3D10.1091%2Fmbc.E07-09-0878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Liu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, J. P.</span><span> </span><span class="NLM_article-title">Tubulin inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1517/13543776.2014.859247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1517%2F13543776.2014.859247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=24313741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSlurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=69-88&author=Y.+M.+Liuauthor=H.+L.+Chenauthor=H.+Y.+Leeauthor=J.+P.+Liou&title=Tubulin+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2014.859247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin inhibitors: a patent review</span></div><div class="casAuthors">Liu, Yi-Min; Chen, Hsiao-Ling; Lee, Hsueh-Yun; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-88</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Microtubules play an important role in several cellular processes, particularly in the formation of the mitotic spindle during the process of mitosis.  These highly dynamic mitotic-spindle microtubules have become a successful target of cancer therapy.  Microtubule-targeting agents, such as vinca alkaloids and taxanes, were used in clinic over 50 years.  In past decades, development of new antimicrotubule agents that possess different structure and binding sites of tubulin has shown potent activity against the proliferation of various cancer cells, as well as in multidrug-resistant cancers.  Interestingly, many of these agents represent an attractive ability that targeting the tumor blood vessels results in tumor vascular disruption.  Therefore, exploring new agents and strategies may provide more effective therapeutic options in the related treatment of cancer.  Areas covered: In past few years, there are many chem. compds. that successfully interferes the microtubules and display antitumor effect.  In these, published compds. supply the fresh minds in modification of present drugs and new insights into the development of tubulin inhibitors.  Expert opinion: This article arranges the microtubule-targeting agents that have published in patent in recent years.  It may help in the investigation of new tubulin binding site and development of novel drug candidate in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtnvpvVK8NmrVg90H21EOLACvtfcHk0lj15yJDAof0tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSlurvP&md5=e17a15b0f0538911f2a80035edbf89b7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.859247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.859247%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DChen%26aufirst%3DH.%2BL.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DLiou%26aufirst%3DJ.%2BP.%26atitle%3DTubulin%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D69%26epage%3D88%26doi%3D10.1517%2F13543776.2014.859247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gascoigne, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">How do anti-mitotic drugs kill cancer cells?</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2585</span><span class="refDoi"> DOI: 10.1242/jcs.039719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1242%2Fjcs.039719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19625502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGhsL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=2579-2585&author=K.+E.+Gascoigneauthor=S.+S.+Taylor&title=How+do+anti-mitotic+drugs+kill+cancer+cells%3F&doi=10.1242%2Fjcs.039719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">How do anti-mitotic drugs kill cancer cells?</span></div><div class="casAuthors">Gascoigne, Karen E.; Taylor, Stephen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2579-2585</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2007, over 12-million people were diagnosed with cancer.  According to the American Cancer Society, at least one third of these individuals are not expected to survive the disease, making cancer the second most prevalent cause of death worldwide.  Systemic chemotherapy forms the mainstay of cancer treatment, and agents that disrupt mitotic spindle assembly - so called 'anti-mitotics' - are commonly used to treat a wide variety of cancers.  Traditional anti-mitotic agents include the microtubule toxins such as taxol, other taxanes and the vinca alkaloids, all of which have proven successful in the clinic.  However, patient response remains highly unpredictable, and drug resistance is common.  In addn., toxicity is a problem.  To address these limitations, a new generation of anti-mitotic drugs is being developed.  As the first wave of these new agents enters clin. trails, much hope rests on their outcome.  Meanwhile, significant attention is being focused on trying to predict which tumor types are likely to respond.  In this commentary, the authors outline recent advances in our understanding of how cancer cells respond to anti-mitotic drugs, and discuss the relevance of these studies to their use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlOxbKmqBe5bVg90H21EOLACvtfcHk0lj15yJDAof0tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGhsL7F&md5=76a39836b4f069883cc6a4400e7edd92</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1242%2Fjcs.039719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.039719%26sid%3Dliteratum%253Aachs%26aulast%3DGascoigne%26aufirst%3DK.%2BE.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DHow%2520do%2520anti-mitotic%2520drugs%2520kill%2520cancer%2520cells%253F%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2009%26volume%3D122%26spage%3D2579%26epage%3D2585%26doi%3D10.1242%2Fjcs.039719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Urra, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordova-Delgado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessoa-Mahana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez-Rodríguez, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss-Lopez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araya-Maturana, R.</span><span> </span><span class="NLM_article-title">Mitochondria: a promising target for anticancer alkaloids</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2171</span><span class="NLM_x">–</span> <span class="NLM_lpage">2183</span><span class="refDoi"> DOI: 10.2174/15680266113139990150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.2174%2F15680266113139990150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=23978135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyrsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=2171-2183&author=F.+A.+Urraauthor=M.+Cordova-Delgadoauthor=H.+Pessoa-Mahanaauthor=O.+Ram%C3%ADrez-Rodr%C3%ADguezauthor=B.+Weiss-Lopezauthor=J.+Ferreiraauthor=R.+Araya-Maturana&title=Mitochondria%3A+a+promising+target+for+anticancer+alkaloids&doi=10.2174%2F15680266113139990150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria: A Promising Target for Anticancer Alkaloids</span></div><div class="casAuthors">Urra, Felix A.; Cordova-Delgado, Miguel; Pessoa-Mahana, Hernan; Ramirez-Rodriguez, Oney; Weiss-Lopez, Boris; Ferreira, Jorge; Araya-Maturana, Ramiro</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2171-2183</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A great no. of alkaloids exhibit high potential in cancer research.  Some of them are anticancer drugs with well-defined clin. uses, exerting their action on microtubules dynamics or DNA replication and topol.  On the other hand, mitochondria have been recognized as an essential organelle in the establishment of tumor characteristics, esp. the resistance to cell death, high proliferative capacity and adaptation to unfavorable cellular environment.  Interestingly, many alkaloids exert their anticancer activities affecting selectively some functions of the tumor mitochondria by (1) modulating OXPHOS and ADP/ATP transport, (2) increasing ROS levels and mitochondrial potential dissipation by crosstalk between endoplasmic reticulum (ER) and mitochondria, (3) inducing mitochondria-dependent apoptosis and autophagy, (4) inhibiting mitochondrial metabolic pathways and (5) by alteration of the morphol. and biogenesis of this organelle.  These antecedents show the relevance of developing research about the effects of alkaloids on functions controlled by tumor mitochondria, offering an attractive target for the design of new alkaloid derivs., considering organelle-specific delivery strategies.  This review describes mitochondria as a central component in the anticancer action of a set of alkaloids, in a way to illustrate the importance of this organelle in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIsLKfm7FUMLVg90H21EOLACvtfcHk0ljzvmz3MUUPnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyrsLzO&md5=b211a21ccdc5f901c36172d4cbd09525</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990150%26sid%3Dliteratum%253Aachs%26aulast%3DUrra%26aufirst%3DF.%2BA.%26aulast%3DCordova-Delgado%26aufirst%3DM.%26aulast%3DPessoa-Mahana%26aufirst%3DH.%26aulast%3DRam%25C3%25ADrez-Rodr%25C3%25ADguez%26aufirst%3DO.%26aulast%3DWeiss-Lopez%26aufirst%3DB.%26aulast%3DFerreira%26aufirst%3DJ.%26aulast%3DAraya-Maturana%26aufirst%3DR.%26atitle%3DMitochondria%253A%2520a%2520promising%2520target%2520for%2520anticancer%2520alkaloids%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D2171%26epage%3D2183%26doi%3D10.2174%2F15680266113139990150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span> </span><span class="NLM_article-title">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1038/nrm3722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrm3722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=24355989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=49-63&author=P.+E.+Czabotarauthor=G.+Lesseneauthor=A.+Strasserauthor=J.+M.+Adams&title=Control+of+apoptosis+by+the+BCL-2+protein+family%3A+implications+for+physiology+and+therapy&doi=10.1038%2Fnrm3722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span></div><div class="casAuthors">Czabotar, Peter E.; Lessene, Guillaume; Strasser, Andreas; Adams, Jerry M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-63</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The BCL-2 protein family dets. the commitment of cells to apoptosis, an ancient cell suicide program that is essential for development, tissue homeostasis and immunity.  Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischemic conditions and drive neurodegeneration.  We discuss the biochem., structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold.  These mechanistic insights into the functions of the BCL-2 family are illuminating the physiol. control of apoptosis, the pathol. consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVpm2heUGBbVg90H21EOLACvtfcHk0ljzvmz3MUUPnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI&md5=c18d528c2819c2df93b6798e62132372</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrm3722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3722%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DControl%2520of%2520apoptosis%2520by%2520the%2520BCL-2%2520protein%2520family%253A%2520implications%2520for%2520physiology%2520and%2520therapy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D49%26epage%3D63%26doi%3D10.1038%2Fnrm3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. C.</span><span> </span><span class="NLM_article-title">CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents</span> <span class="citation_source-journal">Cell Biol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1002/cbin.10259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fcbin.10259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=24677263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslylur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=737-746&author=L.+Zhouauthor=X.+Caiauthor=X.+Hanauthor=N.+Xuauthor=D.+C.+Chang&title=CDK1+switches+mitotic+arrest+to+apoptosis+by+phosphorylating+Bcl-2%2FBax+family+proteins+during+treatment+with+microtubule+interfering+agents&doi=10.1002%2Fcbin.10259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents</span></div><div class="casAuthors">Zhou, Lingli; Cai, Xiaoling; Han, Xueyao; Xu, Naihan; Chang, Donald C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-746</span>CODEN:
                <span class="NLM_cas:coden">CBIIEV</span>;
        ISSN:<span class="NLM_cas:issn">1065-6995</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Microtubule interfering agents (MIAs), that can stabilize or depolymerise microtubules, are an important class of cancer chemotherapeutic drugs.  They can lead to mitotic arrest and subsequent apoptosis.  We demonstrate that cell cycle-dependent kinase 1 (CDK1) is important in switching cells from mitotic arrest to apoptosis during MIAs treatment.  Overexpression of non-degradable cyclin B1 sustained CDK1 activation and mitotic arrest, followed by caspase-3 dependent apoptosis.  CDK1 is responsible for the phosphorylation of several pro- and anti-apoptotic Bcl-2 family proteins during MIAs treatment.  CDK1-mediated Bcl-2 serine 70 phosphorylation enhances its pro-apoptotic function, whereas CDK1-mediated Bad serine 128 phosphorylation promotes apoptosis.  Blockage of CDK1 activity with a specific pharmacol. inhibitor suppresses Mcl-1 phosphorylation, degrdn. and its anti-apoptotic function.  Therefore, the death of cancer cells under MIAs treatment was caused by imbalance between CDK1-induced alterations in the pro-apoptotic and anti-apoptotic functions of phosphorylated Bcl-2 family proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYHxMEXY9tubVg90H21EOLACvtfcHk0ljzvmz3MUUPnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslylur4%253D&md5=a1b1be983d9be232cb5d466d9501eddb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbin.10259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbin.10259%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DChang%26aufirst%3DD.%2BC.%26atitle%3DCDK1%2520switches%2520mitotic%2520arrest%2520to%2520apoptosis%2520by%2520phosphorylating%2520Bcl-2%252FBax%2520family%2520proteins%2520during%2520treatment%2520with%2520microtubule%2520interfering%2520agents%26jtitle%3DCell%2520Biol.%2520Int.%26date%3D2014%26volume%3D38%26spage%3D737%26epage%3D746%26doi%3D10.1002%2Fcbin.10259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, B.</span><span> </span><span class="NLM_article-title">Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span><span class="refDoi"> DOI: 10.4161/auto.6788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.4161%2Fauto.6788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=18769111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12rurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=949-951&author=Y.+Weiauthor=S.+Sinhaauthor=B.+Levine&title=Dual+role+of+JNK1-mediated+phosphorylation+of+Bcl-2+in+autophagy+and+apoptosis+regulation&doi=10.4161%2Fauto.6788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation</span></div><div class="casAuthors">Wei, Yongjie; Sinha, Sangita; Levine, Beth</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">949-951</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Autophagy and apoptosis are fundamental cellular pathways that are both regulated by JNK-mediated Bcl-2 phosphorylation.  Several years ago, JNK-mediated Bcl-2 phosphorylation was shown to interfere with its binding to proapoptotic BH3 domain-contg. proteins such as Bax and recently, our lab. demonstrated that JNK1-mediated Bcl-2 phosphorylation interferes with its binding to the proautophagy BH3 domain-contg. protein Beclin 1.  Here, we examd. the kinetic relationship between Bcl-2 phosphorylation, Bcl-2-Beclin 1 interactions, Bcl-2-Bax interactions, and caspase 3 activation during nutrient starvation.  We found that after a short period of nutrient deprivation (4 h), a small amt. of Bcl-2 phosphorylation dissocs. Bcl-2 from the Bcl-2-Beclin 1 complex but not from the Bcl-2-Bax complex.  After 16 h of nutrient deprivation, Bcl-2 phosphorylation readies maximal levels, the Bcl-2-Bax complex is disrupted, and active caspase 3 is detected, indicating the initiation of apoptosis.  Based on this result, we propose a speculative model for understanding the interrelationship between autophagy and apoptosis regulated by JNK1-mediated Bcl-2 phosphorylation.  According to this model, rapid Bcl-2 phosphorylation may occur initially to promote cell survival by disrupting the Bcl-2-Beclin 1 complex and activating autophagy.  At a certain point when autophagy is no longer able to keep the cell alive, Bcl-2 phosphorylation might then serve to inactivate its antiapoptotic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCZBQajDxy7rVg90H21EOLACvtfcHk0lipqS6FUmJ8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12rurnM&md5=656cd9117b0f913ecab3b25146a50178</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4161%2Fauto.6788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6788%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DY.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DLevine%26aufirst%3DB.%26atitle%3DDual%2520role%2520of%2520JNK1-mediated%2520phosphorylation%2520of%2520Bcl-2%2520in%2520autophagy%2520and%2520apoptosis%2520regulation%26jtitle%3DAutophagy%26date%3D2008%26volume%3D4%26spage%3D949%26epage%3D951%26doi%3D10.4161%2Fauto.6788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bogoyevitch, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobe, B.</span><span> </span><span class="NLM_article-title">Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases</span> <span class="citation_source-journal">Microbiol. Mol. Biol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1128/MMBR.00025-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1128%2FMMBR.00025-06" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1061-1095&author=M.+A.+Bogoyevitchauthor=B.+Kobe&title=Uses+for+JNK%3A+the+many+and+varied+substrates+of+the+c-Jun+N-terminal+kinases&doi=10.1128%2FMMBR.00025-06"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00025-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00025-06%26sid%3Dliteratum%253Aachs%26aulast%3DBogoyevitch%26aufirst%3DM.%2BA.%26aulast%3DKobe%26aufirst%3DB.%26atitle%3DUses%2520for%2520JNK%253A%2520the%2520many%2520and%2520varied%2520substrates%2520of%2520the%2520c-Jun%2520N-terminal%2520kinases%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2006%26volume%3D70%26spage%3D1061%26epage%3D1095%26doi%3D10.1128%2FMMBR.00025-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Chen, F.</span><span> </span><span class="NLM_article-title">JNK-induced apoptosis, compensatory growth, and cancer stem cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-1982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1158%2F0008-5472.CAN-11-1982" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=379-386&author=F.+Chen&title=JNK-induced+apoptosis%2C+compensatory+growth%2C+and+cancer+stem+cells&doi=10.1158%2F0008-5472.CAN-11-1982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-1982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-1982%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26atitle%3DJNK-induced%2520apoptosis%252C%2520compensatory%2520growth%252C%2520and%2520cancer%2520stem%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D379%26epage%3D386%26doi%3D10.1158%2F0008-5472.CAN-11-1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, D.</span><span> </span><span class="NLM_article-title">Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1194/jlr.M024398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1194%2Fjlr.M024398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=1093-1105&author=J.+Maauthor=L.+Zhangauthor=W.+Hanauthor=T.+Shenauthor=C.+Maauthor=Y.+Liuauthor=X.+Nieauthor=M.+Liuauthor=Y.+Ranauthor=D.+Zhu&title=Activation+of+JNK%2Fc-Jun+is+required+for+the+proliferation%2C+survival%2C+and+angiogenesis+induced+by+EET+in+pulmonary+artery+endothelial+cells&doi=10.1194%2Fjlr.M024398"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M024398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M024398%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNie%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DD.%26atitle%3DActivation%2520of%2520JNK%252Fc-Jun%2520is%2520required%2520for%2520the%2520proliferation%252C%2520survival%252C%2520and%2520angiogenesis%2520induced%2520by%2520EET%2520in%2520pulmonary%2520artery%2520endothelial%2520cells%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2012%26volume%3D53%26spage%3D1093%26epage%3D1105%26doi%3D10.1194%2Fjlr.M024398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Avisetti, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalivendi, S. V.</span><span> </span><span class="NLM_article-title">Activation of p38/JNK pathway is responsible for embelin induced apoptosis in lung cancer cells: transitional role of reactive oxygen species</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e87050</span><span class="refDoi"> DOI: 10.1371/journal.pone.0087050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1371%2Fjournal.pone.0087050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e87050&author=D.+R.+Avisettiauthor=K.+S.+Babuauthor=S.+V.+Kalivendi&title=Activation+of+p38%2FJNK+pathway+is+responsible+for+embelin+induced+apoptosis+in+lung+cancer+cells%3A+transitional+role+of+reactive+oxygen+species&doi=10.1371%2Fjournal.pone.0087050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0087050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0087050%26sid%3Dliteratum%253Aachs%26aulast%3DAvisetti%26aufirst%3DD.%2BR.%26aulast%3DBabu%26aufirst%3DK.%2BS.%26aulast%3DKalivendi%26aufirst%3DS.%2BV.%26atitle%3DActivation%2520of%2520p38%252FJNK%2520pathway%2520is%2520responsible%2520for%2520embelin%2520induced%2520apoptosis%2520in%2520lung%2520cancer%2520cells%253A%2520transitional%2520role%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De87050%26doi%3D10.1371%2Fjournal.pone.0087050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Deng, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. K.</span><span> </span><span class="NLM_article-title">Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1002/mc.20583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fmc.20583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19777565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFSjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=141-151&author=Y.+T.+Dengauthor=H.+C.+Huangauthor=J.+K.+Lin&title=Rotenone+induces+apoptosis+in+MCF-7+human+breast+cancer+cell-mediated+ROS+through+JNK+and+p38+signaling&doi=10.1002%2Fmc.20583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling</span></div><div class="casAuthors">Deng, Yea-Tzy; Huang, Hsiu-Chen; Lin, Jen-Kun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-151</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Rotenone is an inhibitor of the mitochondrial electron transport chain complex I, resulting in the generation of reactive oxygen species (ROS).  Rotenone has been shown to display anticancer activity through the induction of apoptosis in various cancer cells.  However, the underlying mechanism is still not fully understood.  Here, rotenone showed a strong growth inhibitory effect against human breast cancer MCF-7 cells.  DNA flow cytometric anal., chromatin condensation, and poly (ADP-ribose) polymerase (PARP) cleavage indicated rotenone actively induced apoptosis in MCF-7 cells.  The antiapoptotic protein, Bcl-2, was decreased, whereas the apoptotic protein, Bax, was increased in a time-dependent manner in rotenone-induced apoptosis.  Moreover, the treatment of rotenone in MCF-7 cells caused the activation of c-jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinases (MAPKs), and the inactivation of extracellular signal-regulated protein kinase 1/2 (ERK1/2).  The pharmacol. inhibition of JNK and p38 MAPK revealed significant protection against rotenone-induced apoptosis.  Taken together, these results indicate rotenone may induce apoptosis through ROS and JNK/p38 MAPKs activation in MCF-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzifnzoA1jzLVg90H21EOLACvtfcHk0lipqS6FUmJ8iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFSjsro%253D&md5=9ae02acfd5ce1aa7b530a8f7343703ba</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fmc.20583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20583%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DY.%2BT.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DLin%26aufirst%3DJ.%2BK.%26atitle%3DRotenone%2520induces%2520apoptosis%2520in%2520MCF-7%2520human%2520breast%2520cancer%2520cell-mediated%2520ROS%2520through%2520JNK%2520and%2520p38%2520signaling%26jtitle%3DMol.%2520Carcinog.%26date%3D2010%26volume%3D49%26spage%3D141%26epage%3D151%26doi%3D10.1002%2Fmc.20583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kolomeichuk, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrano, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabapathy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, T. C.</span><span> </span><span class="NLM_article-title">Distinct signaling pathways of microtubule inhibitors--vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1889</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2008.06349.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1111%2Fj.1742-4658.2008.06349.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=1889-1899&author=S.+N.+Kolomeichukauthor=D.+T.+Terranoauthor=C.+S.+Lyleauthor=K.+Sabapathyauthor=T.+C.+Chambers&title=Distinct+signaling+pathways+of+microtubule+inhibitors%2D%2Dvinblastine+and+Taxol+induce+JNK-dependent+cell+death+but+through+AP-1-dependent+and+AP-1-independent+mechanisms%2C+respectively&doi=10.1111%2Fj.1742-4658.2008.06349.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2008.06349.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2008.06349.x%26sid%3Dliteratum%253Aachs%26aulast%3DKolomeichuk%26aufirst%3DS.%2BN.%26aulast%3DTerrano%26aufirst%3DD.%2BT.%26aulast%3DLyle%26aufirst%3DC.%2BS.%26aulast%3DSabapathy%26aufirst%3DK.%26aulast%3DChambers%26aufirst%3DT.%2BC.%26atitle%3DDistinct%2520signaling%2520pathways%2520of%2520microtubule%2520inhibitors--vinblastine%2520and%2520Taxol%2520induce%2520JNK-dependent%2520cell%2520death%2520but%2520through%2520AP-1-dependent%2520and%2520AP-1-independent%2520mechanisms%252C%2520respectively%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D1889%26epage%3D1899%26doi%3D10.1111%2Fj.1742-4658.2008.06349.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Choi, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanh, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, Q. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harikishore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanga, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharatham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, H. S.</span><span> </span><span class="NLM_article-title">Suprafenacine, an indazole-hydrazide agent, targets cancer cells through microtubule destabilization</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e110955</span><span class="refDoi"> DOI: 10.1371/journal.pone.0110955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1371%2Fjournal.pone.0110955" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e110955&author=B.+H.+Choiauthor=S.+Chattopadhayaauthor=L.+N.+Thanhauthor=L.+Fengauthor=Q.+T.+Nguyenauthor=C.+B.+Limauthor=A.+Harikishoreauthor=R.+P.+Nangaauthor=N.+Bharathamauthor=Y.+Zhaoauthor=X.+Liuauthor=H.+S.+Yoon&title=Suprafenacine%2C+an+indazole-hydrazide+agent%2C+targets+cancer+cells+through+microtubule+destabilization&doi=10.1371%2Fjournal.pone.0110955"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0110955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0110955%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DB.%2BH.%26aulast%3DChattopadhaya%26aufirst%3DS.%26aulast%3DThanh%26aufirst%3DL.%2BN.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DNguyen%26aufirst%3DQ.%2BT.%26aulast%3DLim%26aufirst%3DC.%2BB.%26aulast%3DHarikishore%26aufirst%3DA.%26aulast%3DNanga%26aufirst%3DR.%2BP.%26aulast%3DBharatham%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26atitle%3DSuprafenacine%252C%2520an%2520indazole-hydrazide%2520agent%252C%2520targets%2520cancer%2520cells%2520through%2520microtubule%2520destabilization%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De110955%26doi%3D10.1371%2Fjournal.pone.0110955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span> </span><span class="NLM_article-title">Microtubules as a target for anticancer drugs</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1038/nrc1317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrc1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=15057285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=253-265&author=M.+A.+Jordanauthor=L.+Wilson&title=Microtubules+as+a+target+for+anticancer+drugs&doi=10.1038%2Fnrc1317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules as a target for anticancer drugs</span></div><div class="casAuthors">Jordan, Mary Ann; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-265</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy.  Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass.  Although these effects might have a role in their chemotherapeutic actions, we now know that at lower concns., microtubule-targeted drugs can suppress microtubule dynamics without changing microtubule mass; this action leads to mitotic block and apoptosis.  In addn. to the expanding array of chem. diverse antimitotic agents, some microtubule-targeted drugs can act as vascular-targeting agents, rapidly depolymg. microtubules of newly formed vasculature to shut down the blood supply to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJbrFnzwqjbVg90H21EOLACvtfcHk0liKf8X2zLFWmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D&md5=bbbf212e03ffe6763098fc41f21a8158</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrc1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1317%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMicrotubules%2520as%2520a%2520target%2520for%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D253%26epage%3D265%26doi%3D10.1038%2Fnrc1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Pasquier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavallaris, M.</span><span> </span><span class="NLM_article-title">Microtubules: a dynamic target in cancer therapy</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1002/iub.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fiub.25" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=165-170&author=E.+Pasquierauthor=M.+Kavallaris&title=Microtubules%3A+a+dynamic+target+in+cancer+therapy&doi=10.1002%2Fiub.25"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fiub.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fiub.25%26sid%3Dliteratum%253Aachs%26aulast%3DPasquier%26aufirst%3DE.%26aulast%3DKavallaris%26aufirst%3DM.%26atitle%3DMicrotubules%253A%2520a%2520dynamic%2520target%2520in%2520cancer%2520therapy%26jtitle%3DIUBMB%2520Life%26date%3D2008%26volume%3D60%26spage%3D165%26epage%3D170%26doi%3D10.1002%2Fiub.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Roll-Mecak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, F. J.</span><span> </span><span class="NLM_article-title">Microtubule-severing enzymes</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1016/j.ceb.2009.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.ceb.2009.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19963362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslWqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=96-103&author=A.+Roll-Mecakauthor=F.+J.+McNally&title=Microtubule-severing+enzymes&doi=10.1016%2Fj.ceb.2009.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-severing enzymes</span></div><div class="casAuthors">Roll-Mecak, Antonina; McNally, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-103</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In 1993, an enzyme with an ATP-dependent microtubule-severing activity was purified from sea urchin eggs and named katanin, after the Japanese word for sword.  It is now known that katanin, spastin, and fidgetin form a family of closely related microtubule-severing enzymes that is widely distributed in eukaryotes ranging from Tetrahymena and Chlamydomonas to humans.  Here, the authors review the diverse in vivo functions of these proteins and the recent significant advances in deciphering the biophys. mechanism of microtubule severing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0R3Af87sWTLVg90H21EOLACvtfcHk0liKf8X2zLFWmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslWqtr0%253D&md5=988b74105af4271c3bf529e513153e9c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DRoll-Mecak%26aufirst%3DA.%26aulast%3DMcNally%26aufirst%3DF.%2BJ.%26atitle%3DMicrotubule-severing%2520enzymes%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2010%26volume%3D22%26spage%3D96%26epage%3D103%26doi%3D10.1016%2Fj.ceb.2009.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Ahmad, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baas, P. W.</span><span> </span><span class="NLM_article-title">An essential role for katanin in severing microtubules in the neuron</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1083/jcb.145.2.305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1083%2Fjcb.145.2.305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1999&pages=305-315&author=F.+J.+Ahmadauthor=W.+Yuauthor=F.+J.+McNallyauthor=P.+W.+Baas&title=An+essential+role+for+katanin+in+severing+microtubules+in+the+neuron&doi=10.1083%2Fjcb.145.2.305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1083%2Fjcb.145.2.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.145.2.305%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DF.%2BJ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMcNally%26aufirst%3DF.%2BJ.%26aulast%3DBaas%26aufirst%3DP.%2BW.%26atitle%3DAn%2520essential%2520role%2520for%2520katanin%2520in%2520severing%2520microtubules%2520in%2520the%2520neuron%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1999%26volume%3D145%26spage%3D305%26epage%3D315%26doi%3D10.1083%2Fjcb.145.2.305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Sudo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baas, P. W.</span><span> </span><span class="NLM_article-title">Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">7215</span><span class="NLM_x">–</span> <span class="NLM_lpage">7226</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0048-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1523%2FJNEUROSCI.0048-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=20505088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVOis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=7215-7226&author=H.+Sudoauthor=P.+W.+Baas&title=Acetylation+of+microtubules+influences+their+sensitivity+to+severing+by+katanin+in+neurons+and+fibroblasts&doi=10.1523%2FJNEUROSCI.0048-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts</span></div><div class="casAuthors">Sudo, Haruka; Baas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7215-7226</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Here we investigated whether the sensitivity of microtubules to severing by katanin is regulated by acetylation of the microtubules.  During interphase, fibroblasts display long microtubules with discrete regions rich in acetylated tubulin.  Overexpression of katanin for short periods of time produced breaks preferentially in these regions.  In fibroblasts with exptl. enhanced or diminished microtubule acetylation, the sensitivity of the microtubules to severing by katanin was increased or decreased, resp.  In neurons, microtubules are notably more acetylated in axons than in dendrites.  Exptl. manipulation of microtubule acetylation in neurons yielded similar results on dendrites as obsd. on fibroblasts.  However, under these exptl. conditions, axonal microtubules microtubule were not appreciably altered with regard to their sensitivity to katanin.  We hypothesized that this may be attributable to the effects of tau on the axonal microtubules, and this was validated by studies in which overexpression of tau caused microtubules in dendrites and fibroblasts to be more resistant to severing by katanin in a manner that was not dependent on the acetylation state of the microtubules.  Interestingly, none of these various findings apply to spastin, because the severing of microtubules by spastin does not appear to be strongly influenced by either the acetylation state of the microtubules or tau.  We conclude that sensitivity to microtubule severing by katanin is regulated by a balance of factors, including the acetylation state of the microtubules and te binding of tau to the microtubules.  In the neuron, this contributes to regional differences in the microtubule arrays of axons and dendrites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6G5g-v-rY7Vg90H21EOLACvtfcHk0lhNUZt8hA2IdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVOis7g%253D&md5=b0529df3f92697ce80c4ff1cce1e4857</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0048-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0048-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DSudo%26aufirst%3DH.%26aulast%3DBaas%26aufirst%3DP.%2BW.%26atitle%3DAcetylation%2520of%2520microtubules%2520influences%2520their%2520sensitivity%2520to%2520severing%2520by%2520katanin%2520in%2520neurons%2520and%2520fibroblasts%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D7215%26epage%3D7226%26doi%3D10.1523%2FJNEUROSCI.0048-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Shiina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">Microtubule-severing activity in M phase</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1016/S0962-8924(00)89040-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2FS0962-8924%2800%2989040-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=14732113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADyaK2MXntValtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=283-286&author=N.+Shiinaauthor=Y.+Gotohauthor=E.+Nishida&title=Microtubule-severing+activity+in+M+phase&doi=10.1016%2FS0962-8924%2800%2989040-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-severing activity in M phase</span></div><div class="casAuthors">Shiina, Nobuyuki; Gotoh, Yukiko; Nishida, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">283-6</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    </div><div class="casAbstract">A review, with 41 refs.  The stable cytoplasmic microtubules that emanate from centrosomes in eukaryotic cells disappear at the onset of M phase and are replaced by the dynamic microtubules of the mitotic spindle.  Microtubule-severing activity increases significantly under the control of maturation-promoting factor at the transition between G2 phase and M phase, and is thought to be involved in the microtubule reorganization.  This review highlights three microtubule-severing factors that may be responsible for microtubule-severing activity in M phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUPxeA16nMVLVg90H21EOLACvtfcHk0lhNUZt8hA2IdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntValtbw%253D&md5=daf597cca84e50bd711d3e9f1dac2ab4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2800%2989040-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252800%252989040-6%26sid%3Dliteratum%253Aachs%26aulast%3DShiina%26aufirst%3DN.%26aulast%3DGotoh%26aufirst%3DY.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DMicrotubule-severing%2520activity%2520in%2520M%2520phase%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1995%26volume%3D5%26spage%3D283%26epage%3D286%26doi%3D10.1016%2FS0962-8924%2800%2989040-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">McNally, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audhya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oegema, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, F. J.</span><span> </span><span class="NLM_article-title">Katanin controls mitotic and meiotic spindle length</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1083/jcb.200608117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1083%2Fjcb.200608117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2006&pages=881-891&author=K.+McNallyauthor=A.+Audhyaauthor=K.+Oegemaauthor=F.+J.+McNally&title=Katanin+controls+mitotic+and+meiotic+spindle+length&doi=10.1083%2Fjcb.200608117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200608117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200608117%26sid%3Dliteratum%253Aachs%26aulast%3DMcNally%26aufirst%3DK.%26aulast%3DAudhya%26aufirst%3DA.%26aulast%3DOegema%26aufirst%3DK.%26aulast%3DMcNally%26aufirst%3DF.%2BJ.%26atitle%3DKatanin%2520controls%2520mitotic%2520and%2520meiotic%2520spindle%2520length%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2006%26volume%3D175%26spage%3D881%26epage%3D891%26doi%3D10.1083%2Fjcb.200608117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Maddika, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span> </span><span class="NLM_article-title">Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1038/ncb1848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fncb1848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19287380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVynu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=409-419&author=S.+Maddikaauthor=J.+Chen&title=Protein+kinase+DYRK2+is+a+scaffold+that+facilitates+assembly+of+an+E3+ligase&doi=10.1038%2Fncb1848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase</span></div><div class="casAuthors">Maddika, Subbareddy; Chen, Junjie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-419</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein kinases have central functions in various cellular signal transduction pathways through their substrate phosphorylation.  Here we show that a protein kinase, DYRK2, has unexpected role as a scaffold for an E3 ubiquitin ligase complex.  DYRK2 assocs. with an E3 ligase complex contg. EDD, DDB1, and VPRBP proteins (EDVP complex).  Strikingly, DYRK2 serves as a scaffold for the EDVP complex, because small-interfering-RNA-mediated depletion of DYRK2 disrupts the formation of the EDD-DDB1-VPRBP complex.  Although the kinase activity of DYRK2 is dispensable for its ability to mediate EDVP complex formation, it is required for the phosphorylation and subsequent degrdn. of its downstream substrate, katanin p60.  Collectively, our results reveal a new type of E3-ubiquitin ligase complex in humans that depends on a protein kinase for complex formation as well as for the subsequent phosphorylation, ubiquitylation, and degrdn. of their substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrplBXU0xLBhbVg90H21EOLACvtfcHk0lhNUZt8hA2IdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVynu7g%253D&md5=a57e254a3a24d2bfd50e19ea78aba6e8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncb1848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1848%26sid%3Dliteratum%253Aachs%26aulast%3DMaddika%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DProtein%2520kinase%2520DYRK2%2520is%2520a%2520scaffold%2520that%2520facilitates%2520assembly%2520of%2520an%2520E3%2520ligase%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2009%26volume%3D11%26spage%3D409%26epage%3D419%26doi%3D10.1038%2Fncb1848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Toyo-Oka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuoka, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muramatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraiwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynshaw-Boris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirotsune, S.</span><span> </span><span class="NLM_article-title">Recruitment of katanin p60 by phosphorylated NDEL1, an LIS1 interacting protein, is essential for mitotic cell division and neuronal migration</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3113</span><span class="NLM_x">–</span> <span class="NLM_lpage">3128</span><span class="refDoi"> DOI: 10.1093/hmg/ddi339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1093%2Fhmg%2Fddi339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=16203747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=3113-3128&author=K.+Toyo-Okaauthor=S.+Sasakiauthor=Y.+Yanoauthor=D.+Moriauthor=T.+Kobayashiauthor=Y.+Y.+Toyoshimaauthor=S.+M.+Tokuokaauthor=S.+Ishiiauthor=T.+Shimizuauthor=M.+Muramatsuauthor=N.+Hiraiwaauthor=A.+Yoshikiauthor=A.+Wynshaw-Borisauthor=S.+Hirotsune&title=Recruitment+of+katanin+p60+by+phosphorylated+NDEL1%2C+an+LIS1+interacting+protein%2C+is+essential+for+mitotic+cell+division+and+neuronal+migration&doi=10.1093%2Fhmg%2Fddi339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Recruitment of katanin p60 by phosphorylated NDEL1, an LIS1 interacting protein, is essential for mitotic cell division and neuronal migration</span></div><div class="casAuthors">Toyo-Oka, Kazuhito; Sasaki, Shinji; Yano, Yoshihisa; Mori, Daisuke; Kobayashi, Takuya; Toyoshima, Yoko Y.; Tokuoka, Suzumi M.; Ishii, Satoshi; Shimizu, Takao; Muramatsu, Masami; Hiraiwa, Noriko; Yoshiki, Atsushi; Wynshaw-Boris, Anthony; Hirotsune, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3113-3128</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">LIS1 is mutated in the human neuronal migration defect lissencephaly and along with NDEL1 (formerly NUDEL) participates in the regulation of cytoplasmic dynein function during neuronal development.  Targeted disruption of Ndel1 suggested that NDEL1 could have other mol. targets that regulate microtubule organization for proper neuronal migration.  To further understanding the mol. mechanism of LIS1 and lissencephaly, we identified the katanin p60 microtubule-severing protein as an addnl. mol. target of NDEL1.  We demonstrate that phosphorylation of NDEL1 by Cdk5 facilitates interaction between NDEL1 and p60, suggesting that P-NDEL1 regulates the distribution of katanin p60.  Abnormal accumulation of p60 in nucleus of Ndel1 null mutants supports an essential role of NDEL1 in p60 regulation.  Complete loss of NDEL1 or expression of dominant neg. mutants of p60 in migrating neurons results in defective migration and elongation of nuclear-centrosomal distance.  Our results suggest that NDEL1 is essential for mitotic cell division and neuronal migration not only via regulation of cytoplasmic dynein function but also by modulation of katanin p60 localization and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoet3lb5au2DbVg90H21EOLACvtfcHk0liGm7R3KUhLaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtL7E&md5=5d1e4532bf17204b3e66d006cef9c814</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddi339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddi339%26sid%3Dliteratum%253Aachs%26aulast%3DToyo-Oka%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DYano%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DD.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DToyoshima%26aufirst%3DY.%2BY.%26aulast%3DTokuoka%26aufirst%3DS.%2BM.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DMuramatsu%26aufirst%3DM.%26aulast%3DHiraiwa%26aufirst%3DN.%26aulast%3DYoshiki%26aufirst%3DA.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DHirotsune%26aufirst%3DS.%26atitle%3DRecruitment%2520of%2520katanin%2520p60%2520by%2520phosphorylated%2520NDEL1%252C%2520an%2520LIS1%2520interacting%2520protein%252C%2520is%2520essential%2520for%2520mitotic%2520cell%2520division%2520and%2520neuronal%2520migration%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2005%26volume%3D14%26spage%3D3113%26epage%3D3128%26doi%3D10.1093%2Fhmg%2Fddi339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Toyo-oka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraiwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muramatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynshaw-Boris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirotsune, S.</span><span> </span><span class="NLM_article-title">Protein phosphatase 4 catalytic subunit regulates Cdk1 activity and microtubule organization via NDEL1 dephosphorylation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1147</span><span class="refDoi"> DOI: 10.1083/jcb.200705148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1083%2Fjcb.200705148" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=1133-1147&author=K.+Toyo-okaauthor=D.+Moriauthor=Y.+Yanoauthor=M.+Shiotaauthor=H.+Iwaoauthor=H.+Gotoauthor=M.+Inagakiauthor=N.+Hiraiwaauthor=M.+Muramatsuauthor=A.+Wynshaw-Borisauthor=A.+Yoshikiauthor=S.+Hirotsune&title=Protein+phosphatase+4+catalytic+subunit+regulates+Cdk1+activity+and+microtubule+organization+via+NDEL1+dephosphorylation&doi=10.1083%2Fjcb.200705148"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200705148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200705148%26sid%3Dliteratum%253Aachs%26aulast%3DToyo-oka%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DD.%26aulast%3DYano%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DM.%26aulast%3DIwao%26aufirst%3DH.%26aulast%3DGoto%26aufirst%3DH.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DHiraiwa%26aufirst%3DN.%26aulast%3DMuramatsu%26aufirst%3DM.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DYoshiki%26aufirst%3DA.%26aulast%3DHirotsune%26aufirst%3DS.%26atitle%3DProtein%2520phosphatase%25204%2520catalytic%2520subunit%2520regulates%2520Cdk1%2520activity%2520and%2520microtubule%2520organization%2520via%2520NDEL1%2520dephosphorylation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D1133%26epage%3D1147%26doi%3D10.1083%2Fjcb.200705148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. A.</span><span> </span><span class="NLM_article-title">Microtubule-binding agents: a dynamic field of cancer therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.1038/nrd3253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrd3253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=20885410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1akur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=790-803&author=C.+Dumontetauthor=M.+A.+Jordan&title=Microtubule-binding+agents%3A+a+dynamic+field+of+cancer+therapeutics&doi=10.1038%2Fnrd3253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-binding agents: a dynamic field of cancer therapeutics</span></div><div class="casAuthors">Dumontet, Charles; Jordan, Mary Ann</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">790-803</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Microtubules are dynamic filamentous cytoskeletal proteins composed of tubulin and are an important therapeutic target in tumor cells.  Agents that bind to microtubules have been part of the pharmacopoeia of anticancer therapy for decades and until the advent of targeted therapy, microtubules were the only alternative to DNA as a therapeutic target in cancer.  The screening of a range of botanical species and marine organisms has yielded promising new antitubulin agents with novel properties.  In the current search for novel microtubule-binding agents, enhanced tumor specificity, reduced neurotoxicity and insensitivity to chemoresistance mechanisms are the three main objectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ43DyXjdN7rVg90H21EOLACvtfcHk0liGm7R3KUhLaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1akur%252FI&md5=9fc6fd966859785605936ecbe6dca44e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnrd3253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3253%26sid%3Dliteratum%253Aachs%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DMicrotubule-binding%2520agents%253A%2520a%2520dynamic%2520field%2520of%2520cancer%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D790%26epage%3D803%26doi%3D10.1038%2Fnrd3253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kavallaris, M.</span><span> </span><span class="NLM_article-title">Microtubules and resistance to tubulin-binding agents</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1038/nrc2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrc2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=20147901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVKrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=194-204&author=M.+Kavallaris&title=Microtubules+and+resistance+to+tubulin-binding+agents&doi=10.1038%2Fnrc2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules and resistance to tubulin-binding agents</span></div><div class="casAuthors">Kavallaris, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-204</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Microtubules are dynamic structures composed of α-β-tubulin heterodimers that are essential in cell division and are important targets for cancer drugs.  Mutations in β-tubulin that affect microtubule polymer mass and/or drug binding are assocd. with resistance to tubulin-binding agents such as paclitaxel.  The aberrant expression of specific β-tubulin isotypes, in particular βIII-tubulin, or of microtubule-regulating proteins is important clin. in tumor aggressiveness and resistance to chemotherapy.  In addn., changes in actin regulation can also mediate resistance to tubulin-binding agents.  Understanding the mol. mechanisms that mediate resistance to tubulin-binding agents will be vital to improve the efficacy of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNkoVu03ikmrVg90H21EOLACvtfcHk0liGm7R3KUhLaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVKrtbg%253D&md5=1ce71cc537091459d7ee6866c0950b33</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnrc2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2803%26sid%3Dliteratum%253Aachs%26aulast%3DKavallaris%26aufirst%3DM.%26atitle%3DMicrotubules%2520and%2520resistance%2520to%2520tubulin-binding%2520agents%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D194%26epage%3D204%26doi%3D10.1038%2Fnrc2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Huzil, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurgan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuszynski, J. A.</span><span> </span><span class="NLM_article-title">The roles of beta-tubulin mutations and isotype expression in acquired drug resistance</span> <span class="citation_source-journal">Cancer Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19455242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1emsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=159-181&author=J.+T.+Huzilauthor=K.+Chenauthor=L.+Kurganauthor=J.+A.+Tuszynski&title=The+roles+of+beta-tubulin+mutations+and+isotype+expression+in+acquired+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The roles of β-tubulin mutations and isotype expression in acquired drug resistance</span></div><div class="casAuthors">Huzil, J. Torin; Chen, Ke; Kurgan, Lukasz; Tuszynski, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Informatics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-181</span>CODEN:
                <span class="NLM_cas:coden">CIANCJ</span>;
        ISSN:<span class="NLM_cas:issn">1176-9351</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica Ltd.</span>)
        </div><div class="casAbstract">A review.  The antitumor drug paclitaxel stabilizes microtubules and reduces their dynamicity, promoting mitotic arrest and eventually apoptosis.  Upon assembly of the α/β-tubulin heterodimer, GTP becomes bound to both the α and β-tubulin monomers.  During microtubule assembly, the GTP bound to β-tubulin is hydrolyzed to GDP, eventually reaching steady-state equil. between free tubulin dimers and those polymd. into microtubules.  Tubulin-binding drugs such as paclitaxel interact with β-tubulin, resulting in the disruption of this equil.  In spite of several crystal structures of tubulin, there is little biochem. insight into the mechanism by which anti-tubulin drugs target microtubules and alter their normal behavior.  The mechanism of drug action is further complicated, as the description of altered β-tubulin isotype expression and/or mutations in tubulin genes may lead to drug resistance as has been described in the literature.  Because of the relationship between β-tubulin isotype expression and mutations within β-tubulin, both leading to resistance, we examd. the properties of altered residues within the taxane, colchicine and Vinca binding sites.  The amt. of data now available, allows us to investigate common patterns that lead to microtubule disruption and may provide a guide to the rational design of novel compds. that can inhibit microtubule dynamics for specific tubulin isotypes or, indeed resistant cell lines.  Because of the vast amt. of data published to date, we will only provide a broad overview of the mutational results and how these correlate with differences between tubulin isotypes.  We also note that clin. studies describe a no. of predictive factors for the response to anti-tubulin drugs and attempt to develop an understanding of the features within tubulin that may help explain how they may affect both microtubule assembly and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeAbT02MpM3bVg90H21EOLACvtfcHk0liHyOxsps9_RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1emsw%253D%253D&md5=e3294e203384c130a611f2bf539a724d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuzil%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKurgan%26aufirst%3DL.%26aulast%3DTuszynski%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520roles%2520of%2520beta-tubulin%2520mutations%2520and%2520isotype%2520expression%2520in%2520acquired%2520drug%2520resistance%26jtitle%3DCancer%2520Inf.%26date%3D2007%26volume%3D3%26spage%3D159%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Chu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span> </span><span class="NLM_article-title">Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1165/ajrcmb.17.3.2837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1165%2Fajrcmb.17.3.2837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=9308922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVOrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=353-360&author=Y.+W.+Chuauthor=P.+C.+Yangauthor=S.+C.+Yangauthor=Y.+C.+Shyuauthor=M.+J.+Hendrixauthor=R.+Wuauthor=C.+W.+Wu&title=Selection+of+invasive+and+metastatic+subpopulations+from+a+human+lung+adenocarcinoma+cell+line&doi=10.1165%2Fajrcmb.17.3.2837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line</span></div><div class="casAuthors">Chu, Yi-Wen; Yang, Pan-Chyr; Yang, Shuenn-Chen; Shyu, Yu-Chiau; Hendrix, Mary J. C.; Wu, Reen; Wu, Cheng-Wen</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-360</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Lung Association</span>)
        </div><div class="casAbstract">To better understand the mechanism(s) underlying lung cancer invasion and metastasis, a Transwell invasion chamber was used to select progressively more invasive cancer cell populations from a clonal cell line of human lung adenocarcinoma, CL1.  Five sublines with progressive invasiveness, designated CL1-1, CL1-2, CL1-3, CL1-4, and CL1-5, were obtained through this in vitro selection process.  Their invasive abilities through basement membrane matrix showed a 4-6-fold increase over that of the parental cells.  Moreover, the sublines manifested an increase in their colony-forming ability on soft agar, tumorigenicity, and metastatic potency in severe combined immunodeficiency (SCID) mice.  Examg. the phenotypes of the cell lines revealed increased expression of 92-kDa gelatinase and an increase in the cell population stained with anti-keratin-8 and -18 antibodies.  Clonal isolation of anti-keratin-18-antibody-pos. and -neg. cell populations demonstrated a correlated enhancement of the invasiveness of these cells and their expression of keratin-18.  Thus, the metastatic behavior of lung cancer cells can be characterized with this in vitro system, and the properties of these progressively invasive cancer cells can be clonally studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqf3X5hlC0wLVg90H21EOLACvtfcHk0liHyOxsps9_RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVOrs7c%253D&md5=d5ea3f2aa0517622c6e6026663cc1a03</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.17.3.2837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.17.3.2837%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DY.%2BW.%26aulast%3DYang%26aufirst%3DP.%2BC.%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DShyu%26aufirst%3DY.%2BC.%26aulast%3DHendrix%26aufirst%3DM.%2BJ.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DC.%2BW.%26atitle%3DSelection%2520of%2520invasive%2520and%2520metastatic%2520subpopulations%2520from%2520a%2520human%2520lung%2520adenocarcinoma%2520cell%2520line%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1997%26volume%3D17%26spage%3D353%26epage%3D360%26doi%3D10.1165%2Fajrcmb.17.3.2837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wen Shuai, Guan Wang, Yiwen Zhang, Faqian Bu, Sicheng Zhang, Duane D. Miller, Wei Li, Liang Ouyang, <span class="NLM_string-name hlFld-ContribAuthor">Yuxi Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7963-7990. <a href="https://doi.org/10.1021/acs.jmedchem.1c00100" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bon%252BTubulin%252BInhibitors%252Bwith%252BDual%252BTargeting%252BCapabilities%252Bfor%252BCancer%252BTherapy%26aulast%3DShuai%26aufirst%3DWen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19012021%26date%3D08062021%26volume%3D64%26issue%3D12%26spage%3D7963%26epage%3D7990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chia-Yi Lin, Hsin-Yi Wu, Yuan-Ling Hsu, Ting-Jen Rachel Cheng, Jyung-Hurng Liu, Rou-Jie Huang, Tzu-Hung Hsiao, Chia-Jen Wang, Pei-Fang Hung, Albert Lan, Szu-Hua Pan, Rong-Jie Chein, Chi-Huey Wong, <span class="NLM_string-name hlFld-ContribAuthor">Pan-Chyr Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3172-3187. <a href="https://doi.org/10.1021/acs.jmedchem.9b01783" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01783%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSuppression%252Bof%252BDrug-Resistant%252BNon-Small-Cell%252BLung%252BCancer%252Bwith%252BInhibitors%252BTargeting%252BMinichromosomal%252BMaintenance%252BProtein%26aulast%3DLin%26aufirst%3DChia-Yi%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26112019%26date%3D17032020%26date%3D03032020%26volume%3D63%26issue%3D6%26spage%3D3172%26epage%3D3187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juanping  Zhuge</span>, <span class="hlFld-ContribAuthor ">Ziyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Wei  Jiang</span>, <span class="hlFld-ContribAuthor ">Gary  Histand</span>, <span class="hlFld-ContribAuthor ">Dongen  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-catalyzed oxidative functionalization of purines with (thio)ethers or methylarenes for the synthesis of purin-8-one analogues. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (23)
                                     , 5121-5126. <a href="https://doi.org/10.1039/D1OB00118C" title="DOI URL">https://doi.org/10.1039/D1OB00118C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00118C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00118C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DIodine-catalyzed%252Boxidative%252Bfunctionalization%252Bof%252Bpurines%252Bwith%252B%252528thio%252529ethers%252Bor%252Bmethylarenes%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpurin-8-one%252Banalogues%26aulast%3DZhuge%26aufirst%3DJuanping%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D23%26spage%3D5121%26epage%3D5126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tommaso  Cupido</span>, <span class="hlFld-ContribAuthor ">Natalie H.  Jones</span>, <span class="hlFld-ContribAuthor ">Michael J.  Grasso</span>, <span class="hlFld-ContribAuthor ">Rudolf  Pisa</span>, <span class="hlFld-ContribAuthor ">Tarun M.  Kapoor</span>. </span><span class="cited-content_cbyCitation_article-title">A chemical genetics approach to examine the functions of AAA proteins. </span><span class="cited-content_cbyCitation_journal-name">Nature Structural & Molecular Biology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (4)
                                     , 388-397. <a href="https://doi.org/10.1038/s41594-021-00575-9" title="DOI URL">https://doi.org/10.1038/s41594-021-00575-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41594-021-00575-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41594-021-00575-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Structural%2520%2526%2520Molecular%2520Biology%26atitle%3DA%252Bchemical%252Bgenetics%252Bapproach%252Bto%252Bexamine%252Bthe%252Bfunctions%252Bof%252BAAA%252Bproteins%26aulast%3DCupido%26aufirst%3DTommaso%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D4%26spage%3D388%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Jicheng  Tantai</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Katanin P60: a potential biomarker for lymph node metastasis and prognosis for non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Surgical Oncology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12957-020-01939-z" title="DOI URL">https://doi.org/10.1186/s12957-020-01939-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12957-020-01939-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12957-020-01939-z%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Surgical%2520Oncology%26atitle%3DKatanin%252BP60%25253A%252Ba%252Bpotential%252Bbiomarker%252Bfor%252Blymph%252Bnode%252Bmetastasis%252Band%252Bprognosis%252Bfor%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DWang%26aufirst%3DLei%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srihari  Konduri</span>, <span class="hlFld-ContribAuthor ">Jyothi  Prashanth</span>, <span class="hlFld-ContribAuthor ">Vagolu Siva  Krishna</span>, <span class="hlFld-ContribAuthor ">Dharmarajan  Sriram</span>, <span class="hlFld-ContribAuthor ">J.N.  Behera</span>, <span class="hlFld-ContribAuthor ">Dionicio  Siegel</span>, <span class="hlFld-ContribAuthor ">Koya Prabhakara  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of purine connected piperazine derivatives as novel inhibitors of Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (22)
                                     , 127512. <a href="https://doi.org/10.1016/j.bmcl.2020.127512" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127512%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bpurine%252Bconnected%252Bpiperazine%252Bderivatives%252Bas%252Bnovel%252Binhibitors%252Bof%252BMycobacterium%252Btuberculosis%26aulast%3DKonduri%26aufirst%3DSrihari%26date%3D2020%26volume%3D30%26issue%3D22%26spage%3D127512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Yiping  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non–small‐cell lung cancer patients. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Laboratory Analysis</span><span> <strong>2020,</strong> <em>34 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/jcla.23141" title="DOI URL">https://doi.org/10.1002/jcla.23141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcla.23141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcla.23141%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Laboratory%2520Analysis%26atitle%3DKatanin%252BP80%252Bcorrelates%252Bwith%252Blarger%252Btumor%252Bsize%25252C%252Blymph%252Bnode%252Bmetastasis%25252C%252Band%252Badvanced%252BTNM%252Bstage%252Band%252Bpredicts%252Bpoor%252Bprognosis%252Bin%252Bnon%2525E2%252580%252593small%2525E2%252580%252590cell%252Blung%252Bcancer%252Bpatients%26aulast%3DYe%26aufirst%3DQing%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Ruo  Huang</span>, <span class="hlFld-ContribAuthor ">Yuan-Ling  Hsu</span>, <span class="hlFld-ContribAuthor ">Tzu-Chen  Lin</span>, <span class="hlFld-ContribAuthor ">Ting-Jen  Cheng</span>, <span class="hlFld-ContribAuthor ">Ling-Wei  Li</span>, <span class="hlFld-ContribAuthor ">Yu-Wei  Tseng</span>, <span class="hlFld-ContribAuthor ">Yu-shu  Chou</span>, <span class="hlFld-ContribAuthor ">Jyung-Hurng  Liu</span>, <span class="hlFld-ContribAuthor ">Szu-Hua  Pan</span>, <span class="hlFld-ContribAuthor ">Jim-Min  Fang</span>, <span class="hlFld-ContribAuthor ">Chi-Huey  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111551. <a href="https://doi.org/10.1016/j.ejmech.2019.07.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-guided%252Bdevelopment%252Bof%252Bpurine%252Bamide%25252C%252Bhydroxamate%25252C%252Band%252Bamidoxime%252Bfor%252Bthe%252Binhibition%252Bof%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DHuang%26aufirst%3DMeng-Ruo%26date%3D2019%26volume%3D181%26spage%3D111551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Gao</span>, <span class="hlFld-ContribAuthor ">Yuru  Liang</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiayi  Cheng</span>, <span class="hlFld-ContribAuthor ">Kuiling  Ding</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 177-194. <a href="https://doi.org/10.1016/j.ejmech.2019.05.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bantitumor%252Bactivities%252Band%252Bbiological%252Bstudies%252Bof%252Bnovel%252Bdiaryl%252Bsubstituted%252Bfused%252Bheterocycles%252Bas%252Bdual%252Bligands%252Btargeting%252Btubulin%252Band%252Bkatanin%26aulast%3DGao%26aufirst%3DFeng%26date%3D2019%26volume%3D178%26spage%3D177%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan B  Steinman</span>, <span class="hlFld-ContribAuthor ">Tarun M  Kapoor</span>. </span><span class="cited-content_cbyCitation_article-title">Using chemical inhibitors to probe AAA protein conformational dynamics and cellular functions. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2019,</strong> <em>50 </em>, 45-54. <a href="https://doi.org/10.1016/j.cbpa.2019.02.019" title="DOI URL">https://doi.org/10.1016/j.cbpa.2019.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2019.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2019.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DUsing%252Bchemical%252Binhibitors%252Bto%252Bprobe%252BAAA%252Bprotein%252Bconformational%252Bdynamics%252Band%252Bcellular%252Bfunctions%26aulast%3DSteinman%26aufirst%3DJonathan%2BB%26date%3D2019%26volume%3D50%26spage%3D45%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tommaso  Cupido</span>, <span class="hlFld-ContribAuthor ">Rudolf  Pisa</span>, <span class="hlFld-ContribAuthor ">Megan E.  Kelley</span>, <span class="hlFld-ContribAuthor ">Tarun M.  Kapoor</span>. </span><span class="cited-content_cbyCitation_article-title">Designing a chemical inhibitor for the AAA protein spastin using active site mutations. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2019,</strong> <em>15 </em>
                                    (5)
                                     , 444-452. <a href="https://doi.org/10.1038/s41589-019-0225-6" title="DOI URL">https://doi.org/10.1038/s41589-019-0225-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-019-0225-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-019-0225-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DDesigning%252Ba%252Bchemical%252Binhibitor%252Bfor%252Bthe%252BAAA%252Bprotein%252Bspastin%252Busing%252Bactive%252Bsite%252Bmutations%26aulast%3DCupido%26aufirst%3DTommaso%26date%3D2019%26date%3D2019%26volume%3D15%26issue%3D5%26spage%3D444%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gautam  Achar</span>, <span class="hlFld-ContribAuthor ">C.R.  Shahini</span>, <span class="hlFld-ContribAuthor ">Siddappa A.  Patil</span>, <span class="hlFld-ContribAuthor ">Jan Grzegorz  Małecki</span>, <span class="hlFld-ContribAuthor ">Szu-Hua  Pan</span>, <span class="hlFld-ContribAuthor ">Albert  Lan</span>, <span class="hlFld-ContribAuthor ">Xuan-Ren  Chen</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Budagumpi</span>. </span><span class="cited-content_cbyCitation_article-title">Sterically modulated silver(I) complexes of coumarin substituted benzimidazol–2–ylidenes: Synthesis, crystal structures and evaluation of their antimicrobial and antilung cancer potentials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2018,</strong> <em>183 </em>, 43-57. <a href="https://doi.org/10.1016/j.jinorgbio.2018.02.012" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2018.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2018.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2018.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DSterically%252Bmodulated%252Bsilver%252528I%252529%252Bcomplexes%252Bof%252Bcoumarin%252Bsubstituted%252Bbenzimidazol%2525E2%252580%2525932%2525E2%252580%252593ylidenes%25253A%252BSynthesis%25252C%252Bcrystal%252Bstructures%252Band%252Bevaluation%252Bof%252Btheir%252Bantimicrobial%252Band%252Bantilung%252Bcancer%252Bpotentials%26aulast%3DAchar%26aufirst%3DGautam%26date%3D2018%26volume%3D183%26spage%3D43%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao-Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuan-Di  Zhao</span>, <span class="hlFld-ContribAuthor ">Xin-Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong-Hua  Li</span>, <span class="hlFld-ContribAuthor ">Zhang-Xu  He</span>, <span class="hlFld-ContribAuthor ">Xin-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian-Jia  Liang</span>, <span class="hlFld-ContribAuthor ">Li-Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 327-338. <a href="https://doi.org/10.1016/j.ejmech.2018.03.084" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B6-chloro-2-%252528propylthio%252529-8%25252C9-dihydro-7H-purines%252Bcontaining%252Ba%252Bcarboxamide%252Bmoiety%252Bas%252Bpotential%252Bselective%252Banti-lung%252Bcancer%252Bagents%26aulast%3DZhao%26aufirst%3DTao-Qian%26date%3D2018%26volume%3D151%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao-Wei  Cheng</span>, <span class="hlFld-ContribAuthor ">Rong-Jie  Chein</span>, <span class="hlFld-ContribAuthor ">Ting-Jen  Cheng</span>, <span class="hlFld-ContribAuthor ">Pei-Shan  Wu</span>, <span class="hlFld-ContribAuthor ">Hsin-Yi  Wu</span>, <span class="hlFld-ContribAuthor ">Pei-Fang  Hung</span>, <span class="hlFld-ContribAuthor ">Chia-Jen  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan-Ling  Hsu</span>, <span class="hlFld-ContribAuthor ">Jau-Min  Wong</span>, <span class="hlFld-ContribAuthor ">Ang  Yuan</span>, <span class="hlFld-ContribAuthor ">Chi-Huey  Wong</span>, <span class="hlFld-ContribAuthor ">Pan-Chyr  Yang</span>, <span class="hlFld-ContribAuthor ">Szu-Hua  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2018,</strong> <em>109 </em>
                                    (3)
                                     , 832-842. <a href="https://doi.org/10.1111/cas.13489" title="DOI URL">https://doi.org/10.1111/cas.13489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.13489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.13489%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3D2-anilino-4-amino-5-aroylthiazole-type%252Bcompound%252BAS7128%252Binhibits%252Blung%252Bcancer%252Bgrowth%252Bthrough%252Bdecreased%252BiASPP%252Band%252Bp53%252Binteraction%26aulast%3DCheng%26aufirst%3DHao-Wei%26date%3D2018%26date%3D2018%26volume%3D109%26issue%3D3%26spage%3D832%26epage%3D842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Zuo</span>, <span class="hlFld-ContribAuthor ">Jiang-Shan  Ying</span>, <span class="hlFld-ContribAuthor ">Feng-Chun  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying-Chun  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor tissue katanin P60 expression correlates with lymph node metastasis and worse prognosis in patients with breast cancer: A cohort study. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biomarkers</span><span> <strong>2018,</strong> <em>21 </em>
                                    (2)
                                     , 425-432. <a href="https://doi.org/10.3233/CBM-170666" title="DOI URL">https://doi.org/10.3233/CBM-170666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/CBM-170666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FCBM-170666%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biomarkers%26atitle%3DTumor%252Btissue%252Bkatanin%252BP60%252Bexpression%252Bcorrelates%252Bwith%252Blymph%252Bnode%252Bmetastasis%252Band%252Bworse%252Bprognosis%252Bin%252Bpatients%252Bwith%252Bbreast%252Bcancer%25253A%252BA%252Bcohort%252Bstudy%26aulast%3DZuo%26aufirst%3DLi%26date%3D2018%26volume%3D21%26issue%3D2%26spage%3D425%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenrong  Fu</span>, <span class="hlFld-ContribAuthor ">Hui  Wu</span>, <span class="hlFld-ContribAuthor ">Zhengjiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Shaojun  Huang</span>, <span class="hlFld-ContribAuthor ">Hui  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">The role of katanin p60 in breast cancer bone metastasis. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/ol.2018.7942" title="DOI URL">https://doi.org/10.3892/ol.2018.7942</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2018.7942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2018.7942%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DThe%252Brole%252Bof%252Bkatanin%252Bp60%252Bin%252Bbreast%252Bcancer%252Bbone%252Bmetastasis%26aulast%3DFu%26aufirst%3DWenrong%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manh Tuan  Ha</span>, <span class="hlFld-ContribAuthor ">Manh Hung  Tran</span>, <span class="hlFld-ContribAuthor ">Thien Thuong  Phuong</span>, <span class="hlFld-ContribAuthor ">Jeong Ah  Kim</span>, <span class="hlFld-ContribAuthor ">Mi Hee  Woo</span>, <span class="hlFld-ContribAuthor ">Jae Sue  Choi</span>, <span class="hlFld-ContribAuthor ">Suhyun  Lee</span>, <span class="hlFld-ContribAuthor ">Jeong Hyung  Lee</span>, <span class="hlFld-ContribAuthor ">Hyeong Kyu  Lee</span>, <span class="hlFld-ContribAuthor ">Byung Sun  Min</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic and apoptosis-inducing activities against human lung cancer cell lines of cassaine diterpenoids from the bark of Erythrophleum fordii. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (13)
                                     , 2946-2952. <a href="https://doi.org/10.1016/j.bmcl.2017.05.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCytotoxic%252Band%252Bapoptosis-inducing%252Bactivities%252Bagainst%252Bhuman%252Blung%252Bcancer%252Bcell%252Blines%252Bof%252Bcassaine%252Bditerpenoids%252Bfrom%252Bthe%252Bbark%252Bof%252BErythrophleum%252Bfordii%26aulast%3DHa%26aufirst%3DManh%2BTuan%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2946%26epage%3D2952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Purine-Type Compounds <b>5a</b>–<b>5g</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>5a</b> inhibits tumor growth in vitro and in vivo. (A) Inhibitory activities of <b>5a</b> against different human nonsmall-cell lung cancer cell lines. The cells were treated with <b>5a</b> for 72 h, and cell proliferation was examined by MTT assay. Data are expressed as the mean of four determinations. (B) H1975 cells were treated with <b>5a</b> (300 nM) for 14 days. The colonies were fixed and stained with crystal violet and counted. Data are expressed as the mean ± SEM of three determinations. (C) H1975 cells were injected subcutaneously into the right flank region of nude mice. Three days after the injection, the mice were treated with vehicle (DMSO) or <b>5a</b> (2 mg/kg) twice a week intraperitoneally for 28 days. Representative tumor images and H&E-stained sections of tumors taken from mice treated for 28 days with either vehicle or <b>5a</b> are shown. The tumor size was measured with a caliper rule every time before compound delivery. Data are presented as the mean tumor volumes of mice in both the treatment and vehicle groups on the days of pretreatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>5a</b> causes cell cycle arrest and induces cell apoptosis in H1975 lung cancer cells. H1975 cells were treated with 300 nM <b>5a</b> for the indicated time periods. Then, the cells were harvested for (A) annexin V–PI double staining of apoptosis FACScan flow cytometer. Data are expressed as the mean ± SEM of three determinations. (B,C) The protein expressions were detected by immunoblotting. The data are representative of three independent experiments. (D) The cytosolic and mitochondrial fractions were obtained for the detection of the cytochrome C protein level by immunoblotting. (E) The cells were fixed and stained with PI to analyze the DNA content with a FACScan flow cytometer. The data are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. JNK-related signaling pathway involved in <b>5a</b>-induced cancer cell apoptosis. (A) H1975 cells were incubated in the absence or presence of <b>5a</b> (300 nM) for 9 h. The cells were then harvested and lysed to detect the phosphorylation level of the proteins included in the human phosphor-kinase antibody array. The phosphorylation level of particulate proteins was quantified using the computerized image analysis system ImageJ. (B) H1975 cells treated with <b>5a</b> (300 nM) were harvested and lysed to detect the existence of phospho-JNK and phospho-c-Jun. The data are representative of three independent experiments. (C) H1975 cells were incubated in the indicated agent (<b>5a</b>, 300 nM; SP600125, 10 μM) for 48 h. Then, the cells were harvested and lysed to examine the expression levels of cleavage caspase-3, PARP-1, and phospho-c-Jun. The data are representative of three independent experiments. (D) H1975 cells were treated with the indicated agent (<b>5a</b>, 300 nM; SP600125, 10 μM) for 48 h. Then, the cells were harvested for the annexin V–PI double staining of the apoptosis FACScan flow cytometer. The data are expressed as the mean ± SEM of three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Treatment of <b>5a</b> interrupts microtubule organization in H1975 lung cancer cells. (A) H1975 cells were incubated with vehicle or <b>5a</b> (300 nM) for the indicated times. Then, the cells were fixed and stained with anti-α-tubulin primary antibody. FITC-labeled secondary antibodies were used (green fluorescence), and the protein was detected by a confocal laser microscopic system. The nuclei were detected by DAPI staining (blue fluorescence). (B) H1975 cells were incubated with vehicle, <b>5a</b>, paclitaxel, or nocodazole for 1 h. Then, the cells were harvested and separated into soluble (S, tubulin monomer) and particulate form (P, tubulin polymers), and the level of α-tubulin protein in each fraction was detected by immunoblotting. The protein level of α-tubulin was quantified using the computerized image analysis system ImageJ. (C) H1975 cells were incubated in the absence or presence of <b>5a</b> (300 nM) for 12 h. Then, the cells were harvested and lysed for gel filtration chromatography. The drop-by-drop flowthrough was collected in ∼0.5 mL fractions. The protein level of α-tubulin in each fraction was detected by immunoblotting. (D) Purified tubulins were incubated at 37 °C with GTP in the vehicle (control) or in the presence of <b>5a</b> (10 μM or 300 nM), paclitaxel (10 μM), vincristine (10 μM), or nocodazole (10 μM). Tubulin polymerization was examined turbidimetrically. Data are expressed as the mean of three determinations. (E) Purified tubulins were incubated with GTP and paclitaxel at 37 °C for 30 min and then were held at room temperature for at least 1 h to obtain microtubule stock. The microtubule stock was further incubated at 37 °C with GTP in the vehicle (control) or in the presence of <b>5a</b> (10 μM, 3 μM, or 300 nM), paclitaxel (30 μM), or vincristine (30 μM). Tubulin depolymerization was examined turbidimetrically. The data are expressed as the mean of three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Amides <b>8</b> and the Biotin-Annexed Probes <b>9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>5a</b> direct interacts with katanin protein as a p60–<b>5a</b> complex. (A) H1975 cell lysate was incubated with probe <b>9</b> or a linker without the purine component (as control) for 24 h. Then, the streptavidin-conjugated beads were added into the lysate and incubated for 2 h. The lysate was washed with IP lysis buffer six times. The binding proteins were visualized by immunoblotting. The data are representative of three independent experiments. H1975 cells were transfected with scrambled control siRNA or katanin p60 siRNA. (B–E) Pharmacophore model and predicted binding modes between katanin p60 hexamer and <b>5a</b>. (B) Best pharmacophore model Hypo-1 represented with distance constraints. (C) Hypo-1 mapping with <b>5a</b>. Pharmacophore features are color-coded as follows: green, hydrogen bond acceptor (HBA); magenta, hydrogen bond donor (HBD); cyan, hydrophobic (HY); orange, ring aromatic (RA). (D,E) Two binding modes with equal predicted binding affinities (Δ<i>G</i> = −10.7 kcal/mol). The green background highlights the amino acids from subunit A of the p60 hexamer, and the pink background highlights those that belong to subunit F.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/medium/jm-2016-007977_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>5a</b> induces cell apoptosis through interacting with the katanin protein complex. (A) The cells were treated with <b>5a</b> for 1 h. Then, the cells were harvested and separated into soluble (S, tubulin monomer) and particulate (P, tubulin polymers) forms, and the level of α-tubulin protein in each fraction was detected by immunoblotting. The protein level of α-tubulin was quantified using the computerized image analysis system ImageJ. (B) H1975 cells were incubated with vehicle or <b>5a</b> for 12 h. Then, the cells were fixed and stained with primary antibody to α-tubulin. FITC-labeled secondary antibodies were used (green fluorescence), and the protein was detected by a confocal laser microscopic system. The nuclei were detected by DAPI staining (blue fluorescence). (C,D) H1975 cells were incubated with vehicle or <b>5a</b> for 24 h. Then, the cells were harvested for the identification of indicated proteins by immunoblotting. (E) The cell proliferation activity was examined by MTT assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-18/acs.jmedchem.6b00797/20160916/images/large/jm-2016-007977_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00797&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naishadham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer statistics, 2012</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.3322/caac.20138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.3322%2Fcaac.20138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=22237781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A280%3ADC%252BC387jvVaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=10-29&author=R.+Siegelauthor=D.+Naishadhamauthor=A.+Jemal&title=Cancer+statistics%2C+2012&doi=10.3322%2Fcaac.20138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2012</span></div><div class="casAuthors">Siegel Rebecca; Naishadham Deepa; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics.  A total of 1,638,910 new cancer cases and 577,190 deaths from cancer are projected to occur in the United States in 2012.  During the most recent 5 years for which there are data (2004-2008), overall cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.6% per year in women.  Over the past 10 years of available data (1999-2008), cancer death rates have declined by more than 1% per year in men and women of every racial/ethnic group with the exception of American Indians/Alaska Natives, among whom rates have remained stable.  The most rapid declines in death rates occurred among African American and Hispanic men (2.4% and 2.3% per year, respectively).  Death rates continue to decline for all 4 major cancer sites (lung, colorectum, breast, and prostate), with lung cancer accounting for almost 40% of the total decline in men and breast cancer accounting for 34% of the total decline in women.  The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 1,024,400 deaths from cancer.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzMtZQZY6EXFMGsG_HTXYFfW6udTcc2eayhLOfwAto_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387jvVaitg%253D%253D&md5=4d68e55759bf217f9a46c22be1af7f86</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20138%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DNaishadham%26aufirst%3DD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202012%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2012%26volume%3D62%26spage%3D10%26epage%3D29%26doi%3D10.3322%2Fcaac.20138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Nguyen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span> </span><span class="NLM_article-title">Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway</span> <span class="citation_source-journal">Clin. Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.3816/CLC.2009.n.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.3816%2FCLC.2009.n.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19632948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSms7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=281-289&author=K.+S.+Nguyenauthor=S.+Kobayashiauthor=D.+B.+Costa&title=Acquired+resistance+to+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitors+in+non-small-cell+lung+cancers+dependent+on+the+epidermal+growth+factor+receptor+pathway&doi=10.3816%2FCLC.2009.n.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway</span></div><div class="casAuthors">Nguyen, Kim-Son H.; Kobayashi, Susumu; Costa, Daniel B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Lung Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-289</span>CODEN:
                <span class="NLM_cas:coden">CLCLCA</span>;
        ISSN:<span class="NLM_cas:issn">1525-7304</span>.
    
            (<span class="NLM_cas:orgname">CIG Media Group, LP</span>)
        </div><div class="casAbstract">A review.  Most advanced non-small-cell lung cancers (NSCLCs) with activating epidermal growth factor receptor (EGFR) mutations (exon 19 deletions or L858R) initially respond to the EGFR tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib.  However, over time (median of 6-12 mo), most tumors develop acquired resistance to EGFR TKIs.  Intense research in these NSCLCs has identified two major mechanisms of resistance to gefitinib/erlotinib: secondary resistance mutations and "oncogene kinase switch" systems.  The secondary T790M mutation occurs in 50% of EGFR-mutated patients with TKI resistance, and in vitro, this mutation negates the hypersensitivity of activating EGFR mutations.  Sensitive detection methods have identified a proportion of TKI-naive tumors that carry T790M, and these resistant clones may be selected after exposure to gefitinib or erlotinib.  Other secondary resistance mutations (D761Y, L747S, T854A) seem to be rare.  The amplification of the MET oncogene is present in 20% of TKI-resistant tumors; however, in half of the cases with this "oncogene kinase switch" mechanism the T790M is coexistent.  It is possible that other kinases (such as insulin-like growth factor-1 receptor [IGF-1R]) might also be selected to bypass EGFR pathways in resistant tumors.  The growing preclin. data in EGFR-mutated NSCLCs with acquired resistance to gefitinib or erlotinib has spawned the initiation or conception of clin. trials testing novel EGFR inhibitors that in vitro inhibit T790M (neratinib, XL647, BIBW 2992, and PF-00299804), MET, or IGF-1R inhibitors in combination with EGFR TKIs, and heat shock protein 90 inhibitors.  Ongoing preclin. and clin. research in EGFR-mutated NSCLC has the potential to significantly improve the outcomes of patients with these somatic mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzBC9bsn7YdrVg90H21EOLACvtfcHk0lieeJ1jtMLLtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSms7bO&md5=3522508ea4f2761e4dcedea18d914fe7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3816%2FCLC.2009.n.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCLC.2009.n.039%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DK.%2BS.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26atitle%3DAcquired%2520resistance%2520to%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%2520in%2520non-small-cell%2520lung%2520cancers%2520dependent%2520on%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520pathway%26jtitle%3DClin.%2520Lung%2520Cancer%26date%3D2009%26volume%3D10%26spage%3D281%26epage%3D289%26doi%3D10.3816%2FCLC.2009.n.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Nguyen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neal, J. W.</span><span> </span><span class="NLM_article-title">First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors</span> <span class="citation_source-journal">Biologics: Targets & Therapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span><span class="refDoi"> DOI: 10.2147/BTT.S26558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.2147%2FBTT.S26558" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=337-345&author=K.+S.+Nguyenauthor=J.+W.+Neal&title=First-line+treatment+of+EGFR-mutant+non-small-cell+lung+cancer%3A+the+role+of+erlotinib+and+other+tyrosine+kinase+inhibitors&doi=10.2147%2FBTT.S26558"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2147%2FBTT.S26558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FBTT.S26558%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DK.%2BS.%26aulast%3DNeal%26aufirst%3DJ.%2BW.%26atitle%3DFirst-line%2520treatment%2520of%2520EGFR-mutant%2520non-small-cell%2520lung%2520cancer%253A%2520the%2520role%2520of%2520erlotinib%2520and%2520other%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBiologics%253A%2520Targets%2520%2526%2520Therapy%26date%3D2012%26volume%3D6%26spage%3D337%26epage%3D345%26doi%3D10.2147%2FBTT.S26558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Camidge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sequist, L. V.</span><span> </span><span class="NLM_article-title">Acquired resistance to TKIs in solid tumours: learning from lung cancer</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1038/nrclinonc.2014.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrclinonc.2014.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=24981256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWisLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=473-481&author=D.+R.+Camidgeauthor=W.+Paoauthor=L.+V.+Sequist&title=Acquired+resistance+to+TKIs+in+solid+tumours%3A+learning+from+lung+cancer&doi=10.1038%2Fnrclinonc.2014.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired resistance to TKIs in solid tumours: learning from lung cancer</span></div><div class="casAuthors">Camidge, D. Ross; Pao, William; Sequist, Lecia V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The use of advanced mol. profiling to direct the use of targeted therapy, such as tyrosine kinase inhibitors (TKIs) for patients with advanced-stage non-small-cell lung cancer (NSCLC), has revolutionized the treatment of this disease.  However, acquired resistance, defined as progression after initial benefit, to targeted therapies inevitably occurs.  This Review explores breakthroughs in the understanding and treatment of acquired resistance in NSCLC, focusing on EGFR mutant and ALK rearrangement-pos. disease, which may be relevant across multiple different solid malignancies with oncogene-addicted subtypes.  Mechanisms of acquired resistance may be pharmacol. (i.e., failure of delivery of the drug to its target) or biol., resulting from evolutionary selection on molecularly diverse tumors.  A no. of clin. approaches can maintain control of the disease in the acquired resistance setting, including the use of radiation to treat isolated areas of progression and adding or switching to cytotoxic chemotherapy.  Furthermore, novel approaches that have already proven successful include the development of second-generation and third-generation inhibitors and the combination of some of these inhibitors with antibodies directed against the same target.  With our increased understanding of the spectrum of acquired resistance, major changes in how we conduct clin. research in this setting are now underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp00ixSKYoDuLVg90H21EOLACvtfcHk0lhbTi9ZUvQyow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWisLrL&md5=13cc2f49f7ef320ad54f7e84f5102816</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2014.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2014.104%26sid%3Dliteratum%253Aachs%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26atitle%3DAcquired%2520resistance%2520to%2520TKIs%2520in%2520solid%2520tumours%253A%2520learning%2520from%2520lung%2520cancer%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D11%26spage%3D473%26epage%3D481%26doi%3D10.1038%2Fnrclinonc.2014.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Higa, G. M.</span><span> </span><span class="NLM_article-title">The microtubule as a breast cancer target</span> <span class="citation_source-journal">Breast Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span><span class="refDoi"> DOI: 10.1007/s12282-010-0224-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1007%2Fs12282-010-0224-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=103-119&author=G.+M.+Higa&title=The+microtubule+as+a+breast+cancer+target&doi=10.1007%2Fs12282-010-0224-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs12282-010-0224-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12282-010-0224-7%26sid%3Dliteratum%253Aachs%26aulast%3DHiga%26aufirst%3DG.%2BM.%26atitle%3DThe%2520microtubule%2520as%2520a%2520breast%2520cancer%2520target%26jtitle%3DBreast%2520Cancer%26date%3D2011%26volume%3D18%26spage%3D103%26epage%3D119%26doi%3D10.1007%2Fs12282-010-0224-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Stanton, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gernert, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aneja, R.</span><span> </span><span class="NLM_article-title">Drugs that target dynamic microtubules: a new molecular perspective</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span><span class="refDoi"> DOI: 10.1002/med.20242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fmed.20242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=21381049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=443-481&author=R.+A.+Stantonauthor=K.+M.+Gernertauthor=J.+H.+Nettlesauthor=R.+Aneja&title=Drugs+that+target+dynamic+microtubules%3A+a+new+molecular+perspective&doi=10.1002%2Fmed.20242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs that target dynamic microtubules: A new molecular perspective</span></div><div class="casAuthors">Stanton, Richard A.; Gernert, Kim M.; Nettles, James H.; Aneja, Ritu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">443-481</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle app.  As such, there is a wide variety of compds. currently in clin. use and in development that act as antimitotic agents by altering microtubule dynamics.  Although these diverse mols. are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research.  In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biol. function relative to the mol. vectors of microtubule assembly or disassembly.  These "biol. vectors" can thus be used as a spatiotemporal context to describe mol. mechanisms by which microtubule-targeting drugs work. © 2011 Wiley Periodicals, Inc.  Med Res Rev, 31, No. 3, 443-481, 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB6_lcUQbXYrVg90H21EOLACvtfcHk0lhbTi9ZUvQyow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVKlsLs%253D&md5=acce5b9cc89581a7dab0236072b68c72</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fmed.20242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20242%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DR.%2BA.%26aulast%3DGernert%26aufirst%3DK.%2BM.%26aulast%3DNettles%26aufirst%3DJ.%2BH.%26aulast%3DAneja%26aufirst%3DR.%26atitle%3DDrugs%2520that%2520target%2520dynamic%2520microtubules%253A%2520a%2520new%2520molecular%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2011%26volume%3D31%26spage%3D443%26epage%3D481%26doi%3D10.1002%2Fmed.20242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Joshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belani, C. P.</span><span> </span><span class="NLM_article-title">Taxanes, past, present, and future impact on non-small cell lung cancer</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.1097/CAD.0000000000000080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1097%2FCAD.0000000000000080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=571-583&author=M.+Joshiauthor=X.+Liuauthor=C.+P.+Belani&title=Taxanes%2C+past%2C+present%2C+and+future+impact+on+non-small+cell+lung+cancer&doi=10.1097%2FCAD.0000000000000080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000080%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBelani%26aufirst%3DC.%2BP.%26atitle%3DTaxanes%252C%2520past%252C%2520present%252C%2520and%2520future%2520impact%2520on%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2014%26volume%3D25%26spage%3D571%26epage%3D583%26doi%3D10.1097%2FCAD.0000000000000080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Etienne-Manneville, S.</span><span> </span><span class="NLM_article-title">From signaling pathways to microtubule dynamics: the key players</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/j.ceb.2009.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.ceb.2009.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=20031384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslWqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=104-111&author=S.+Etienne-Manneville&title=From+signaling+pathways+to+microtubule+dynamics%3A+the+key+players&doi=10.1016%2Fj.ceb.2009.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">From signaling pathways to microtubule dynamics: the key players</span></div><div class="casAuthors">Etienne-Manneville, Sandrine</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-111</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Microtubules are highly dynamic structures whose regulation is crucial for cell division, cell polarity, cell migration, or neuronal differentiation.  Because they contribute to most cellular functions, they must be regulated in response to extracellular and intracellular signals.  The parameters of microtubule dynamics are numerous and complex and the connection between signaling pathways and regulation of microtubule dynamics remain obscure.  Recent observations reveal key players that can both integrate the diversity of signaling cascades and directly influence microtubule dynamics.  Here, the author reviews how modifications of the tubulin dimer, tubulin-modifying enzymes, and microtubule-assocd. proteins are directly involved in the regulation of microtubule behavior and functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNxwveP-IRE7Vg90H21EOLACvtfcHk0lhbTi9ZUvQyow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslWqsLc%253D&md5=d333c13b17b20a6d0776a7f2d92927bf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DEtienne-Manneville%26aufirst%3DS.%26atitle%3DFrom%2520signaling%2520pathways%2520to%2520microtubule%2520dynamics%253A%2520the%2520key%2520players%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2010%26volume%3D22%26spage%3D104%26epage%3D111%26doi%3D10.1016%2Fj.ceb.2009.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Van der Vaart, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhmanova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straube, A.</span><span> </span><span class="NLM_article-title">Regulation of microtubule dynamic instability</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1013</span><span class="refDoi"> DOI: 10.1042/BST0371007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1042%2FBST0371007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19754441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlsL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1007-1013&author=B.+Van+der+Vaartauthor=A.+Akhmanovaauthor=A.+Straube&title=Regulation+of+microtubule+dynamic+instability&doi=10.1042%2FBST0371007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of microtubule dynamic instability</span></div><div class="casAuthors">van der Vaart, Babet; Akhmanova, Anna; Straube, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1007-1013</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Proper regulation of microtubule (MT) dynamics is essential for various vital processes, including the segregation of chromosomes, directional cell migration, and differentiation.  MT assembly and disassembly is modulated by a complex network of intracellular factors that cooperate or antagonize each other, are highly regulated in space and time, and are thus attuned to the cell cycle and differentiation processes.  While researchers have only begun to appreciate how the concerted action of MT stabilizers and destabilizers shapes different MT patterns, a clear picture of how individual factors affect the MT structure is emerging.  Here, the authors review current knowledge about proteins that modulate MT dynamic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4-8yAuqr4-LVg90H21EOLACvtfcHk0libiAjHqXZv-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlsL%252FN&md5=e64a92e3eb9359801448028954985c7c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2FBST0371007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0371007%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BVaart%26aufirst%3DB.%26aulast%3DAkhmanova%26aufirst%3DA.%26aulast%3DStraube%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520microtubule%2520dynamic%2520instability%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2009%26volume%3D37%26spage%3D1007%26epage%3D1013%26doi%3D10.1042%2FBST0371007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Rovini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braguer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carré, M.</span><span> </span><span class="NLM_article-title">Microtubule-targeted agents: when mitochondria become essential to chemotherapy</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Bioenerg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1807</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span><span class="refDoi"> DOI: 10.1016/j.bbabio.2011.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.bbabio.2011.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=21216222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFSitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1807&publication_year=2011&pages=679-688&author=A.+Roviniauthor=A.+Savryauthor=D.+Braguerauthor=M.+Carr%C3%A9&title=Microtubule-targeted+agents%3A+when+mitochondria+become+essential+to+chemotherapy&doi=10.1016%2Fj.bbabio.2011.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-targeted agents: When mitochondria become essential to chemotherapy</span></div><div class="casAuthors">Rovini, A.; Savry, A.; Braguer, D.; Carre, M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Bioenergetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1807</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">679-688</span>CODEN:
                <span class="NLM_cas:coden">BBBEB4</span>;
        ISSN:<span class="NLM_cas:issn">0005-2728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Microtubule-Targeting Agents (MTAs) constitute a class of drugs largely used for cancer treatment in adults and children.  In cancer cells, they suppress microtubule dynamics, and induce cell death via the mitochondrial intrinsic pathway.  To date, links between mitochondria and microtubule network disturbance in MTAs mechanism of action are not obvious.  The aim of the present contribution is to provide elements that could answer to the question: how far are mitochondria essential to anticancer chemotherapy that targets the microtubule cytoskeleton We review the main mol. candidates to link microtubule alteration with the apoptotic mitochondrial pathway control.  Involvement of direct targeting of mitochondria in MTA efficacy is also discussed.  Furthermore, we line up current evidence and emerging concepts on the participation of both mitochondria and microtubule in MTA neurotoxic side effects.  To decipher the interconnections between the mitochondrial and the microtubule networks may help to improve cancer cell response to chemotherapy.  This article is part of a Special Issue entitled: Bioenergetics of Cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHCjULnreE0rVg90H21EOLACvtfcHk0libiAjHqXZv-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFSitro%253D&md5=2afa1b9807076eaa0696d5d959f9457b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbabio.2011.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbabio.2011.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DRovini%26aufirst%3DA.%26aulast%3DSavry%26aufirst%3DA.%26aulast%3DBraguer%26aufirst%3DD.%26aulast%3DCarr%25C3%25A9%26aufirst%3DM.%26atitle%3DMicrotubule-targeted%2520agents%253A%2520when%2520mitochondria%2520become%2520essential%2520to%2520chemotherapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Bioenerg.%26date%3D2011%26volume%3D1807%26spage%3D679%26epage%3D688%26doi%3D10.1016%2Fj.bbabio.2011.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Katsetos, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dráber, P.</span><span> </span><span class="NLM_article-title">Tubulins as therapeutic targets in cancer: from bench to bedside</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2778</span><span class="NLM_x">–</span> <span class="NLM_lpage">2792</span><span class="refDoi"> DOI: 10.2174/138161212800626193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.2174%2F138161212800626193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=22390762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslCrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2778-2792&author=C.+D.+Katsetosauthor=P.+Dr%C3%A1ber&title=Tubulins+as+therapeutic+targets+in+cancer%3A+from+bench+to+bedside&doi=10.2174%2F138161212800626193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulins as therapeutic targets in cancer: from bench to bedside</span></div><div class="casAuthors">Katsetos, Christos D.; Draber, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2778-2792</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tubulin is the target of some of the most widely used and time-honored anticancer tubulin-binding agents (TBAs).  The clin. usefulness of many TBAs has been held back as a result of tumor cell drug-resistance.  The elucidation of the three-dimensional structure of αβ-tubulin dimer has provided an opportunity for rational drug design aimed at generating compds. that will target tubulin in therapeutically more efficacious ways compared to presently available drugs.  An issue to be addressed is which one(s) of the tubulin species, their isotypes, or their posttranslationally modified forms, should be specifically targeted in cancer chemotherapy.  This review offers a crit. appraisal of current knowledge on tubulins in cancer and an update on new anti-neoplastic microtubule-targeted treatment strategies.  Specifically, it examines, across disciplines, cellular/mol., biochem., clin./pathol., and pharmacol. aspects of β-tubulin isotypes, posttranslational modifications of tubulin dimers, γ-tubulin and microtubule nucleation, and microtubule regulatory proteins.  Emphasis is placed on the overexpression of (i) the βIII isotypes, which functions as a survival factor assocd. with dynamic instability of microtubules; (ii) γ-tubulin, a key microtubule nucleating protein; and (iii) the microtubule severing enzyme spastin, involved in cell motility and proliferation of glioblastoma cells.  The role of βIII-tubulin in resistance of cancer cells to taxanes is examd.  Attention is called to the novel concept that βIII-tubulin functions as a "gateway" for prosurvival signals in partnership with GTPases, such as GBP1.  Appraisal is also offered on epothilones and the concept of hypersensitization to TBAs as promising therapeutic strategies in taxane resistant epithelial cancers and in high-grade gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxdmReNG2Qw7Vg90H21EOLACvtfcHk0libiAjHqXZv-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslCrs7k%253D&md5=cc9638610d51334759aa081a624f7abe</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F138161212800626193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212800626193%26sid%3Dliteratum%253Aachs%26aulast%3DKatsetos%26aufirst%3DC.%2BD.%26aulast%3DDr%25C3%25A1ber%26aufirst%3DP.%26atitle%3DTubulins%2520as%2520therapeutic%2520targets%2520in%2520cancer%253A%2520from%2520bench%2520to%2520bedside%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D2778%26epage%3D2792%26doi%3D10.2174%2F138161212800626193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Perez, E. A.</span><span> </span><span class="NLM_article-title">Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2086</span><span class="NLM_x">–</span> <span class="NLM_lpage">2095</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1158%2F1535-7163.MCT-09-0366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19671735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvFCnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2086-2095&author=E.+A.+Perez&title=Microtubule+inhibitors%3A+Differentiating+tubulin-inhibiting+agents+based+on+mechanisms+of+action%2C+clinical+activity%2C+and+resistance&doi=10.1158%2F1535-7163.MCT-09-0366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance</span></div><div class="casAuthors">Perez, Edith A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2086-2095</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Microtubules are important cellular targets for anticancer therapy because of their key role in mitosis.  Microtubule inhibitors (MTI) such as taxanes, vinca alkaloids, and epothilones stabilize or destabilize microtubules, thereby suppressing microtubule dynamics required for proper mitotic function, effectively blocking cell cycle progression and resulting in apoptosis.  In spite of their antitumor activity, innate or acquired drug resistance to MTIs such as the taxanes is common, limiting their overall clin. efficacy.  Further insight into the mechanisms of action of microtubule-targeting drugs has lead to the discovery of novel agents that may provide higher efficacy with limited toxicity and help overcome resistance to conventional MTIs.  This review will focus on the different mechanisms of action of MTIs, potential factors related to resistance and tolerability, and will discuss the recent approval as well as the development of new antineoplastic agents. [Mol Cancer Ther 2009;8(8):2086-95].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1HM8JP4QG8LVg90H21EOLACvtfcHk0ljD817UcBavQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvFCnurw%253D&md5=1d8dec9ed6c0f061032cec57c96c833e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0366%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DE.%2BA.%26atitle%3DMicrotubule%2520inhibitors%253A%2520Differentiating%2520tubulin-inhibiting%2520agents%2520based%2520on%2520mechanisms%2520of%2520action%252C%2520clinical%2520activity%252C%2520and%2520resistance%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D2086%26epage%3D2095%26doi%3D10.1158%2F1535-7163.MCT-09-0366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bhat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setaluri, V.</span><span> </span><span class="NLM_article-title">Microtubule-associated proteins as targets in cancer chemotherapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2849</span><span class="NLM_x">–</span> <span class="NLM_lpage">2854</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-3040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1158%2F1078-0432.CCR-06-3040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=17504982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Krsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2849-2854&author=K.+M.+Bhatauthor=V.+Setaluri&title=Microtubule-associated+proteins+as+targets+in+cancer+chemotherapy&doi=10.1158%2F1078-0432.CCR-06-3040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-Associated Proteins as Targets in Cancer Chemotherapy</span></div><div class="casAuthors">Bhat, Kumar M. R.; Setaluri, Vijayasaradhi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2849-2854</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Natural and synthetic compds. that disrupt microtubule dynamics are among the most successful and widely used cancer chemotherapeutic agents.  However, lack of reliable markers that predict sensitivity of cancers to these agents and development of resistance remain vexing issues.  There is accumulating evidence that a family of cellular proteins that are assocd. with and alter the dynamics of microtubules can det. sensitivity of cancer cells to microtubule-targeting agents and play a role in tumor cell resistance to these agents.  This growing family of microtubule-assocd. proteins (MAP) includes products of oncogenes, tumor suppressors, and apoptosis regulators, suggesting that alteration of microtubule dynamics may be one of the crit. events in tumorigenesis and tumor progression.  The objective of this review is to integrate the knowledge on these seemingly unrelated proteins that share a common function and examine their relevance to microtubule-targeting therapies and highlight MAPs-tubulin-drug interactions as a novel avenue for new drug discovery.  Based on the available evidence, we propose that rational microtubule-targeting cancer therapeutic approaches should ideally include proteomic profiling of tumor MAPs before administration of microtubule-stabilizing/destabilizing agents preferentially in combination with agents that modulate the expression of relevant MAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJCwiEFkyEsrVg90H21EOLACvtfcHk0ljD817UcBavQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Krsrw%253D&md5=719cc6f219556505b5562b1201171911</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-3040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-3040%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DK.%2BM.%26aulast%3DSetaluri%26aufirst%3DV.%26atitle%3DMicrotubule-associated%2520proteins%2520as%2520targets%2520in%2520cancer%2520chemotherapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D2849%26epage%3D2854%26doi%3D10.1158%2F1078-0432.CCR-06-3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Miceli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S. J.</span><span> </span><span class="NLM_article-title">Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer</span> <span class="citation_source-journal">Cancer Gene Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1038/cgt.2013.21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fcgt.2013.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=23618950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms1WgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=298-307&author=C.+Miceliauthor=A.+Tejadaauthor=A.+Castanedaauthor=S.+J.+Mistry&title=Cell+cycle+inhibition+therapy+that+targets+stathmin+in+in+vitro+and+in+vivo+models+of+breast+cancer&doi=10.1038%2Fcgt.2013.21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer</span></div><div class="casAuthors">Miceli, C.; Tejada, A.; Castaneda, A.; Mistry, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Gene Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">298-307</span>CODEN:
                <span class="NLM_cas:coden">CGTHEG</span>;
        ISSN:<span class="NLM_cas:issn">0929-1903</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Stathmin is the founding member of a family of microtubule-destabilizing proteins that have a crit. role in the regulation of mitosis.  Stathmin is expressed at high levels in breast cancer and its overexpression is linked to disease progression.  Although there is a large body of evidence to support a role for stathmin in breast cancer progression, the validity of stathmin as a viable therapeutic target for breast cancer has not been investigated.  Here, we used a bicistronic adenoviral vector that co-expresses green fluorescent protein and a ribozyme that targets stathmin mRNA in preclin. breast cancer models with different estrogen receptor (ER) status.  We examd. the effects of anti-stathmin ribozyme on the malignant phenotype of breast cancer cells in vitro and in xenograft models in vivo both as a single agent and in combination with chemotherapeutic agents.  Adenovirus-mediated gene transfer of anti-stathmin ribozyme resulted in a dose-dependent inhibition of proliferation and clonogenicity assocd. with a G2/M arrest and increase in apoptosis in both ER-pos. and ER-neg. breast cancer cell lines.  This inhibition was markedly enhanced when stathmin-inhibited breast cancer cells were exposed to low concns. of taxol, which resulted in virtually complete loss of the malignant phenotype.  Interestingly, breast cancer xenografts treated with low doses of anti-stathmin therapy and taxol showed regression in a majority of tumors, while some tumors stopped growing completely.  In contrast, combination of anti-stathmin ribozyme and adriamycin resulted in only a modest inhibition of growth in vitro and in breast cancer xenografts in vivo.  Although inhibition of tumor growth was obsd. in both the combination treatment groups compared with groups treated with single agent alone, combination of anti-stathmin therapy and taxol had a more profound inhibition of tumorigenicity, as both agents target the microtubule pathway.  Clin., these findings are highly relevant because taxol is one of the most active chemotherapeutic agents in breast cancer.  These studies provide the proof-of-principle that stathmin provides an attractive mol. target, which could serve as a primary focus of novel approaches to breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphv_lNDGlXpbVg90H21EOLACvtfcHk0ljD817UcBavQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms1WgurY%253D&md5=89ae7276231c16300b47fec32ee30dc5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fcgt.2013.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcgt.2013.21%26sid%3Dliteratum%253Aachs%26aulast%3DMiceli%26aufirst%3DC.%26aulast%3DTejada%26aufirst%3DA.%26aulast%3DCastaneda%26aufirst%3DA.%26aulast%3DMistry%26aufirst%3DS.%2BJ.%26atitle%3DCell%2520cycle%2520inhibition%2520therapy%2520that%2520targets%2520stathmin%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520of%2520breast%2520cancer%26jtitle%3DCancer%2520Gene%2520Ther.%26date%3D2013%26volume%3D20%26spage%3D298%26epage%3D307%26doi%3D10.1038%2Fcgt.2013.21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Rouzier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuerer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symmans, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pusztai, L.</span><span> </span><span class="NLM_article-title">Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8315</span><span class="NLM_x">–</span> <span class="NLM_lpage">8320</span><span class="refDoi"> DOI: 10.1073/pnas.0408974102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1073%2Fpnas.0408974102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8315-8320&author=R.+Rouzierauthor=R.+Rajanauthor=P.+Wagnerauthor=K.+R.+Hessauthor=D.+L.+Goldauthor=J.+Stecauthor=M.+Ayersauthor=J.+S.+Rossauthor=P.+Zhangauthor=T.+A.+Buchholzauthor=H.+Kuererauthor=M.+Greenauthor=B.+Arunauthor=G.+N.+Hortobagyiauthor=W.+F.+Symmansauthor=L.+Pusztai&title=Microtubule-associated+protein+tau%3A+a+marker+of+paclitaxel+sensitivity+in+breast+cancer&doi=10.1073%2Fpnas.0408974102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0408974102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0408974102%26sid%3Dliteratum%253Aachs%26aulast%3DRouzier%26aufirst%3DR.%26aulast%3DRajan%26aufirst%3DR.%26aulast%3DWagner%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DK.%2BR.%26aulast%3DGold%26aufirst%3DD.%2BL.%26aulast%3DStec%26aufirst%3DJ.%26aulast%3DAyers%26aufirst%3DM.%26aulast%3DRoss%26aufirst%3DJ.%2BS.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DBuchholz%26aufirst%3DT.%2BA.%26aulast%3DKuerer%26aufirst%3DH.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DArun%26aufirst%3DB.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26aulast%3DSymmans%26aufirst%3DW.%2BF.%26aulast%3DPusztai%26aufirst%3DL.%26atitle%3DMicrotubule-associated%2520protein%2520tau%253A%2520a%2520marker%2520of%2520paclitaxel%2520sensitivity%2520in%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D8315%26epage%3D8320%26doi%3D10.1073%2Fpnas.0408974102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sharp, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. L.</span><span> </span><span class="NLM_article-title">Microtubule-severing enzymes at the cutting edge</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2561</span><span class="NLM_x">–</span> <span class="NLM_lpage">2569</span><span class="refDoi"> DOI: 10.1242/jcs.101139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1242%2Fjcs.101139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=22595526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=2561-2569&author=D.+J.+Sharpauthor=J.+L.+Ross&title=Microtubule-severing+enzymes+at+the+cutting+edge&doi=10.1242%2Fjcs.101139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-severing enzymes at the cutting edge</span></div><div class="casAuthors">Sharp, David J.; Ross, Jennifer L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2561-2569</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  ATP-dependent severing of microtubules was first reported in Xenopus laevis egg exts. in 1991.  Two years later this observation led to the purifn. of the first known microtubule-severing enzyme, katanin.  Katanin homologs have now been identified throughout the animal kingdom and in plants.  Moreover, members of two closely related enzyme subfamilies, spastin and fidgetin, have been found to sever microtubules and might act alongside katanins in some contexts.  Over the past few years, it has become clear that microtubule-severing enzymes contribute to a wide range of cellular activities including mitosis and meiosis, morphogenesis, cilia biogenesis and disassembly, and cell migration.  Thus, this group of enzymes is revealing itself to be among the most important of the microtubule regulators.  This Commentary focuses on our growing understanding of how microtubule-severing enzymes contribute to the organization and dynamics of diverse microtubule arrays, as well as the structural and biophys. characteristics that afford them the unique capacity to catalyze the removal of tubulin from the interior microtubule lattice.  Our goal is to provide a broader perspective, focusing on a limited no. of particularly informative, representative and/or timely findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg2sHb_W6V1LVg90H21EOLACvtfcHk0ljWwx9HQsDzTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrsrzO&md5=3effc3d0c73720e2a9d77fff656eb6b0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1242%2Fjcs.101139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.101139%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DD.%2BJ.%26aulast%3DRoss%26aufirst%3DJ.%2BL.%26atitle%3DMicrotubule-severing%2520enzymes%2520at%2520the%2520cutting%2520edge%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2012%26volume%3D125%26spage%3D2561%26epage%3D2569%26doi%3D10.1242%2Fjcs.101139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Baas, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V.</span><span> </span><span class="NLM_article-title">Cell migration: katanin gives microtubules a trim</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1016/j.cub.2011.03.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.cub.2011.03.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVOnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=302-304&author=P.+W.+Baasauthor=V.+Sharma&title=Cell+migration%3A+katanin+gives+microtubules+a+trim&doi=10.1016%2Fj.cub.2011.03.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cell migration: Katanin gives microtubules a trim</span></div><div class="casAuthors">Baas, Peter W.; Sharma, Vandana</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">R302-R304</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  New evidence suggests that katanin, best known for severing microtubules in their more stable regions, localizes at the leading edge of migratory cells and trims microtubules at their dynamic plus-ends.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOPdg8P7VAgrVg90H21EOLACvtfcHk0ljWwx9HQsDzTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVOnt70%253D&md5=45c6860667406206961432966e1ccd63</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2011.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2011.03.051%26sid%3Dliteratum%253Aachs%26aulast%3DBaas%26aufirst%3DP.%2BW.%26aulast%3DSharma%26aufirst%3DV.%26atitle%3DCell%2520migration%253A%2520katanin%2520gives%2520microtubules%2520a%2520trim%26jtitle%3DCurr.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D302%26epage%3D304%26doi%3D10.1016%2Fj.cub.2011.03.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ghosh, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, A.</span><span> </span><span class="NLM_article-title">Models, regulations, and functions of microtubule severing by katanin</span> <span class="citation_source-journal">ISRN Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.5402/2012/596289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.5402%2F2012%2F596289" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1-14&author=D.+K.+Ghoshauthor=D.+Dasguptaauthor=A.+Guha&title=Models%2C+regulations%2C+and+functions+of+microtubule+severing+by+katanin&doi=10.5402%2F2012%2F596289"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.5402%2F2012%2F596289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5402%252F2012%252F596289%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%2BK.%26aulast%3DDasgupta%26aufirst%3DD.%26aulast%3DGuha%26aufirst%3DA.%26atitle%3DModels%252C%2520regulations%252C%2520and%2520functions%2520of%2520microtubule%2520severing%2520by%2520katanin%26jtitle%3DISRN%2520Mol.%2520Biol.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D14%26doi%3D10.5402%2F2012%2F596289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ye, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choueiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logothetis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu-Lee, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. H.</span><span> </span><span class="NLM_article-title">Aberrant expression of katanin p60 in prostate cancer bone metastasis</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span><span class="refDoi"> DOI: 10.1002/pros.21431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fpros.21431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=21681775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjsl2itA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=291-300&author=X.+Yeauthor=Y.+C.+Leeauthor=M.+Choueiriauthor=K.+Chuauthor=C.+F.+Huangauthor=W.+W.+Tsaiauthor=R.+Kobayashiauthor=C.+J.+Logothetisauthor=L.+Y.+Yu-Leeauthor=S.+H.+Lin&title=Aberrant+expression+of+katanin+p60+in+prostate+cancer+bone+metastasis&doi=10.1002%2Fpros.21431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant expression of katanin p60 in prostate cancer bone metastasis</span></div><div class="casAuthors">Ye, Xiangcang; Lee, Yu-Chen; Choueiri, Michel; Chu, Khoi; Huang, Chih-Fen; Tsai, Wen-Wei; Kobayashi, Ryuji; Logothetis, Christopher J.; Yu-Lee, Li-Yuan; Lin, Sue-Hwa</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-300</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Katanin p60 is a microtubule-severing protein and is involved in microtubule cytoskeleton organization in both mitotic and non-mitotic processes.  Its role in cancer metastasis is unknown.  Differential protein profiles of bone marrow aspirates were analyzed by chromatog., electrophoresis, and mass spectrometry.  Expression of katanin p60 in primary and metastatic prostate cancer was examd. by immunohistochem.  Cellular function of katanin p60 was further examd. in prostate cell lines.  In a proteomic profiling of bone marrow aspirates from men with prostate cancer, we found that katanin p60 was one of the proteins differentially expressed in bone metastasis samples.  Immunohistochem. staining showed that katanin p60 was expressed in the basal cells in normal human prostate glands.  In prostatic adenocarcinomas, in which the basal cells were absent, katanin p60 was expressed in the prostate cancer cells.  In the specimens from bone metastasis, katanin p60 was detectable in the metastatic cancer cells.  Strikingly, some of the metastatic cancer cells also co-expressed basal cell biomarkers including the tumor suppressor p53-homologous protein p63 and the high mol. wt. cytokeratins, suggesting that the metastatic prostate cancer cells may have a basal cell-like phenotype.  Moreover, overexpression of katanin p60 inhibited prostate cancer cell proliferation but enhanced cell migration activity.  Katanin p60 was aberrantly expressed during prostate cancer progression.  Its expression in the metastatic cells in bone was assocd. with the re-emergence of a basal cell-like phenotype.  The elevated katanin p60 expression may contribute to cancer cell metastasis via a stimulatory effect on cell motility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9sgS_WA-2CbVg90H21EOLACvtfcHk0ljWwx9HQsDzTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjsl2itA%253D%253D&md5=f1d4077463247cff8591da9126e1adc7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fpros.21431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.21431%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DChoueiri%26aufirst%3DM.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%2BF.%26aulast%3DTsai%26aufirst%3DW.%2BW.%26aulast%3DKobayashi%26aufirst%3DR.%26aulast%3DLogothetis%26aufirst%3DC.%2BJ.%26aulast%3DYu-Lee%26aufirst%3DL.%2BY.%26aulast%3DLin%26aufirst%3DS.%2BH.%26atitle%3DAberrant%2520expression%2520of%2520katanin%2520p60%2520in%2520prostate%2520cancer%2520bone%2520metastasis%26jtitle%3DProstate%26date%3D2012%26volume%3D72%26spage%3D291%26epage%3D300%26doi%3D10.1002%2Fpros.21431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sudo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maru, Y.</span><span> </span><span class="NLM_article-title">LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2086</span><span class="NLM_x">–</span> <span class="NLM_lpage">2100</span><span class="refDoi"> DOI: 10.1096/fj.06-7254com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1096%2Ffj.06-7254com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=17351128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvVagsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2086-2100&author=H.+Sudoauthor=Y.+Maru&title=LAPSER1+is+a+putative+cytokinetic+tumor+suppressor+that+shows+the+same+centrosome+and+midbody+subcellular+localization+pattern+as+p80+katanin&doi=10.1096%2Ffj.06-7254com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin</span></div><div class="casAuthors">Sudo, Haruka; Maru, Yoshiro</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2086-2100, 10.1096/fj.06-7254com</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Prostate cancer is one of the most common cancers in men, with more than 500,000 new worldwide cases reported annually, resulting in 200,000 deaths of mainly older men in developed countries.  Existing treatments have not proved very effective in managing prostate cancer, and continuing efforts therefore are ongoing to explore novel targets and strategies for future therapies.  LAPSER1 has been identified as a candidate tumor suppressor gene in prostate cancer, but its true functions remain unknown.  We report here that LAPSER1 colocalizes to the centrosomes and mid-bodies in mitotic cells with γ-tubulin, MKLP1, and p80 katanin, and is involved in cytokinesis.  Moreover, RNAi-mediated disruption of LAPSER1, which is accompanied by the mislocalization of p80 katanin, results in malformation of the central spindle.  Significantly, the enhanced expression of LAPSER1 induces binucleation and renders the cells resistant to oncogenic transformation.  In cells transformed by the v-Fps oncogene, overexpressed LAPSER1 induces abortive cytokinesis, followed by mitotic catastrophe in a p80 katanin-dependent manner.  Cells that are rescued from this apoptotic pathway with Z-VAD-fmk display karyokinesis.  These results suggest that LAPSER1 participates in cytokinesis by interacting with p80 katanin, the disruption of which may potentially cause genetic instability and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6HEJ2ibPbU7Vg90H21EOLACvtfcHk0ljxYjl-utYfjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvVagsL8%253D&md5=d615348025024af922cb3d487f08e641</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-7254com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-7254com%26sid%3Dliteratum%253Aachs%26aulast%3DSudo%26aufirst%3DH.%26aulast%3DMaru%26aufirst%3DY.%26atitle%3DLAPSER1%2520is%2520a%2520putative%2520cytokinetic%2520tumor%2520suppressor%2520that%2520shows%2520the%2520same%2520centrosome%2520and%2520midbody%2520subcellular%2520localization%2520pattern%2520as%2520p80%2520katanin%26jtitle%3DFASEB%2520J.%26date%3D2007%26volume%3D21%26spage%3D2086%26epage%3D2100%26doi%3D10.1096%2Ffj.06-7254com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Yeh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. Y.</span><span> </span><span class="NLM_article-title">Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span><span class="refDoi"> DOI: 10.1164/rccm.201207-1180OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1164%2Frccm.201207-1180OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=23024022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2012&pages=1180-1188&author=C.+T.+Yehauthor=A.+T.+Wuauthor=P.+M.+Changauthor=K.+Y.+Chenauthor=C.+N.+Yangauthor=S.+C.+Yangauthor=C.+C.+Hoauthor=C.+C.+Chenauthor=Y.+L.+Kuoauthor=P.+Y.+Leeauthor=Y.+W.+Liuauthor=C.+C.+Yenauthor=M.+Hsiaoauthor=P.+J.+Luauthor=J.+M.+Laiauthor=L.+S.+Wangauthor=C.+H.+Wuauthor=J.+F.+Chiouauthor=P.+C.+Yangauthor=C.+Y.+Huang&title=Trifluoperazine%2C+an+antipsychotic+agent%2C+inhibits+cancer+stem+cell+growth+and+overcomes+drug+resistance+of+lung+cancer&doi=10.1164%2Frccm.201207-1180OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer</span></div><div class="casAuthors">Yeh, Chi-Tai; Wu, Alexander T. H.; Chang, Peter M.-H.; Chen, Kuan-Yu; Yang, Chia-Ning; Yang, Shuenn-Chen; Ho, Chao-Chi; Chen, Chun-Chi; Kuo, Yu-Lun; Lee, Pei-Ying; Liu, Yu-Wen; Yen, Chueh-Chuan; Hsiao, Michael; Lu, Pei-Jung; Lai, Jin-Mei; Wang, Liang-Shun; Wu, Chih-Hsiung; Chiou, Jeng-Fong; Yang, Pan-Chyr; Huang, Chi-Ying F.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1180-1188</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Cancer stem cell (CSC) theory has drawn much attention, with evidence supporting the contribution of stem cells to tumor initiation, relapse, and therapy resistance.  Objectives: To screen drugs that target CSCs to improve the current treatment outcome and overcome drug resistance in patients with lung cancer.  Methods: We used publicly available embryonic stem cell and CSC-assocd. gene signatures to query the Connectivity Map for potential drugs that can, at least in part, reverse the gene expression profile of CSCs.  High scores were noted for several phenothiazine-like antipsychotic drugs, including trifluoperazine.  We then treated lung CSCs with different EGFR mutation status with trifluoperazine to examine its anti-CSC properties.  Lung CSCs resistant to epidermal growth factor receptor-tyrosine kinase inhibitor or cisplatin were treated with trifluoperazine plus gefitinib or trifluoperazine plus cisplatin.  Animal models were used for in vivo validation of the anti-CSC effect and synergistic effect of trifluoperazine with gefitinib.  Measurements and Main Results: We demonstrated that trifluoperazine inhibited CSC tumor spheroid formation and down-regulated the expression of CSC markers (CD44/CD133).  Trifluoperazine inhibited Wnt/β-catenin signaling in gefitinib-resistant lung cancer spheroids.  The combination of trifluoperazine with either gefitinib or cisplatin overcame drug resistance in lung CSCs.  Trifluoperazine inhibited the tumor growth and enhanced the inhibitory activity of gefitinib in lung cancer metastatic and orthotopic CSC animal models.  Conclusions: Using in silico drug screening by Connectivity Map followed by empirical validations, we repurposed an existing phenothiazine-like antipsychotic drug, trifluoperazine, as a potential anti-CSC agent that could overcome epidermal growth factor receptor-tyrosine kinase inhibitor and chemotherapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPf24lWeMWQbVg90H21EOLACvtfcHk0ljxYjl-utYfjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOjtro%253D&md5=0bc2a899c88f4f891170194d22a32de9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1164%2Frccm.201207-1180OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201207-1180OC%26sid%3Dliteratum%253Aachs%26aulast%3DYeh%26aufirst%3DC.%2BT.%26aulast%3DWu%26aufirst%3DA.%2BT.%26aulast%3DChang%26aufirst%3DP.%2BM.%26aulast%3DChen%26aufirst%3DK.%2BY.%26aulast%3DYang%26aufirst%3DC.%2BN.%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DHo%26aufirst%3DC.%2BC.%26aulast%3DChen%26aufirst%3DC.%2BC.%26aulast%3DKuo%26aufirst%3DY.%2BL.%26aulast%3DLee%26aufirst%3DP.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BW.%26aulast%3DYen%26aufirst%3DC.%2BC.%26aulast%3DHsiao%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DP.%2BJ.%26aulast%3DLai%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DL.%2BS.%26aulast%3DWu%26aufirst%3DC.%2BH.%26aulast%3DChiou%26aufirst%3DJ.%2BF.%26aulast%3DYang%26aufirst%3DP.%2BC.%26aulast%3DHuang%26aufirst%3DC.%2BY.%26atitle%3DTrifluoperazine%252C%2520an%2520antipsychotic%2520agent%252C%2520inhibits%2520cancer%2520stem%2520cell%2520growth%2520and%2520overcomes%2520drug%2520resistance%2520of%2520lung%2520cancer%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D186%26spage%3D1180%26epage%3D1188%26doi%3D10.1164%2Frccm.201207-1180OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Booth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proença, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaki, M. E. A.</span><span> </span><span class="NLM_article-title">The reactions of diaminomaleonitrile with isocyanates and either aldehydes or ketones revisited</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8436</span><span class="NLM_x">–</span> <span class="NLM_lpage">8441</span><span class="refDoi"> DOI: 10.1021/jo010595w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo010595w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=8436-8441&author=B.+L.+Boothauthor=A.+M.+Diasauthor=M.+F.+Proen%C3%A7aauthor=M.+E.+A.+Zaki&title=The+reactions+of+diaminomaleonitrile+with+isocyanates+and+either+aldehydes+or+ketones+revisited&doi=10.1021%2Fjo010595w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo010595w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010595w%26sid%3Dliteratum%253Aachs%26aulast%3DBooth%26aufirst%3DB.%2BL.%26aulast%3DDias%26aufirst%3DA.%2BM.%26aulast%3DProen%25C3%25A7a%26aufirst%3DM.%2BF.%26aulast%3DZaki%26aufirst%3DM.%2BE.%2BA.%26atitle%3DThe%2520reactions%2520of%2520diaminomaleonitrile%2520with%2520isocyanates%2520and%2520either%2520aldehydes%2520or%2520ketones%2520revisited%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D8436%26epage%3D8441%26doi%3D10.1021%2Fjo010595w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Davies, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunger, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span> </span><span class="NLM_article-title">Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.str.2008.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.str.2008.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=18462676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslGrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=715-726&author=J.+M.+Daviesauthor=A.+T.+Brungerauthor=W.+I.+Weis&title=Improved+structures+of+full-length+p97%2C+an+AAA+ATPase%3A+implications+for+mechanisms+of+nucleotide-dependent+conformational+change&doi=10.1016%2Fj.str.2008.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Structures of Full-Length p97, an AAA ATPase: Implications for Mechanisms of Nucleotide-Dependent Conformational Change</span></div><div class="casAuthors">Davies, Jason M.; Brunger, Axel T.; Weis, William I.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">715-726</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The ATPases assocd. with various cellular activities (AAA) protein p97 has been implicated in a variety of cellular processes, including endoplasmic reticulum-assocd. degrdn. and homotypic membrane fusion. p97 belongs to a subgroup of AAA proteins that contains two nucleotide binding domains, D1 and D2.  We detd. the crystal structure of D2 at 3.0 Å resoln.  This model enabled rerefinement of full-length p97 in different nucleotide states against previously reported low-resoln. diffraction data to significantly improved R values and Ramachandran statistics.  Although the overall fold remained similar, there are significant improvements, esp. around the D2 nucleotide binding site.  The rerefinement illustrates the importance of knowledge of high-resoln. structures of fragments covering most of the whole mol.  The structures suggest that nucleotide hydrolysis is transformed into larger conformational changes by pushing of one D2 domain by its neighbor in the hexamer, and transmission of nucleotide-state information through the D1-D2 linker to displace the N-terminal, effector binding domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopNlv0unl11rVg90H21EOLACvtfcHk0lhvdNju-QYwig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslGrtrY%253D&md5=bd90feb2579bd98e76c9e22f5814d605</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2008.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2008.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DJ.%2BM.%26aulast%3DBrunger%26aufirst%3DA.%2BT.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DImproved%2520structures%2520of%2520full-length%2520p97%252C%2520an%2520AAA%2520ATPase%253A%2520implications%2520for%2520mechanisms%2520of%2520nucleotide-dependent%2520conformational%2520change%26jtitle%3DStructure%26date%3D2008%26volume%3D16%26spage%3D715%26epage%3D726%26doi%3D10.1016%2Fj.str.2008.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kelley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezulis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wass, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternberg, M. J.</span><span> </span><span class="NLM_article-title">The Phyre2 web portal for protein modeling, prediction and analysis</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span><span class="refDoi"> DOI: 10.1038/nprot.2015.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnprot.2015.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=25950237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFSqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=845-858&author=L.+A.+Kelleyauthor=S.+Mezulisauthor=C.+M.+Yatesauthor=M.+N.+Wassauthor=M.+J.+Sternberg&title=The+Phyre2+web+portal+for+protein+modeling%2C+prediction+and+analysis&doi=10.1038%2Fnprot.2015.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Phyre2 web portal for protein modeling, prediction and analysis</span></div><div class="casAuthors">Kelley, Lawrence A.; Mezulis, Stefans; Yates, Christopher M.; Wass, Mark N.; Sternberg, Michael J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">845-858</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phyre2 is a suite of tools available on the web to predict and analyze protein structure, function and mutations.  The focus of Phyre2 is to provide biologists with a simple and intuitive interface to state-of-the-art protein bioinformatics tools.  Phyre2 replaces Phyre, the original version of the server for which the authors previously published a paper in Nature Protocols.  In this updated protocol, the authors describe Phyre2, which uses advanced remote homol. detection methods to build 3D models, predict ligand binding sites and analyze the effect of amino acid variants (e.g., nonsynonymous SNPs (nsSNPs)) for a user's protein sequence.  Users are guided through results by a simple interface at a level of detail they det.  This protocol will guide users from submitting a protein sequence to interpreting the secondary and tertiary structure of their models, their domain compn. and model quality.  A range of addnl. available tools is described to find a protein structure in a genome, to submit large no. of sequences at once and to automatically run weekly searches for proteins that are difficult to model.  The server is available at http://www.sbg.bio.ic.ac.uk/phyre2.  A typical structure prediction will be returned between 30 min and 2 h after submission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNEic1KXsLCrVg90H21EOLACvtfcHk0lhvdNju-QYwig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFSqurs%253D&md5=e69b1b5c799cc3b8e3a562c90299a813</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2015.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2015.053%26sid%3Dliteratum%253Aachs%26aulast%3DKelley%26aufirst%3DL.%2BA.%26aulast%3DMezulis%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DC.%2BM.%26aulast%3DWass%26aufirst%3DM.%2BN.%26aulast%3DSternberg%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520Phyre2%2520web%2520portal%2520for%2520protein%2520modeling%252C%2520prediction%2520and%2520analysis%26jtitle%3DNat.%2520Protoc.%26date%3D2015%26volume%3D10%26spage%3D845%26epage%3D858%26doi%3D10.1038%2Fnprot.2015.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0ljprOQ116ndAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hartman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vale, R. D.</span><span> </span><span class="NLM_article-title">Microtubule disassembly by ATP-dependent oligomerization of the AAA enzyme katanin</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span><span class="refDoi"> DOI: 10.1126/science.286.5440.782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1126%2Fscience.286.5440.782" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=782-785&author=J.+J.+Hartmanauthor=R.+D.+Vale&title=Microtubule+disassembly+by+ATP-dependent+oligomerization+of+the+AAA+enzyme+katanin&doi=10.1126%2Fscience.286.5440.782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.782%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DJ.%2BJ.%26aulast%3DVale%26aufirst%3DR.%2BD.%26atitle%3DMicrotubule%2520disassembly%2520by%2520ATP-dependent%2520oligomerization%2520of%2520the%2520AAA%2520enzyme%2520katanin%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D782%26epage%3D785%26doi%3D10.1126%2Fscience.286.5440.782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowska, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karabay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korulu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baas, P. W.</span><span> </span><span class="NLM_article-title">The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span><span class="refDoi"> DOI: 10.1091/mbc.E07-09-0878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1091%2Fmbc.E07-09-0878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=18234839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1485-1498&author=W.+Yuauthor=L.+Qiangauthor=J.+M.+Solowskaauthor=A.+Karabayauthor=S.+Koruluauthor=P.+W.+Baas&title=The+microtubule-severing+proteins+spastin+and+katanin+participate+differently+in+the+formation+of+axonal+branches&doi=10.1091%2Fmbc.E07-09-0878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches</span></div><div class="casAuthors">Yu, Wenqian; Qiang, Liang; Solowska, Joanna M.; Karabay, Arzu; Korulu, Sirin; Baas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1485-1498</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Neurons express 2 different microtubule-severing proteins, namely p60-katanin and spastin.  Here, the authors performed studies with cultured neurons to ascertain whether these 2 proteins participate differently in axonal branch formation.  The protein, p60-katanin, was more highly expressed in the neuron, but spastin is more concd. at sites of branch formation.  Overexpression of spastin dramatically enhanced the formation of branches, whereas overexpression of p60-katanin did not.  The excess spastin resulted in large nos. of short microtubules, whereas the excess p60-katanin resulted in short microtubules intermingled with longer microtubules.  The authors hypothesized that these different microtubule-severing patterns may be due to the presence of mols. such as tau on the microtubules that more strongly shield them from being severed by p60-katanin than by spastin.  Consistent with this hypothesis, it was found that axons depleted of tau showed a greater propensity to branch, and that this was true whether or not the axons were also depleted of spastin.  It was proposed that there are 2 modes by which microtubule severing is orchestrated during axonal branch formation, one based on the local concn. of spastin at branch sites and the other based on local detachment from microtubules of mols. such as tau that regulate the severing properties of p60-katanin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsDVWe6cKEtbVg90H21EOLACvtfcHk0ljprOQ116ndAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemtLs%253D&md5=af4798f7192e067c0f75d771933dd336</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E07-09-0878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E07-09-0878%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DSolowska%26aufirst%3DJ.%2BM.%26aulast%3DKarabay%26aufirst%3DA.%26aulast%3DKorulu%26aufirst%3DS.%26aulast%3DBaas%26aufirst%3DP.%2BW.%26atitle%3DThe%2520microtubule-severing%2520proteins%2520spastin%2520and%2520katanin%2520participate%2520differently%2520in%2520the%2520formation%2520of%2520axonal%2520branches%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26spage%3D1485%26epage%3D1498%26doi%3D10.1091%2Fmbc.E07-09-0878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Liu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, J. P.</span><span> </span><span class="NLM_article-title">Tubulin inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1517/13543776.2014.859247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1517%2F13543776.2014.859247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=24313741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSlurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=69-88&author=Y.+M.+Liuauthor=H.+L.+Chenauthor=H.+Y.+Leeauthor=J.+P.+Liou&title=Tubulin+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2014.859247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tubulin inhibitors: a patent review</span></div><div class="casAuthors">Liu, Yi-Min; Chen, Hsiao-Ling; Lee, Hsueh-Yun; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-88</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Microtubules play an important role in several cellular processes, particularly in the formation of the mitotic spindle during the process of mitosis.  These highly dynamic mitotic-spindle microtubules have become a successful target of cancer therapy.  Microtubule-targeting agents, such as vinca alkaloids and taxanes, were used in clinic over 50 years.  In past decades, development of new antimicrotubule agents that possess different structure and binding sites of tubulin has shown potent activity against the proliferation of various cancer cells, as well as in multidrug-resistant cancers.  Interestingly, many of these agents represent an attractive ability that targeting the tumor blood vessels results in tumor vascular disruption.  Therefore, exploring new agents and strategies may provide more effective therapeutic options in the related treatment of cancer.  Areas covered: In past few years, there are many chem. compds. that successfully interferes the microtubules and display antitumor effect.  In these, published compds. supply the fresh minds in modification of present drugs and new insights into the development of tubulin inhibitors.  Expert opinion: This article arranges the microtubule-targeting agents that have published in patent in recent years.  It may help in the investigation of new tubulin binding site and development of novel drug candidate in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtnvpvVK8NmrVg90H21EOLACvtfcHk0ljprOQ116ndAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSlurvP&md5=e17a15b0f0538911f2a80035edbf89b7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.859247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.859247%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DChen%26aufirst%3DH.%2BL.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DLiou%26aufirst%3DJ.%2BP.%26atitle%3DTubulin%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D69%26epage%3D88%26doi%3D10.1517%2F13543776.2014.859247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gascoigne, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">How do anti-mitotic drugs kill cancer cells?</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2585</span><span class="refDoi"> DOI: 10.1242/jcs.039719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1242%2Fjcs.039719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19625502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGhsL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=2579-2585&author=K.+E.+Gascoigneauthor=S.+S.+Taylor&title=How+do+anti-mitotic+drugs+kill+cancer+cells%3F&doi=10.1242%2Fjcs.039719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">How do anti-mitotic drugs kill cancer cells?</span></div><div class="casAuthors">Gascoigne, Karen E.; Taylor, Stephen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2579-2585</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2007, over 12-million people were diagnosed with cancer.  According to the American Cancer Society, at least one third of these individuals are not expected to survive the disease, making cancer the second most prevalent cause of death worldwide.  Systemic chemotherapy forms the mainstay of cancer treatment, and agents that disrupt mitotic spindle assembly - so called 'anti-mitotics' - are commonly used to treat a wide variety of cancers.  Traditional anti-mitotic agents include the microtubule toxins such as taxol, other taxanes and the vinca alkaloids, all of which have proven successful in the clinic.  However, patient response remains highly unpredictable, and drug resistance is common.  In addn., toxicity is a problem.  To address these limitations, a new generation of anti-mitotic drugs is being developed.  As the first wave of these new agents enters clin. trails, much hope rests on their outcome.  Meanwhile, significant attention is being focused on trying to predict which tumor types are likely to respond.  In this commentary, the authors outline recent advances in our understanding of how cancer cells respond to anti-mitotic drugs, and discuss the relevance of these studies to their use in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlOxbKmqBe5bVg90H21EOLACvtfcHk0lhQbvtsftw6QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGhsL7F&md5=76a39836b4f069883cc6a4400e7edd92</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1242%2Fjcs.039719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.039719%26sid%3Dliteratum%253Aachs%26aulast%3DGascoigne%26aufirst%3DK.%2BE.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DHow%2520do%2520anti-mitotic%2520drugs%2520kill%2520cancer%2520cells%253F%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2009%26volume%3D122%26spage%3D2579%26epage%3D2585%26doi%3D10.1242%2Fjcs.039719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Urra, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordova-Delgado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessoa-Mahana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez-Rodríguez, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss-Lopez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araya-Maturana, R.</span><span> </span><span class="NLM_article-title">Mitochondria: a promising target for anticancer alkaloids</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2171</span><span class="NLM_x">–</span> <span class="NLM_lpage">2183</span><span class="refDoi"> DOI: 10.2174/15680266113139990150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.2174%2F15680266113139990150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=23978135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyrsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=2171-2183&author=F.+A.+Urraauthor=M.+Cordova-Delgadoauthor=H.+Pessoa-Mahanaauthor=O.+Ram%C3%ADrez-Rodr%C3%ADguezauthor=B.+Weiss-Lopezauthor=J.+Ferreiraauthor=R.+Araya-Maturana&title=Mitochondria%3A+a+promising+target+for+anticancer+alkaloids&doi=10.2174%2F15680266113139990150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria: A Promising Target for Anticancer Alkaloids</span></div><div class="casAuthors">Urra, Felix A.; Cordova-Delgado, Miguel; Pessoa-Mahana, Hernan; Ramirez-Rodriguez, Oney; Weiss-Lopez, Boris; Ferreira, Jorge; Araya-Maturana, Ramiro</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2171-2183</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A great no. of alkaloids exhibit high potential in cancer research.  Some of them are anticancer drugs with well-defined clin. uses, exerting their action on microtubules dynamics or DNA replication and topol.  On the other hand, mitochondria have been recognized as an essential organelle in the establishment of tumor characteristics, esp. the resistance to cell death, high proliferative capacity and adaptation to unfavorable cellular environment.  Interestingly, many alkaloids exert their anticancer activities affecting selectively some functions of the tumor mitochondria by (1) modulating OXPHOS and ADP/ATP transport, (2) increasing ROS levels and mitochondrial potential dissipation by crosstalk between endoplasmic reticulum (ER) and mitochondria, (3) inducing mitochondria-dependent apoptosis and autophagy, (4) inhibiting mitochondrial metabolic pathways and (5) by alteration of the morphol. and biogenesis of this organelle.  These antecedents show the relevance of developing research about the effects of alkaloids on functions controlled by tumor mitochondria, offering an attractive target for the design of new alkaloid derivs., considering organelle-specific delivery strategies.  This review describes mitochondria as a central component in the anticancer action of a set of alkaloids, in a way to illustrate the importance of this organelle in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIsLKfm7FUMLVg90H21EOLACvtfcHk0lhQbvtsftw6QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyrsLzO&md5=b211a21ccdc5f901c36172d4cbd09525</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990150%26sid%3Dliteratum%253Aachs%26aulast%3DUrra%26aufirst%3DF.%2BA.%26aulast%3DCordova-Delgado%26aufirst%3DM.%26aulast%3DPessoa-Mahana%26aufirst%3DH.%26aulast%3DRam%25C3%25ADrez-Rodr%25C3%25ADguez%26aufirst%3DO.%26aulast%3DWeiss-Lopez%26aufirst%3DB.%26aulast%3DFerreira%26aufirst%3DJ.%26aulast%3DAraya-Maturana%26aufirst%3DR.%26atitle%3DMitochondria%253A%2520a%2520promising%2520target%2520for%2520anticancer%2520alkaloids%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D2171%26epage%3D2183%26doi%3D10.2174%2F15680266113139990150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span> </span><span class="NLM_article-title">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1038/nrm3722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrm3722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=24355989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=49-63&author=P.+E.+Czabotarauthor=G.+Lesseneauthor=A.+Strasserauthor=J.+M.+Adams&title=Control+of+apoptosis+by+the+BCL-2+protein+family%3A+implications+for+physiology+and+therapy&doi=10.1038%2Fnrm3722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy</span></div><div class="casAuthors">Czabotar, Peter E.; Lessene, Guillaume; Strasser, Andreas; Adams, Jerry M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-63</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The BCL-2 protein family dets. the commitment of cells to apoptosis, an ancient cell suicide program that is essential for development, tissue homeostasis and immunity.  Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischemic conditions and drive neurodegeneration.  We discuss the biochem., structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold.  These mechanistic insights into the functions of the BCL-2 family are illuminating the physiol. control of apoptosis, the pathol. consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVpm2heUGBbVg90H21EOLACvtfcHk0lhQbvtsftw6QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOjsbvI&md5=c18d528c2819c2df93b6798e62132372</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrm3722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3722%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DControl%2520of%2520apoptosis%2520by%2520the%2520BCL-2%2520protein%2520family%253A%2520implications%2520for%2520physiology%2520and%2520therapy%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D49%26epage%3D63%26doi%3D10.1038%2Fnrm3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D. C.</span><span> </span><span class="NLM_article-title">CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents</span> <span class="citation_source-journal">Cell Biol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1002/cbin.10259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fcbin.10259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=24677263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslylur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=737-746&author=L.+Zhouauthor=X.+Caiauthor=X.+Hanauthor=N.+Xuauthor=D.+C.+Chang&title=CDK1+switches+mitotic+arrest+to+apoptosis+by+phosphorylating+Bcl-2%2FBax+family+proteins+during+treatment+with+microtubule+interfering+agents&doi=10.1002%2Fcbin.10259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents</span></div><div class="casAuthors">Zhou, Lingli; Cai, Xiaoling; Han, Xueyao; Xu, Naihan; Chang, Donald C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-746</span>CODEN:
                <span class="NLM_cas:coden">CBIIEV</span>;
        ISSN:<span class="NLM_cas:issn">1065-6995</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Microtubule interfering agents (MIAs), that can stabilize or depolymerise microtubules, are an important class of cancer chemotherapeutic drugs.  They can lead to mitotic arrest and subsequent apoptosis.  We demonstrate that cell cycle-dependent kinase 1 (CDK1) is important in switching cells from mitotic arrest to apoptosis during MIAs treatment.  Overexpression of non-degradable cyclin B1 sustained CDK1 activation and mitotic arrest, followed by caspase-3 dependent apoptosis.  CDK1 is responsible for the phosphorylation of several pro- and anti-apoptotic Bcl-2 family proteins during MIAs treatment.  CDK1-mediated Bcl-2 serine 70 phosphorylation enhances its pro-apoptotic function, whereas CDK1-mediated Bad serine 128 phosphorylation promotes apoptosis.  Blockage of CDK1 activity with a specific pharmacol. inhibitor suppresses Mcl-1 phosphorylation, degrdn. and its anti-apoptotic function.  Therefore, the death of cancer cells under MIAs treatment was caused by imbalance between CDK1-induced alterations in the pro-apoptotic and anti-apoptotic functions of phosphorylated Bcl-2 family proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYHxMEXY9tubVg90H21EOLACvtfcHk0li153t4U5IFDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslylur4%253D&md5=a1b1be983d9be232cb5d466d9501eddb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbin.10259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbin.10259%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DChang%26aufirst%3DD.%2BC.%26atitle%3DCDK1%2520switches%2520mitotic%2520arrest%2520to%2520apoptosis%2520by%2520phosphorylating%2520Bcl-2%252FBax%2520family%2520proteins%2520during%2520treatment%2520with%2520microtubule%2520interfering%2520agents%26jtitle%3DCell%2520Biol.%2520Int.%26date%3D2014%26volume%3D38%26spage%3D737%26epage%3D746%26doi%3D10.1002%2Fcbin.10259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, B.</span><span> </span><span class="NLM_article-title">Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span><span class="refDoi"> DOI: 10.4161/auto.6788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.4161%2Fauto.6788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=18769111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12rurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=949-951&author=Y.+Weiauthor=S.+Sinhaauthor=B.+Levine&title=Dual+role+of+JNK1-mediated+phosphorylation+of+Bcl-2+in+autophagy+and+apoptosis+regulation&doi=10.4161%2Fauto.6788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation</span></div><div class="casAuthors">Wei, Yongjie; Sinha, Sangita; Levine, Beth</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">949-951</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Autophagy and apoptosis are fundamental cellular pathways that are both regulated by JNK-mediated Bcl-2 phosphorylation.  Several years ago, JNK-mediated Bcl-2 phosphorylation was shown to interfere with its binding to proapoptotic BH3 domain-contg. proteins such as Bax and recently, our lab. demonstrated that JNK1-mediated Bcl-2 phosphorylation interferes with its binding to the proautophagy BH3 domain-contg. protein Beclin 1.  Here, we examd. the kinetic relationship between Bcl-2 phosphorylation, Bcl-2-Beclin 1 interactions, Bcl-2-Bax interactions, and caspase 3 activation during nutrient starvation.  We found that after a short period of nutrient deprivation (4 h), a small amt. of Bcl-2 phosphorylation dissocs. Bcl-2 from the Bcl-2-Beclin 1 complex but not from the Bcl-2-Bax complex.  After 16 h of nutrient deprivation, Bcl-2 phosphorylation readies maximal levels, the Bcl-2-Bax complex is disrupted, and active caspase 3 is detected, indicating the initiation of apoptosis.  Based on this result, we propose a speculative model for understanding the interrelationship between autophagy and apoptosis regulated by JNK1-mediated Bcl-2 phosphorylation.  According to this model, rapid Bcl-2 phosphorylation may occur initially to promote cell survival by disrupting the Bcl-2-Beclin 1 complex and activating autophagy.  At a certain point when autophagy is no longer able to keep the cell alive, Bcl-2 phosphorylation might then serve to inactivate its antiapoptotic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCZBQajDxy7rVg90H21EOLACvtfcHk0li153t4U5IFDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12rurnM&md5=656cd9117b0f913ecab3b25146a50178</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4161%2Fauto.6788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.6788%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DY.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DLevine%26aufirst%3DB.%26atitle%3DDual%2520role%2520of%2520JNK1-mediated%2520phosphorylation%2520of%2520Bcl-2%2520in%2520autophagy%2520and%2520apoptosis%2520regulation%26jtitle%3DAutophagy%26date%3D2008%26volume%3D4%26spage%3D949%26epage%3D951%26doi%3D10.4161%2Fauto.6788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bogoyevitch, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobe, B.</span><span> </span><span class="NLM_article-title">Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases</span> <span class="citation_source-journal">Microbiol. Mol. Biol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1128/MMBR.00025-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1128%2FMMBR.00025-06" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1061-1095&author=M.+A.+Bogoyevitchauthor=B.+Kobe&title=Uses+for+JNK%3A+the+many+and+varied+substrates+of+the+c-Jun+N-terminal+kinases&doi=10.1128%2FMMBR.00025-06"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00025-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00025-06%26sid%3Dliteratum%253Aachs%26aulast%3DBogoyevitch%26aufirst%3DM.%2BA.%26aulast%3DKobe%26aufirst%3DB.%26atitle%3DUses%2520for%2520JNK%253A%2520the%2520many%2520and%2520varied%2520substrates%2520of%2520the%2520c-Jun%2520N-terminal%2520kinases%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2006%26volume%3D70%26spage%3D1061%26epage%3D1095%26doi%3D10.1128%2FMMBR.00025-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Chen, F.</span><span> </span><span class="NLM_article-title">JNK-induced apoptosis, compensatory growth, and cancer stem cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-1982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1158%2F0008-5472.CAN-11-1982" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=379-386&author=F.+Chen&title=JNK-induced+apoptosis%2C+compensatory+growth%2C+and+cancer+stem+cells&doi=10.1158%2F0008-5472.CAN-11-1982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-1982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-1982%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26atitle%3DJNK-induced%2520apoptosis%252C%2520compensatory%2520growth%252C%2520and%2520cancer%2520stem%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D379%26epage%3D386%26doi%3D10.1158%2F0008-5472.CAN-11-1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, D.</span><span> </span><span class="NLM_article-title">Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1194/jlr.M024398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1194%2Fjlr.M024398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=1093-1105&author=J.+Maauthor=L.+Zhangauthor=W.+Hanauthor=T.+Shenauthor=C.+Maauthor=Y.+Liuauthor=X.+Nieauthor=M.+Liuauthor=Y.+Ranauthor=D.+Zhu&title=Activation+of+JNK%2Fc-Jun+is+required+for+the+proliferation%2C+survival%2C+and+angiogenesis+induced+by+EET+in+pulmonary+artery+endothelial+cells&doi=10.1194%2Fjlr.M024398"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M024398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M024398%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNie%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DD.%26atitle%3DActivation%2520of%2520JNK%252Fc-Jun%2520is%2520required%2520for%2520the%2520proliferation%252C%2520survival%252C%2520and%2520angiogenesis%2520induced%2520by%2520EET%2520in%2520pulmonary%2520artery%2520endothelial%2520cells%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2012%26volume%3D53%26spage%3D1093%26epage%3D1105%26doi%3D10.1194%2Fjlr.M024398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Avisetti, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalivendi, S. V.</span><span> </span><span class="NLM_article-title">Activation of p38/JNK pathway is responsible for embelin induced apoptosis in lung cancer cells: transitional role of reactive oxygen species</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e87050</span><span class="refDoi"> DOI: 10.1371/journal.pone.0087050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1371%2Fjournal.pone.0087050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e87050&author=D.+R.+Avisettiauthor=K.+S.+Babuauthor=S.+V.+Kalivendi&title=Activation+of+p38%2FJNK+pathway+is+responsible+for+embelin+induced+apoptosis+in+lung+cancer+cells%3A+transitional+role+of+reactive+oxygen+species&doi=10.1371%2Fjournal.pone.0087050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0087050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0087050%26sid%3Dliteratum%253Aachs%26aulast%3DAvisetti%26aufirst%3DD.%2BR.%26aulast%3DBabu%26aufirst%3DK.%2BS.%26aulast%3DKalivendi%26aufirst%3DS.%2BV.%26atitle%3DActivation%2520of%2520p38%252FJNK%2520pathway%2520is%2520responsible%2520for%2520embelin%2520induced%2520apoptosis%2520in%2520lung%2520cancer%2520cells%253A%2520transitional%2520role%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De87050%26doi%3D10.1371%2Fjournal.pone.0087050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Deng, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. K.</span><span> </span><span class="NLM_article-title">Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling</span> <span class="citation_source-journal">Mol. Carcinog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1002/mc.20583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fmc.20583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19777565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFSjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=141-151&author=Y.+T.+Dengauthor=H.+C.+Huangauthor=J.+K.+Lin&title=Rotenone+induces+apoptosis+in+MCF-7+human+breast+cancer+cell-mediated+ROS+through+JNK+and+p38+signaling&doi=10.1002%2Fmc.20583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling</span></div><div class="casAuthors">Deng, Yea-Tzy; Huang, Hsiu-Chen; Lin, Jen-Kun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-151</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Rotenone is an inhibitor of the mitochondrial electron transport chain complex I, resulting in the generation of reactive oxygen species (ROS).  Rotenone has been shown to display anticancer activity through the induction of apoptosis in various cancer cells.  However, the underlying mechanism is still not fully understood.  Here, rotenone showed a strong growth inhibitory effect against human breast cancer MCF-7 cells.  DNA flow cytometric anal., chromatin condensation, and poly (ADP-ribose) polymerase (PARP) cleavage indicated rotenone actively induced apoptosis in MCF-7 cells.  The antiapoptotic protein, Bcl-2, was decreased, whereas the apoptotic protein, Bax, was increased in a time-dependent manner in rotenone-induced apoptosis.  Moreover, the treatment of rotenone in MCF-7 cells caused the activation of c-jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinases (MAPKs), and the inactivation of extracellular signal-regulated protein kinase 1/2 (ERK1/2).  The pharmacol. inhibition of JNK and p38 MAPK revealed significant protection against rotenone-induced apoptosis.  Taken together, these results indicate rotenone may induce apoptosis through ROS and JNK/p38 MAPKs activation in MCF-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzifnzoA1jzLVg90H21EOLACvtfcHk0lif5mRhjqLjJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFSjsro%253D&md5=9ae02acfd5ce1aa7b530a8f7343703ba</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fmc.20583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20583%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DY.%2BT.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DLin%26aufirst%3DJ.%2BK.%26atitle%3DRotenone%2520induces%2520apoptosis%2520in%2520MCF-7%2520human%2520breast%2520cancer%2520cell-mediated%2520ROS%2520through%2520JNK%2520and%2520p38%2520signaling%26jtitle%3DMol.%2520Carcinog.%26date%3D2010%26volume%3D49%26spage%3D141%26epage%3D151%26doi%3D10.1002%2Fmc.20583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kolomeichuk, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrano, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabapathy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, T. C.</span><span> </span><span class="NLM_article-title">Distinct signaling pathways of microtubule inhibitors--vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1889</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2008.06349.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1111%2Fj.1742-4658.2008.06349.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=1889-1899&author=S.+N.+Kolomeichukauthor=D.+T.+Terranoauthor=C.+S.+Lyleauthor=K.+Sabapathyauthor=T.+C.+Chambers&title=Distinct+signaling+pathways+of+microtubule+inhibitors%2D%2Dvinblastine+and+Taxol+induce+JNK-dependent+cell+death+but+through+AP-1-dependent+and+AP-1-independent+mechanisms%2C+respectively&doi=10.1111%2Fj.1742-4658.2008.06349.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2008.06349.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2008.06349.x%26sid%3Dliteratum%253Aachs%26aulast%3DKolomeichuk%26aufirst%3DS.%2BN.%26aulast%3DTerrano%26aufirst%3DD.%2BT.%26aulast%3DLyle%26aufirst%3DC.%2BS.%26aulast%3DSabapathy%26aufirst%3DK.%26aulast%3DChambers%26aufirst%3DT.%2BC.%26atitle%3DDistinct%2520signaling%2520pathways%2520of%2520microtubule%2520inhibitors--vinblastine%2520and%2520Taxol%2520induce%2520JNK-dependent%2520cell%2520death%2520but%2520through%2520AP-1-dependent%2520and%2520AP-1-independent%2520mechanisms%252C%2520respectively%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D1889%26epage%3D1899%26doi%3D10.1111%2Fj.1742-4658.2008.06349.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Choi, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanh, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, Q. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harikishore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanga, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharatham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, H. S.</span><span> </span><span class="NLM_article-title">Suprafenacine, an indazole-hydrazide agent, targets cancer cells through microtubule destabilization</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e110955</span><span class="refDoi"> DOI: 10.1371/journal.pone.0110955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1371%2Fjournal.pone.0110955" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e110955&author=B.+H.+Choiauthor=S.+Chattopadhayaauthor=L.+N.+Thanhauthor=L.+Fengauthor=Q.+T.+Nguyenauthor=C.+B.+Limauthor=A.+Harikishoreauthor=R.+P.+Nangaauthor=N.+Bharathamauthor=Y.+Zhaoauthor=X.+Liuauthor=H.+S.+Yoon&title=Suprafenacine%2C+an+indazole-hydrazide+agent%2C+targets+cancer+cells+through+microtubule+destabilization&doi=10.1371%2Fjournal.pone.0110955"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0110955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0110955%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DB.%2BH.%26aulast%3DChattopadhaya%26aufirst%3DS.%26aulast%3DThanh%26aufirst%3DL.%2BN.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DNguyen%26aufirst%3DQ.%2BT.%26aulast%3DLim%26aufirst%3DC.%2BB.%26aulast%3DHarikishore%26aufirst%3DA.%26aulast%3DNanga%26aufirst%3DR.%2BP.%26aulast%3DBharatham%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26atitle%3DSuprafenacine%252C%2520an%2520indazole-hydrazide%2520agent%252C%2520targets%2520cancer%2520cells%2520through%2520microtubule%2520destabilization%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De110955%26doi%3D10.1371%2Fjournal.pone.0110955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span> </span><span class="NLM_article-title">Microtubules as a target for anticancer drugs</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1038/nrc1317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrc1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=15057285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=253-265&author=M.+A.+Jordanauthor=L.+Wilson&title=Microtubules+as+a+target+for+anticancer+drugs&doi=10.1038%2Fnrc1317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules as a target for anticancer drugs</span></div><div class="casAuthors">Jordan, Mary Ann; Wilson, Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">253-265</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy.  Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass.  Although these effects might have a role in their chemotherapeutic actions, we now know that at lower concns., microtubule-targeted drugs can suppress microtubule dynamics without changing microtubule mass; this action leads to mitotic block and apoptosis.  In addn. to the expanding array of chem. diverse antimitotic agents, some microtubule-targeted drugs can act as vascular-targeting agents, rapidly depolymg. microtubules of newly formed vasculature to shut down the blood supply to tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJbrFnzwqjbVg90H21EOLACvtfcHk0lif5mRhjqLjJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gmt74%253D&md5=bbbf212e03ffe6763098fc41f21a8158</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrc1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1317%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMicrotubules%2520as%2520a%2520target%2520for%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D253%26epage%3D265%26doi%3D10.1038%2Fnrc1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Pasquier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavallaris, M.</span><span> </span><span class="NLM_article-title">Microtubules: a dynamic target in cancer therapy</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1002/iub.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1002%2Fiub.25" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=165-170&author=E.+Pasquierauthor=M.+Kavallaris&title=Microtubules%3A+a+dynamic+target+in+cancer+therapy&doi=10.1002%2Fiub.25"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fiub.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fiub.25%26sid%3Dliteratum%253Aachs%26aulast%3DPasquier%26aufirst%3DE.%26aulast%3DKavallaris%26aufirst%3DM.%26atitle%3DMicrotubules%253A%2520a%2520dynamic%2520target%2520in%2520cancer%2520therapy%26jtitle%3DIUBMB%2520Life%26date%3D2008%26volume%3D60%26spage%3D165%26epage%3D170%26doi%3D10.1002%2Fiub.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Roll-Mecak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, F. J.</span><span> </span><span class="NLM_article-title">Microtubule-severing enzymes</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span><span class="refDoi"> DOI: 10.1016/j.ceb.2009.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2Fj.ceb.2009.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19963362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslWqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=96-103&author=A.+Roll-Mecakauthor=F.+J.+McNally&title=Microtubule-severing+enzymes&doi=10.1016%2Fj.ceb.2009.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-severing enzymes</span></div><div class="casAuthors">Roll-Mecak, Antonina; McNally, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-103</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In 1993, an enzyme with an ATP-dependent microtubule-severing activity was purified from sea urchin eggs and named katanin, after the Japanese word for sword.  It is now known that katanin, spastin, and fidgetin form a family of closely related microtubule-severing enzymes that is widely distributed in eukaryotes ranging from Tetrahymena and Chlamydomonas to humans.  Here, the authors review the diverse in vivo functions of these proteins and the recent significant advances in deciphering the biophys. mechanism of microtubule severing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0R3Af87sWTLVg90H21EOLACvtfcHk0li7FBH3u4XRSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslWqtr0%253D&md5=988b74105af4271c3bf529e513153e9c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DRoll-Mecak%26aufirst%3DA.%26aulast%3DMcNally%26aufirst%3DF.%2BJ.%26atitle%3DMicrotubule-severing%2520enzymes%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2010%26volume%3D22%26spage%3D96%26epage%3D103%26doi%3D10.1016%2Fj.ceb.2009.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Ahmad, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baas, P. W.</span><span> </span><span class="NLM_article-title">An essential role for katanin in severing microtubules in the neuron</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1083/jcb.145.2.305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1083%2Fjcb.145.2.305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1999&pages=305-315&author=F.+J.+Ahmadauthor=W.+Yuauthor=F.+J.+McNallyauthor=P.+W.+Baas&title=An+essential+role+for+katanin+in+severing+microtubules+in+the+neuron&doi=10.1083%2Fjcb.145.2.305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1083%2Fjcb.145.2.305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.145.2.305%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DF.%2BJ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMcNally%26aufirst%3DF.%2BJ.%26aulast%3DBaas%26aufirst%3DP.%2BW.%26atitle%3DAn%2520essential%2520role%2520for%2520katanin%2520in%2520severing%2520microtubules%2520in%2520the%2520neuron%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1999%26volume%3D145%26spage%3D305%26epage%3D315%26doi%3D10.1083%2Fjcb.145.2.305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Sudo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baas, P. W.</span><span> </span><span class="NLM_article-title">Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">7215</span><span class="NLM_x">–</span> <span class="NLM_lpage">7226</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0048-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1523%2FJNEUROSCI.0048-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=20505088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVOis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=7215-7226&author=H.+Sudoauthor=P.+W.+Baas&title=Acetylation+of+microtubules+influences+their+sensitivity+to+severing+by+katanin+in+neurons+and+fibroblasts&doi=10.1523%2FJNEUROSCI.0048-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts</span></div><div class="casAuthors">Sudo, Haruka; Baas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7215-7226</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Here we investigated whether the sensitivity of microtubules to severing by katanin is regulated by acetylation of the microtubules.  During interphase, fibroblasts display long microtubules with discrete regions rich in acetylated tubulin.  Overexpression of katanin for short periods of time produced breaks preferentially in these regions.  In fibroblasts with exptl. enhanced or diminished microtubule acetylation, the sensitivity of the microtubules to severing by katanin was increased or decreased, resp.  In neurons, microtubules are notably more acetylated in axons than in dendrites.  Exptl. manipulation of microtubule acetylation in neurons yielded similar results on dendrites as obsd. on fibroblasts.  However, under these exptl. conditions, axonal microtubules microtubule were not appreciably altered with regard to their sensitivity to katanin.  We hypothesized that this may be attributable to the effects of tau on the axonal microtubules, and this was validated by studies in which overexpression of tau caused microtubules in dendrites and fibroblasts to be more resistant to severing by katanin in a manner that was not dependent on the acetylation state of the microtubules.  Interestingly, none of these various findings apply to spastin, because the severing of microtubules by spastin does not appear to be strongly influenced by either the acetylation state of the microtubules or tau.  We conclude that sensitivity to microtubule severing by katanin is regulated by a balance of factors, including the acetylation state of the microtubules and te binding of tau to the microtubules.  In the neuron, this contributes to regional differences in the microtubule arrays of axons and dendrites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6G5g-v-rY7Vg90H21EOLACvtfcHk0li7FBH3u4XRSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVOis7g%253D&md5=b0529df3f92697ce80c4ff1cce1e4857</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0048-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0048-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DSudo%26aufirst%3DH.%26aulast%3DBaas%26aufirst%3DP.%2BW.%26atitle%3DAcetylation%2520of%2520microtubules%2520influences%2520their%2520sensitivity%2520to%2520severing%2520by%2520katanin%2520in%2520neurons%2520and%2520fibroblasts%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D7215%26epage%3D7226%26doi%3D10.1523%2FJNEUROSCI.0048-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Shiina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">Microtubule-severing activity in M phase</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1016/S0962-8924(00)89040-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1016%2FS0962-8924%2800%2989040-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=14732113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADyaK2MXntValtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=283-286&author=N.+Shiinaauthor=Y.+Gotohauthor=E.+Nishida&title=Microtubule-severing+activity+in+M+phase&doi=10.1016%2FS0962-8924%2800%2989040-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-severing activity in M phase</span></div><div class="casAuthors">Shiina, Nobuyuki; Gotoh, Yukiko; Nishida, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">283-6</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    </div><div class="casAbstract">A review, with 41 refs.  The stable cytoplasmic microtubules that emanate from centrosomes in eukaryotic cells disappear at the onset of M phase and are replaced by the dynamic microtubules of the mitotic spindle.  Microtubule-severing activity increases significantly under the control of maturation-promoting factor at the transition between G2 phase and M phase, and is thought to be involved in the microtubule reorganization.  This review highlights three microtubule-severing factors that may be responsible for microtubule-severing activity in M phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUPxeA16nMVLVg90H21EOLACvtfcHk0li7FBH3u4XRSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntValtbw%253D&md5=daf597cca84e50bd711d3e9f1dac2ab4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2800%2989040-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252800%252989040-6%26sid%3Dliteratum%253Aachs%26aulast%3DShiina%26aufirst%3DN.%26aulast%3DGotoh%26aufirst%3DY.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DMicrotubule-severing%2520activity%2520in%2520M%2520phase%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1995%26volume%3D5%26spage%3D283%26epage%3D286%26doi%3D10.1016%2FS0962-8924%2800%2989040-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">McNally, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audhya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oegema, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, F. J.</span><span> </span><span class="NLM_article-title">Katanin controls mitotic and meiotic spindle length</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1083/jcb.200608117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1083%2Fjcb.200608117" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2006&pages=881-891&author=K.+McNallyauthor=A.+Audhyaauthor=K.+Oegemaauthor=F.+J.+McNally&title=Katanin+controls+mitotic+and+meiotic+spindle+length&doi=10.1083%2Fjcb.200608117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200608117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200608117%26sid%3Dliteratum%253Aachs%26aulast%3DMcNally%26aufirst%3DK.%26aulast%3DAudhya%26aufirst%3DA.%26aulast%3DOegema%26aufirst%3DK.%26aulast%3DMcNally%26aufirst%3DF.%2BJ.%26atitle%3DKatanin%2520controls%2520mitotic%2520and%2520meiotic%2520spindle%2520length%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2006%26volume%3D175%26spage%3D881%26epage%3D891%26doi%3D10.1083%2Fjcb.200608117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Maddika, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span> </span><span class="NLM_article-title">Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1038/ncb1848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fncb1848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19287380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVynu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=409-419&author=S.+Maddikaauthor=J.+Chen&title=Protein+kinase+DYRK2+is+a+scaffold+that+facilitates+assembly+of+an+E3+ligase&doi=10.1038%2Fncb1848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase</span></div><div class="casAuthors">Maddika, Subbareddy; Chen, Junjie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-419</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein kinases have central functions in various cellular signal transduction pathways through their substrate phosphorylation.  Here we show that a protein kinase, DYRK2, has unexpected role as a scaffold for an E3 ubiquitin ligase complex.  DYRK2 assocs. with an E3 ligase complex contg. EDD, DDB1, and VPRBP proteins (EDVP complex).  Strikingly, DYRK2 serves as a scaffold for the EDVP complex, because small-interfering-RNA-mediated depletion of DYRK2 disrupts the formation of the EDD-DDB1-VPRBP complex.  Although the kinase activity of DYRK2 is dispensable for its ability to mediate EDVP complex formation, it is required for the phosphorylation and subsequent degrdn. of its downstream substrate, katanin p60.  Collectively, our results reveal a new type of E3-ubiquitin ligase complex in humans that depends on a protein kinase for complex formation as well as for the subsequent phosphorylation, ubiquitylation, and degrdn. of their substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrplBXU0xLBhbVg90H21EOLACvtfcHk0ljMO3EjhkKxtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVynu7g%253D&md5=a57e254a3a24d2bfd50e19ea78aba6e8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fncb1848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1848%26sid%3Dliteratum%253Aachs%26aulast%3DMaddika%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DProtein%2520kinase%2520DYRK2%2520is%2520a%2520scaffold%2520that%2520facilitates%2520assembly%2520of%2520an%2520E3%2520ligase%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2009%26volume%3D11%26spage%3D409%26epage%3D419%26doi%3D10.1038%2Fncb1848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Toyo-Oka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuoka, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muramatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraiwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynshaw-Boris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirotsune, S.</span><span> </span><span class="NLM_article-title">Recruitment of katanin p60 by phosphorylated NDEL1, an LIS1 interacting protein, is essential for mitotic cell division and neuronal migration</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3113</span><span class="NLM_x">–</span> <span class="NLM_lpage">3128</span><span class="refDoi"> DOI: 10.1093/hmg/ddi339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1093%2Fhmg%2Fddi339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=16203747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=3113-3128&author=K.+Toyo-Okaauthor=S.+Sasakiauthor=Y.+Yanoauthor=D.+Moriauthor=T.+Kobayashiauthor=Y.+Y.+Toyoshimaauthor=S.+M.+Tokuokaauthor=S.+Ishiiauthor=T.+Shimizuauthor=M.+Muramatsuauthor=N.+Hiraiwaauthor=A.+Yoshikiauthor=A.+Wynshaw-Borisauthor=S.+Hirotsune&title=Recruitment+of+katanin+p60+by+phosphorylated+NDEL1%2C+an+LIS1+interacting+protein%2C+is+essential+for+mitotic+cell+division+and+neuronal+migration&doi=10.1093%2Fhmg%2Fddi339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Recruitment of katanin p60 by phosphorylated NDEL1, an LIS1 interacting protein, is essential for mitotic cell division and neuronal migration</span></div><div class="casAuthors">Toyo-Oka, Kazuhito; Sasaki, Shinji; Yano, Yoshihisa; Mori, Daisuke; Kobayashi, Takuya; Toyoshima, Yoko Y.; Tokuoka, Suzumi M.; Ishii, Satoshi; Shimizu, Takao; Muramatsu, Masami; Hiraiwa, Noriko; Yoshiki, Atsushi; Wynshaw-Boris, Anthony; Hirotsune, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3113-3128</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">LIS1 is mutated in the human neuronal migration defect lissencephaly and along with NDEL1 (formerly NUDEL) participates in the regulation of cytoplasmic dynein function during neuronal development.  Targeted disruption of Ndel1 suggested that NDEL1 could have other mol. targets that regulate microtubule organization for proper neuronal migration.  To further understanding the mol. mechanism of LIS1 and lissencephaly, we identified the katanin p60 microtubule-severing protein as an addnl. mol. target of NDEL1.  We demonstrate that phosphorylation of NDEL1 by Cdk5 facilitates interaction between NDEL1 and p60, suggesting that P-NDEL1 regulates the distribution of katanin p60.  Abnormal accumulation of p60 in nucleus of Ndel1 null mutants supports an essential role of NDEL1 in p60 regulation.  Complete loss of NDEL1 or expression of dominant neg. mutants of p60 in migrating neurons results in defective migration and elongation of nuclear-centrosomal distance.  Our results suggest that NDEL1 is essential for mitotic cell division and neuronal migration not only via regulation of cytoplasmic dynein function but also by modulation of katanin p60 localization and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoet3lb5au2DbVg90H21EOLACvtfcHk0ljMO3EjhkKxtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCjtL7E&md5=5d1e4532bf17204b3e66d006cef9c814</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddi339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddi339%26sid%3Dliteratum%253Aachs%26aulast%3DToyo-Oka%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DYano%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DD.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DToyoshima%26aufirst%3DY.%2BY.%26aulast%3DTokuoka%26aufirst%3DS.%2BM.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DMuramatsu%26aufirst%3DM.%26aulast%3DHiraiwa%26aufirst%3DN.%26aulast%3DYoshiki%26aufirst%3DA.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DHirotsune%26aufirst%3DS.%26atitle%3DRecruitment%2520of%2520katanin%2520p60%2520by%2520phosphorylated%2520NDEL1%252C%2520an%2520LIS1%2520interacting%2520protein%252C%2520is%2520essential%2520for%2520mitotic%2520cell%2520division%2520and%2520neuronal%2520migration%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2005%26volume%3D14%26spage%3D3113%26epage%3D3128%26doi%3D10.1093%2Fhmg%2Fddi339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Toyo-oka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraiwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muramatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynshaw-Boris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirotsune, S.</span><span> </span><span class="NLM_article-title">Protein phosphatase 4 catalytic subunit regulates Cdk1 activity and microtubule organization via NDEL1 dephosphorylation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1147</span><span class="refDoi"> DOI: 10.1083/jcb.200705148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1083%2Fjcb.200705148" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=1133-1147&author=K.+Toyo-okaauthor=D.+Moriauthor=Y.+Yanoauthor=M.+Shiotaauthor=H.+Iwaoauthor=H.+Gotoauthor=M.+Inagakiauthor=N.+Hiraiwaauthor=M.+Muramatsuauthor=A.+Wynshaw-Borisauthor=A.+Yoshikiauthor=S.+Hirotsune&title=Protein+phosphatase+4+catalytic+subunit+regulates+Cdk1+activity+and+microtubule+organization+via+NDEL1+dephosphorylation&doi=10.1083%2Fjcb.200705148"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200705148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200705148%26sid%3Dliteratum%253Aachs%26aulast%3DToyo-oka%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DD.%26aulast%3DYano%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DM.%26aulast%3DIwao%26aufirst%3DH.%26aulast%3DGoto%26aufirst%3DH.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DHiraiwa%26aufirst%3DN.%26aulast%3DMuramatsu%26aufirst%3DM.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DYoshiki%26aufirst%3DA.%26aulast%3DHirotsune%26aufirst%3DS.%26atitle%3DProtein%2520phosphatase%25204%2520catalytic%2520subunit%2520regulates%2520Cdk1%2520activity%2520and%2520microtubule%2520organization%2520via%2520NDEL1%2520dephosphorylation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D1133%26epage%3D1147%26doi%3D10.1083%2Fjcb.200705148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Dumontet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. A.</span><span> </span><span class="NLM_article-title">Microtubule-binding agents: a dynamic field of cancer therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.1038/nrd3253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrd3253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=20885410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1akur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=790-803&author=C.+Dumontetauthor=M.+A.+Jordan&title=Microtubule-binding+agents%3A+a+dynamic+field+of+cancer+therapeutics&doi=10.1038%2Fnrd3253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-binding agents: a dynamic field of cancer therapeutics</span></div><div class="casAuthors">Dumontet, Charles; Jordan, Mary Ann</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">790-803</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Microtubules are dynamic filamentous cytoskeletal proteins composed of tubulin and are an important therapeutic target in tumor cells.  Agents that bind to microtubules have been part of the pharmacopoeia of anticancer therapy for decades and until the advent of targeted therapy, microtubules were the only alternative to DNA as a therapeutic target in cancer.  The screening of a range of botanical species and marine organisms has yielded promising new antitubulin agents with novel properties.  In the current search for novel microtubule-binding agents, enhanced tumor specificity, reduced neurotoxicity and insensitivity to chemoresistance mechanisms are the three main objectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ43DyXjdN7rVg90H21EOLACvtfcHk0li1u7UOYA4wvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1akur%252FI&md5=9fc6fd966859785605936ecbe6dca44e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnrd3253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3253%26sid%3Dliteratum%253Aachs%26aulast%3DDumontet%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26atitle%3DMicrotubule-binding%2520agents%253A%2520a%2520dynamic%2520field%2520of%2520cancer%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D790%26epage%3D803%26doi%3D10.1038%2Fnrd3253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kavallaris, M.</span><span> </span><span class="NLM_article-title">Microtubules and resistance to tubulin-binding agents</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1038/nrc2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1038%2Fnrc2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=20147901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVKrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=194-204&author=M.+Kavallaris&title=Microtubules+and+resistance+to+tubulin-binding+agents&doi=10.1038%2Fnrc2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubules and resistance to tubulin-binding agents</span></div><div class="casAuthors">Kavallaris, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-204</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Microtubules are dynamic structures composed of α-β-tubulin heterodimers that are essential in cell division and are important targets for cancer drugs.  Mutations in β-tubulin that affect microtubule polymer mass and/or drug binding are assocd. with resistance to tubulin-binding agents such as paclitaxel.  The aberrant expression of specific β-tubulin isotypes, in particular βIII-tubulin, or of microtubule-regulating proteins is important clin. in tumor aggressiveness and resistance to chemotherapy.  In addn., changes in actin regulation can also mediate resistance to tubulin-binding agents.  Understanding the mol. mechanisms that mediate resistance to tubulin-binding agents will be vital to improve the efficacy of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNkoVu03ikmrVg90H21EOLACvtfcHk0li1u7UOYA4wvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVKrtbg%253D&md5=1ce71cc537091459d7ee6866c0950b33</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnrc2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2803%26sid%3Dliteratum%253Aachs%26aulast%3DKavallaris%26aufirst%3DM.%26atitle%3DMicrotubules%2520and%2520resistance%2520to%2520tubulin-binding%2520agents%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D194%26epage%3D204%26doi%3D10.1038%2Fnrc2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Huzil, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurgan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuszynski, J. A.</span><span> </span><span class="NLM_article-title">The roles of beta-tubulin mutations and isotype expression in acquired drug resistance</span> <span class="citation_source-journal">Cancer Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=19455242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1emsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=159-181&author=J.+T.+Huzilauthor=K.+Chenauthor=L.+Kurganauthor=J.+A.+Tuszynski&title=The+roles+of+beta-tubulin+mutations+and+isotype+expression+in+acquired+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The roles of β-tubulin mutations and isotype expression in acquired drug resistance</span></div><div class="casAuthors">Huzil, J. Torin; Chen, Ke; Kurgan, Lukasz; Tuszynski, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Informatics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-181</span>CODEN:
                <span class="NLM_cas:coden">CIANCJ</span>;
        ISSN:<span class="NLM_cas:issn">1176-9351</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica Ltd.</span>)
        </div><div class="casAbstract">A review.  The antitumor drug paclitaxel stabilizes microtubules and reduces their dynamicity, promoting mitotic arrest and eventually apoptosis.  Upon assembly of the α/β-tubulin heterodimer, GTP becomes bound to both the α and β-tubulin monomers.  During microtubule assembly, the GTP bound to β-tubulin is hydrolyzed to GDP, eventually reaching steady-state equil. between free tubulin dimers and those polymd. into microtubules.  Tubulin-binding drugs such as paclitaxel interact with β-tubulin, resulting in the disruption of this equil.  In spite of several crystal structures of tubulin, there is little biochem. insight into the mechanism by which anti-tubulin drugs target microtubules and alter their normal behavior.  The mechanism of drug action is further complicated, as the description of altered β-tubulin isotype expression and/or mutations in tubulin genes may lead to drug resistance as has been described in the literature.  Because of the relationship between β-tubulin isotype expression and mutations within β-tubulin, both leading to resistance, we examd. the properties of altered residues within the taxane, colchicine and Vinca binding sites.  The amt. of data now available, allows us to investigate common patterns that lead to microtubule disruption and may provide a guide to the rational design of novel compds. that can inhibit microtubule dynamics for specific tubulin isotypes or, indeed resistant cell lines.  Because of the vast amt. of data published to date, we will only provide a broad overview of the mutational results and how these correlate with differences between tubulin isotypes.  We also note that clin. studies describe a no. of predictive factors for the response to anti-tubulin drugs and attempt to develop an understanding of the features within tubulin that may help explain how they may affect both microtubule assembly and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeAbT02MpM3bVg90H21EOLACvtfcHk0li1u7UOYA4wvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1emsw%253D%253D&md5=e3294e203384c130a611f2bf539a724d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuzil%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKurgan%26aufirst%3DL.%26aulast%3DTuszynski%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520roles%2520of%2520beta-tubulin%2520mutations%2520and%2520isotype%2520expression%2520in%2520acquired%2520drug%2520resistance%26jtitle%3DCancer%2520Inf.%26date%3D2007%26volume%3D3%26spage%3D159%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Chu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyu, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span> </span><span class="NLM_article-title">Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1165/ajrcmb.17.3.2837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=10.1165%2Fajrcmb.17.3.2837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=9308922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVOrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=353-360&author=Y.+W.+Chuauthor=P.+C.+Yangauthor=S.+C.+Yangauthor=Y.+C.+Shyuauthor=M.+J.+Hendrixauthor=R.+Wuauthor=C.+W.+Wu&title=Selection+of+invasive+and+metastatic+subpopulations+from+a+human+lung+adenocarcinoma+cell+line&doi=10.1165%2Fajrcmb.17.3.2837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line</span></div><div class="casAuthors">Chu, Yi-Wen; Yang, Pan-Chyr; Yang, Shuenn-Chen; Shyu, Yu-Chiau; Hendrix, Mary J. C.; Wu, Reen; Wu, Cheng-Wen</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-360</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Lung Association</span>)
        </div><div class="casAbstract">To better understand the mechanism(s) underlying lung cancer invasion and metastasis, a Transwell invasion chamber was used to select progressively more invasive cancer cell populations from a clonal cell line of human lung adenocarcinoma, CL1.  Five sublines with progressive invasiveness, designated CL1-1, CL1-2, CL1-3, CL1-4, and CL1-5, were obtained through this in vitro selection process.  Their invasive abilities through basement membrane matrix showed a 4-6-fold increase over that of the parental cells.  Moreover, the sublines manifested an increase in their colony-forming ability on soft agar, tumorigenicity, and metastatic potency in severe combined immunodeficiency (SCID) mice.  Examg. the phenotypes of the cell lines revealed increased expression of 92-kDa gelatinase and an increase in the cell population stained with anti-keratin-8 and -18 antibodies.  Clonal isolation of anti-keratin-18-antibody-pos. and -neg. cell populations demonstrated a correlated enhancement of the invasiveness of these cells and their expression of keratin-18.  Thus, the metastatic behavior of lung cancer cells can be characterized with this in vitro system, and the properties of these progressively invasive cancer cells can be clonally studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqf3X5hlC0wLVg90H21EOLACvtfcHk0ljqqX2ovZ7yXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVOrs7c%253D&md5=d5ea3f2aa0517622c6e6026663cc1a03</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.17.3.2837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.17.3.2837%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DY.%2BW.%26aulast%3DYang%26aufirst%3DP.%2BC.%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DShyu%26aufirst%3DY.%2BC.%26aulast%3DHendrix%26aufirst%3DM.%2BJ.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DC.%2BW.%26atitle%3DSelection%2520of%2520invasive%2520and%2520metastatic%2520subpopulations%2520from%2520a%2520human%2520lung%2520adenocarcinoma%2520cell%2520line%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1997%26volume%3D17%26spage%3D353%26epage%3D360%26doi%3D10.1165%2Fajrcmb.17.3.2837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CF1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CF1','PDB','3CF1'); return false;">PDB: 3CF1</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00797">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82622"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00797">10.1021/acs.jmedchem.6b00797</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional figures illustrating the body weights and biochemical markers of test mice in anticancer experiments, the procedure of the pharmacophore and organization modeling of <b>5a</b> with the katanin p60 subunit, synthetic procedures and compound characterization, and <sup>1</sup>H and <sup>13</sup>C spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Compound p60–<b>5a</b> mode 1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Compound p60–<b>5a</b> mode 2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Molecular strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_005.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_001.pdf">jm6b00797_si_001.pdf (1.75 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_003.pdb">jm6b00797_si_003.pdb (8.84 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_004.pdb">jm6b00797_si_004.pdb (7.21 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00797/suppl_file/jm6b00797_si_005.csv">jm6b00797_si_005.csv (1.05 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00797&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00797%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-18" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00797" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677abcb6de1e3db2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
